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ABSTRACT 
Cyanobacterial symbionts of Indo-Pacific marine sponges, e.g. Dysidea sp., produce 
hydroxylated (OH-) polybrominated diphenyl ethers (PDBEs) which likely function as chemical 
deterrents owing to their antifungal and antibacterial properties. Limiting the therapeutic 
potential and agricultural use of these antimicrobial natural products are the negative 
connotations associated with non-hydroxylated anthropogenic PBDEs. Anthropogenic PBDEs 
are pervasive global pollutants used as flame retardant additives in many household goods, e.g. 
furniture, textiles, and electronics. These molecules have a propensity to bioaccumulate in living 
organisms, they easily traverse the trophic food-chains, they are readily passed from mother to 
offspring, and many of these compounds are known endocrine disruptors. Bioisosteric 
replacements within the OH-PBDE chemical structure represent an attractive synthetic chemistry 
approach towards developing novel agrochemicals and potential therapeutics. The objective of 
this dissertation was to design, synthesize, and evaluate bioisosteric mimics of the OH-PBDEs in 
an attempt to exploit the antimicrobial benefits of the OH-PBDEs while moving away from their 
related toxicities and concerns. Several novel classes of compounds were successfully designed 
and synthesized, and many of these synthetic analogs proved equipotent to the OH-PBDEs when 
screened for inhibitory activity against various fungi and bacteria. The synthetic analogs 
described herein additionally elicit alluring insecticidal activities and serve as lead molecules for 
future optimizations. 
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PREFACE 
With support from the National Institute of Undersea Science and Technology (NIUST), 
this dissertation was built around their aim to help bring to market new products derived from 
marine ecosystems. Specifically, we sought to design and develop novel agrochemicals, inspired 
by marine natural products, to help protect food crops and allow farmers to continue gaining 
optimal food production from existing farmland. The marine natural product of our interest is a 
potent antimicrobial agent but has many negative connotations associated with its chemical 
structure. 
It may be important to note at this time that the terms ―fungicide‖ and ―fungicidal‖ have 
been used throughout this manuscript, for conciseness, to refer to any agent or chemical that kills 
fungi, or slows its growth and reproduction. In this context, the terms are meant to include 
fungistats (agents that inhibit the growth of fungi) and fungicides (agents that kill fungi). While it 
is important to note the distinctions between fungicide and fungistat, the compounds described 
herein have yet to be designated as true fungicides or fungistats and have therefore been 
described broadly herein as fungicides. 
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I. INTRODUCTION 
Within the modern era of agriculture, agriculturalists stand atop many centuries worth of 
innovative ideas that have helped shaped the way crops are cultivated. From the gargantuan 
aqueducts, to the most miniscule of molecules used as pesticides, farmers call upon a wide array 
of tools to help protect the crops which they cultivate. Billions upon billions of dollars have been 
invested to protect crops so that agriculturalists can continue to supply the more than 6 billion 
people in the world with food, clothing, and other unimaginable ‗naturally based‘ products. 
Unfortunately, with today‘s conveniences, many people in industrialized societies have become 
blasé to the ever present threat of crop disease epidemics, such as the late blight scourge that 
caused the 1845 European potato famine,
1
 the black stem rust epidemic of 1935 that killed more 
than 50% of the wheat crop in Minnesota and the Dakotas,
2
 and more recently the southern corn 
leaf blight epidemic of 1970 that destroyed 15% of the U.S. corn crop worth US$1 billion.
3
 
Consider the fact that people don‘t just consume crops for food and nutrition. Soybeans, 
for instance, are used in the manufacture of worldwide plastics and linoleums. Cotton is used for 
clothing and commercial cooking oils. Turf grasses supply ground cover for sporting arenas and 
golf courses. As well, livestock also depend on reproducible yields of nutritional crops. 
Fungicides help to protect all of these resources. 
Agriculturally, most major societies are at the forefront of innovation. Farmers utilize 
massive spray-booms capable of covering more acreage than ever thought possible. They use 
aerial techniques and equipment to make spray applications faster and more efficient. As well, 
 2 
farmers exploit mammoth irrigation systems to protect their crops from drought. But why, if at 
the top of innovative ideas, do farmers still witness strawberries that rot on the vine mid-season? 
Why do harvested fruits still rot upon storage? Why are vast quantities of fruits, vegetables, and 
other crops, still being decimated by microscopic organisms? Crop disease epidemics, like those 
of recent past, continue to be genuine threats that must actively be guarded against. 
Because of recent globalization, scourges in particular parts of the world no longer affect 
just one region. Walk into nearly any major U.S. grocery store and there, one will likely find 
watermelons and cantaloupes from Guatemala, plums and peaches from Chile, papayas from 
Belize, coconuts from the Dominican Republic, tomatoes and bell peppers from Canada, limes 
and pecans from Mexico, pineapples and mangos from as far away as Thailand, along with 
beans, onions, apples, lettuces, potatoes, and corn grown right here in the U.S. Without chemical 
fungicides, global farmers would fail to provide enough food and resources for everyone. It is 
sometimes easy to forget that adequate nutrition and clean water are often more essential to 
human health than developing groundbreaking pharmaceuticals. Human diseases, such as 
diabetes and coronary disease, would be a thing of the past should the world succumb to famine 
first. 
There are an estimated 20,000 fungal phytopathogens in the world
3
 and only about 150 
marketable fungicides used to control all of them. As regulations change, so do the available 
fungicides. Organomercurials, for example, were introduced onto the market around the 1920s; 
but after more knowledge was gathered about the toxicity of mercury these compounds were 
later phased out of use. Triphenyltins, first introduced around the 1960s, also suffered a similar 
fate. On the other hand, fungal pathogens have their own defenses against chemical fungicides, 
often developing the ability to survive exposure to many fungicides. Benzimidazoles, 2-amino-
 3 
pyrimidines, phenylamides, quinone outside inhibitors, and melanin biosynthesis inhibitors have 
all grappled with such resistance problems. As societies endure a relentless vulnerability to 
losing their agricultural fungicides, there exists an ever present necessity to continuously develop 
more. This research is meant to explore novel fungicides through the use of synthetic chemistry. 
1.1. BACKGROUND TO PURSUEING 
6-OH-BDE-47 AS A NOVEL FUNGICIDE 
6-OH-BDE-47 is a marine natural product originally identified in the early 1980s
4, 5
 
(Figure 1) from the marine sponge Dysidea herbacea and later determined to be a secondary 
metabolite biosynthesized by the cyanobacterial symbiont of the sponge.
6
 Similar hydroxylated 
(OH-) polybrominated diphenyl ethers (PBDEs) were soon isolated from other marine species
7
 
and placed under scrutiny as to what role they played in biological systems. Presently, the 
molecules are known to inhibit several species of fungi, bacteria, and some cancer cell lines,
8, 9
 
though their exact role in biological systems is still not well understood. 
Sharing a striking chemical resemblance to 6-OH-BDE-47, is a pervasive global pollutant 
denoted BDE-47 (Figure 1). Because 6-OH-BDE-47 possesses potent antifungal activity 
amongst a variety of phytopathogenic fungi, but negative associations with BDE-47, it was 
hypothesized that bioisosteric replacements within the molecule 
could potentially provide a more environmentally friendly fungicide. 
Without chemical alteration, the opportunity to exploit the benefits 
of 6-OH-BDE-47 would be hopeless. 
Before starting the synthesis of any 6-OH-BDE-47 
bioisosteres, it was highly noted that anthropogenic PBDEs, e.g. 
BDE-47, are considered hazardous molecules because of their 
 
Figure 1. 
 4 
widespread use and their unknown toxicological impact on the environment. Several studies 
have recently publicized that PBDEs may have toxicological effects on many mammalian 
systems, predominately as endocrine disruptors that can perturb early neurodevelopment.
10-13
 
These studies were primarily initiated because of the structural similarities known to exist 
between PBDEs and endogenous thyroid hormones, e.g. triiodothyronine (T3) and thyroxine 
(T4; Figure 2). 
Though hazardous, PBDEs have long been known for their flame retardant capabilities
14, 
15
 and have been used since the 1970s as additives to many polymer containing products, e.g. 
plastics, textiles, and electronics. No longer just associated with industrial scale activities, 
PBDEs are now present in most home and office furnishings. These molecules have a propensity 
to bioaccumulate in living organisms and can even be passed from mother to offspring through 
breast milk,
16, 17
 as well as possibly getting passed through the placenta during intrauterine life. 
PBDE pollutants are so prevalent that they have been detected in appreciable amounts within 
both the Arctic and Antarctic,
14, 18-21
 and as close to home as to be present in common indoor 
dust.
22, 23
 In fact, humans in many industrialized nations have alarming amounts of quantifiable 
PBDEs within their tissues.
24-26
 
 
Figure 2. Side-by-side structural comparison of mammalian 
hormones, T3 and T4, and anthropogenic pollutant, BDE-47. 
 5 
Aside from the humanitarian reasons to provide agriculturalists with effective, 
environmentally friendly fungicides, there is also a substantial financial benefit to help motivate 
the development of such agricultural tools. DuPont for example, revenued more than US$580 
million in 2009 from the sale of its agrofungicides alone. Figure 3 compares the annual net 
fungicide sales of a few of the industry leaders. And to better illustrate the potential for profit, 
consider that if a fungicide resulting from this research were able to capture only 5% of DuPont‘s 
fungicide market the resulting revenue would be on the order of US$29 million—a substantial 
amount for any fledgling startup company or university. Of course, DuPont represents only one 
company within the market, implying that there is a much larger margin of revenue to be gained. 
Compare DuPont to other fungicide producers, as illustrated in Figure 3, and see that DuPont‘s 
share of the market is only a diminutive percentage of the whole market. In point of fact, 
DuPont‘s agricultural sector only boasts about 5% of the global fungicide market. 
 
Figure 3. Annual net fungicide sales of leading chemical companiess. 
 6 
The total global market value for conventional agrofungicides is currently around US$10 
billion per year,
27, 28
 with most fungicide sales occurring in Europe (Figure 4, p. 7). Considering 
the more country-specific markets, Brazil is the single largest agrofungicide consumer in the 
world (Figure 5, p. 7),
28
 with a growing market valued at US$1.46 billion. France, Japan, the 
U.S., and Germany follow Brazil as major agrofungicide consumers. The global agrofungicide 
market is huge, and with the correct compound in hand, entry barriers into the market could be 
more easily overcome than if the compound of interest were going onto the human drug market. 
Atop the opportunity to bring novel fungicides to the agricultural markets, there also 
exists significant potential to create compounds that could traverse into the pharmaceutical 
markets or, at least, stand as exceptional leads for drug development.
29
 Aside from the obvious 
links between treating crop fungal diseases and human fungal diseases, it should be noted that 
because many fungicides target microtubule formation or kinase activity, it is reasonable to 
consider that some examples may well prove valuable for such things as anticancer drugs. In 
fact, epothilones,
30
 triazolopyrimidines,
31
 fluconazole,
32
 and fenpropidine
33
 originated as 
agrofungicides and subsequently found pharmaceutical applications, namely as anticancer and 
antimycotic agents. With regard back to 6-OH-BDE-47, it and several other OH-PBDEs have 
also already shown promising anticancer
8, 34
 and antibacterial
9
 activities. The significance of this 
innately alludes to the possibilty that antifungal mimics of 6-OH-BDE-47 may also possess 
anticancer or antibacterial activity. Without further assertion, 6-OH-BDE-47 is an exceptional 
choice to be used as a lead molecule in the design of novel fungicides.  
 7 
 
 
Figure 4. Regional fungicide markets with respective market values . 
a
Total market value in 
2009 was US$9,726 million. 
b
North American Free Trade Agreement (NAFTA)—includes 
United States, Canada, & Mexico. Source: Phillips McDougall AgriService. 
 
Figure 5. Top 10 fungicide markets in 2009 with respective values. Total world market in 2009 
was valued at US$9,726 million. Source: Phillips McDougall AgriService. 
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1.2. THE IDEAS BEHIND MAKING 
6-OH-BDE-47 MIMICS A REALITY 
Bioisosteric replacement is an improvement tactic that the pharmaceutical industry has 
embraced for years and, now, with merging chemistries being the largest commonality, the 
agrochemical industry has come to embrace the same tactics when trying to optimize their 
chemical pesticides. Essentially, the concept of bioisosteric replacement involves replacing 
chemical functional groups with equivalent groups of atoms in hopes of mimicking the original 
physicochemical properties of the parent molecule while improving ‗drugability‘. Perhaps the 
best example of classical bioisosteric replacement is the substitution of an –H atom for an –F 
atom, as Zhang et al.
35
 have elegantly showcased in their pursuit of better benzodiazepine 
receptor ligands (Table 1). Following this same line of thinking, industry has unintentionally 
provided a classical bioisostere of 6-OH-BDE-47 commercially known as triclosan (Figure 6). 
 
 
 
Table 1.
35
 In vitro IC50 values of new ligands at the benzodiazepine 
receptor 
compound X IC50 (nM) 
1a H 1000 
1b F 260 
2a H 1000 
2b F 55 
 
 
 
 
 
 
 
Figure 6. Structural comparison of 6-OH-BDE-47 and 
its synthetic bioisostere, triclosan. 
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Triclosan is a relatively small molecule that was introduced 40 years ago and is currently 
used as a safe antibacterial in many worldwide soaps, deodorants, shampoos, and toothpastes.
36
 
Antibacterial cleaning items on the market today typically contain concentrations of triclosan 
ranging from 0.1 to 1%. In addition to cleaning products, triclosan is also infused into many toys, 
kitchen utensils, athletic clothing, furniture, etc. The U.S. Food and Drug Administration (FDA) 
continues to stand behind the assertions that triclosan is not known to be hazardous to humans, 
though because of recent animal studies
37-44
 triclosan is currently under closer review by the 
FDA. Their findings won‘t be released to the public until winter 2012.45 
Particularly fascinating to this research, triclosan is also antifungal, though anecdotal 
evidence shows that triclosan is not nearly as potent a fungicide as 6-OH-BDE-47. Because of 
this suppressed activity, along with the controversial use of triclosan and the flame retardant 
PBDEs, bioisosteric replacements within 6-OH-BDE-47 were predominately focused around its 
phenolic and ethereal moieties in order to completely alter the skeletal characteristics of the 
molecules. Considering the phenol isosteric options, the monovalent amino-hydroxy interchange 
has often successfully been employed (as in Table 2),
46
 as both of these two functionalities can 
typically act as hydrogen bond donors or acceptors. Alternatively, Figure 7 lists a variety of 
nonclassical phenolic bioisosteres that occur in the literature
47-52
 and which were also considered 
 
 
 
 
 
 
Table 2.
46
 Benzodiazepine Receptor Binding Activity 
of Substituted 6-(Dimethylamino)-9-benzyl-9H-purines 
compound R IC50 (µM) 
3a NH2 0.9 
3b OH 1.2 
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for the replacement. Monovalent isosteres involving fluoro-, chloro-, bromo-, and 
trifluoromethyl-interchanges at the –OH position were grossly ignored in this study since 
unpublished evidence produced within this lab suggested that the donatable –H atom within the 
molecule was absolutely necessary for biological activity. This conclusion was drawn by making 
synthetic alkylations and acylations at the phenolic –OH position of 6-OH-BDE-47 then 
subsequently testing for biological activity. 
Ultimately, indole was chosen as the ideal bioisostere to initially substitute the phenolic 
moiety of 6-OH-BDE-47 because it allowed intriguing questions to be answered about rigidity, 
acidity, hydrogen bond donation/acceptation, lipophilicity, and spatial constraints while at the 
same time allowing the ether moiety to be replaced with a more stable carbon linker. Indoles are 
also readily available through facile synthesis. 
The overall intention was to synthesize small libraries of compounds with seemingly 
small changes to various functional groups so that a complete understanding of the molecular 
structure-activity relationship (SAR) could be concluded—that is, this research was anticipated 
to reveal more than just SAR data regarding the phenolic and ethereal moieties. To concentrate 
and build upon success, a deliberate effort was made to submit small batches of compounds to 
 
Figure 7. Examples of phenol bioisosteres. 
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the biological assay, as this strategy allowed subsequent batches of compounds to be built around 
the quintessential components that gave biological activity to previous compounds. Thus, the 
assay was used to drive the decision making process of subsequent syntheses. This approach 
proved flexibly important since it meant not having to adhere strictly to indole-phenol 
interchanges. In fact, indazoles, 2-carboxyindoles, and oxindoles were later chosen to help probe 
deeper questions, like the importance of pKa values. 
1.3. SPECIAL CONSIDERATIONS 
Personal communications with other scientists studying OH-PBDEs suggested that their 
fungicidal activity was almost certainly due the acidic nature of the phenol (Dale Nagle, personal 
communication, fall 2008). Further hypotheses ensued that OH-PBDEs likely elicited their 
activity by either inhibiting succinate dehydrogenase of the mitochondrial electron transport 
chain or by uncoupling oxidative phosphorylation, thus shutting down adenosine triphosphate 
(ATP) production and halting cellular respiration. As of the writing of this dissertation, only a 
modest amount of experimental data supporting these claims has been published.
53
 Regardless, 
when designing experiments for this research, special merit was given to the legitimacy that 
OH-PBDEs could possibly target these aspects of cellular respiration and that their lowered pKas 
could be vital to their fungicidal activity. 
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Phenol and indole are inherently different when considering their respective acidities. 
Phenol, for example, is a rather weak acid which can moderately ionize into its enolate form at 
physiological pHs. Indole, on the other hand, is quite neutral, existing predominately in the non-
ionized form at physiological pHs (Figure 8). However, electron-withdrawing groups (EWGs) 
considerably stabilize the conjugate bases and thus increase the strength of each acid. This has a 
significant effect as Figure 9 clearly illustrates with picric acid and similar phenol derivatives. 
Because of the four bromine atoms on 6-OH-BDE-47, its pKa is more than three log units 
lower than that of phenol, making its acidic characteristics closer to that of carboxylic acids than 
of phenols. In pursuing indole-phenol interchanges while attempting to match the exact bromo 
substitution pattern of 6-OH-BDE-47, the lowest pKa expected of the indole moiety would be ca. 
 
 
Figure 8. Equilibriums observed at physiological pHs. Indole exists 
predominately in the non-ionized form at these pHs. 
 
 
 
Figure 9. pKa lowering effects of EWGs on phenol. 
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12, based on in silico predictions (Figure 10). This is inevitably due to the electrostatic 
differences between nitrogen and oxygen—oxygen being far more capable of holding the 
negative charge. In addition, the peculiarities of how each ring system delocalizes and, thus, 
stabilizes the negative charge of the conjugate base is also of importance to predicting pKas, 
though perhaps to a lesser degree than the obvious electrostatic differences in this case. These 
disparities culminate in a limited pKa range achievable by the indole-phenol interchange and, 
consequently, drove the decision to also incorporate other phenolic bioisosteres into this study. 
Again, in trying to maintain the assertion that questions should be answered about rigidity and 
ether replacement, the original indole proposal was amended to incorporate additional electron-
withdrawing elements into analogous structures, as exemplified in Figure 10. 
Noting that the newly proposed indole derivatives, like those in Figure 10, were lower 
than the desired pKa range, further concerns were largely disregarded at this point because of the 
recollection that the chemical structure of triclosan only partially complements the substitution 
pattern of 6-OH-BDE-47, nor does it contain bromine, yet it retains antifungal activity. Also 
 
 
Figure 10. pKa limitations of various indole derivatives become apparent 
when trying to match exactly the bromo substitution pattern on 6-OH-BDE-
47. 
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influencing this disregard was the predication that if dealing with an inhibitor of succinate 
dehydrogenase or an uncoupler of oxidative phosphorylation, approaches could be taken to 
incorporate similar functionalities as those that exist in currently used fungicides which inhibit 
these targets. Figure 11 illustrates a number commercially important agrofungicides that fall into 
these pharmacological classes. 
In the extreme case that all four bromine atoms within indole 4 were replaced with the 
tenaciously electron-withdrawing nitro group, the pKa of the resulting indole would actually be 
lower than that of 6-OH-BDE-47. Other proposed indole derivatives would in fact be even more 
acidic, as pointed out in Figure 12. In the case of a compound like oxindole 11, notable attention 
must be paid to the detail that this is an amide and will thus behave differently than the indoles. 
 
 
Figure 11. A selection of modern, commercially important agrofungicides. Inhibitors of 
succinate dehydrogenase are colored blue, uncouplers of oxidative phosphorylation are 
red. 
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In addition, compound 11 also lacks the additional aromaticity needed for the most distant 
EWGs to ‗reach‘ the nitrogen, hence its relatively higher pKa of 8.9. Though extreme, this simple 
exercise yields ample evidence that indole-phenol interchanges can be employed with strategic 
placement of suitable EWGs to effectively control pKas. 
In addition to the preparations mentioned thus far, care also had to be taken to ensure that 
this research was not inadvertently going to repeat something that had already been done, thus 
reinventing the wheel, so to speak. Consequently, Chapter 2 is meant as a means of addressing 
this care by providing a brief history and literature review of agrochemical fungicides. Now, 
having gathered an introductory understanding of the planning process that stood behind this 
research, along with an appreciation of the goals it sought to achieve, note that further discussion 
detailing precisely how the milestones and objectives of this project were to be met will be 
postponed until later chapters. 
 
 
Figure 12. Nitro groups are used here to demonstrate that functionalities 
which are more electron-withdrawing than bromine can be used to further 
lower pKas. 
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II. A HISTORY OF 
AGRICULTURAL FUNGICIDES 
It is reasonable to assume that people have been struggling with fungal plant pathogens 
since humans first began cultivating crops in the Neolithic Era. And though it wasn‘t until about 
the most recent 200 years that fungicide development began growing into a science, humans 
have been trying in vain to resolve crop losses for thousands of years. Initially, people once 
thought that fungal crop diseases were the result of poor growing conditions and not a causative 
feature. For this reason, remedies over the ages have ranged from ritualistic prayers and 
sacraments to treating plants with ashes of cow dung and nurturing with milk and honey.
54
 The 
idea of using inorganic sulfur as an antifungal to treat crop diseases didn‘t come about until the 
Late Bronze Age, as evidenced by the ancient Greek poet, Homer, having made reference to 
using ‗pest-averting sulfur‘ in the 8th century B.C.3, 55 Over a slow progression of time, people 
eventually began to realize that fungi were causing their crop losses, rather than simply being the 
effect of inadequate conditions. With this apparentness followed a demand to collect and classify 
the culpable organisms in a meticulous scientific manner. And from this organized effort grew a 
healthier understanding of plant disease epidemiology. 
By about the mid-18
th
 century people were observing that copper sulfate could control 
bunt on wheat (Tilletia caries),
56
 though their explanations were mostly speculative. In addition, 
others, like Mathieu Tillet (1755), had begun to show that chemicals such as saltpeter, lime, and 
brine solutions could partially prevent plant disease. In 1807, after observing that seed wheat 
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steeped in verdigris copper vessels produced bunt-free fields, Bénédict Prévost, through further 
experimentation, published the first scientific evidence that copper sulfate was indeed 
antifungal.
57
 His research, in effect, also conclusively proved that bunt disease on wheat was 
caused by a fungus and, thus, helped to pioneer germ theory. Controversial at the time, many 
people rejected Prévost‘s research and held firm to their beliefs in ‗spontaneous generation‘, the 
theory that regarded fungi as symptomatic aspects of disease. In agreement with Prévost‘s 
observations, John Robertson (1824) accurately interpreted the causative role of fungi and 
successfully demonstrated, by scientific method, that sulfur was able to remedy powdery mildew 
on peaches.
58
 Unfortunately, the work by both scientists went unrecognized and in 1845 potato 
late blight disease descended upon Ireland. Caused by Phytophthora infestans, several successive 
epidemics of the late blight went uncontrolled and caused Ireland to lose more than 20% of its 
population: one million to starvation and another 1.5 million emigrated out of the country.
3
 
In the years following the Irish potato famine, scientific research began to hit its stride. 
Improved microscopes were beginning to help unearth the mysterious nature of living cells, 
Charles Darwin was preparing to release his breakthrough manuscript on the origin of species, 
and individuals, like Anton de Bary and Louis Pasteur, were closely studying microbial life 
cycles while taking careful notes of their cellular peculiarities. And so it wasn‘t until the latter 
half of the 19
th
 century that contemporary thinking began to adapt and the concepts of 
spontaneous generation were slowly abandoned. By the 1860s, it was becoming a generally 
accepted recommendation to use copper sulfate or sulfur to protect crops, though with some 
consequence of phytotoxicity to the plant. As a result, people were adding lime to curb the 
problem. While in the Bordeaux region of France, Pierre Millardet (1882) noticed that farmers 
had been treating their roadside vineyards with solutions of copper sulfate and lime, not to ward 
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off disease but rather to discourage would-be thieves from stealing the grapes. He also noted that 
the vines closest to the roadways showed no signs of downy mildew (Plasmopara viticola), a 
disease which was poorly managed by the lime sulfur mixtures of the day. Although not the first 
to recommend lime and copper sulfate, it was Millardet who best perfected the mixture and 
brought about what is now known as Bordeaux mixture (1885), the world‘s first commercial 
fungicide and still popular today.
59, 60
 Though effective, it would be several more decades before 
organic chemists involved themselves with fungicides. 
2.1. EARLY 20TH CENTURY: A TIME OF 
SUCCESS WITH UNFORTUNATE CONSEQUENCES 
Fungicide development at the turn of the 20
th
 century was marked by a gross neglect for 
safety concerns—both for the environment and for the operators involved with applying the 
chemical treatments. The inorganic compounds of the time were proving sporadically ineffective 
and sometimes phytotoxic. In addition, the inorganics had to be applied frequently and in 
enormous quantities. Within only a few years of Millardet‘s Bordeaux mixture, other more novel 
fungicides began emerging. Unfortunately, most were quite toxic. 
In 1912, German chemists, having knowledge that mercuric chloride was proving itself 
effective in other parts of the world, began dabbling in the research of organomercurials.
61
 
Finding them to be highly effective, 1912 proved to be too early for the organomercurials, as 
most of the compounds were far too expensive for scale-up. However, after the initial discovery 
of their potential value, these compounds were further developed and by the 1940s a number of 
organomercurials were made cheaply available (Figure 13). 
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Aside from the obvious concerns that people today would have with mercury compounds, 
it‘s noteworthy to recognize that the provisions of pre-formulated, premixed ingredients were 
virtually nonexistent at the time. During the early 20
th
 century, only a very miniscule amount of 
fungicides were being sold as ‗ready mix‘ formulations (Bordeaux mixture was one of the few). 
As a direct consequence, much of the hired labor used to chemically treat seed stocks and crops 
fell sick. Often, symptoms of the afflicted ranged from headaches and fatigue to spastic muscle 
movements and deteriorated mental capacity, and as well, death also frequently occurred. 
Additionally, impoverished farming families would sometimes consume bread made from 
mercury-treated wheat seed intended for planting,
62, 63
 and poisonings were also noted from 
having eaten grain-fed livestock raised on mercury-treated seed.
64
 Regrettably, stricter 
regulations didn‘t arise until much later and many countries allowed the use of organomercurials 
well into the 1970s. 
2.2. THE MID-20
TH
 CENTURY: 
THE RISE OF ORGANIC FUNGICIDES 
At long last, the 1930s and 1940s saw the first true success stories begin to emerge. 
Nonconformists, like James Horsfall, were advocating that Bordeaux mixture, because it was 
 
Figure 13. Organomercurials used as fungicides during the early 20
th
 century. 
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deleterious on tomatoes and potatoes, was like a dead horse that just hadn‘t fallen over.65 
Devotees of the inorganics were perturbed by assertions like this and lashed out by claiming that 
farmers would never pay the higher prices for organic fungicides when they could buy Bordeaux 
for 5-10% cost, what amounted to only a few cents per pound. Eager to prove the aficionados 
wrong, supporters of the organic fungicide movement forged ahead. Basing assumptions off the 
tenet that copper induced oxidative stress, Horsfall et al. established that the organic pro-oxidant, 
tetrachloroquinone (chloranil), was similarly fungicidal, and by 1940, New York farmers were 
ecstatic to pay $1.50 per pound.
65, 66
 Detrimental to the overall success of chloranil was the fact 
that it suffered a facile hydrolysis in the sun and the dew. Soon thereafter, 2,3-dichloro-1,4-
naphthoquinone was introduced as the successor to chloranil. Dichlone, as it was later christened, 
displayed resistance to decomposing on the leaf and was warranted commercial use as a foliar 
spray, yet it was still not conducive to protecting all crops, particularly not potatoes. 
In 1934, a few years prior to the introduction of chloranil and dichlone, Wendell Tisdale 
and Ira Williams, both assignors to Du Pont, patented the first organosulfur compounds to be 
used as fungicides,
67
 a class known as the dithiocarbamates. These compounds were originally 
used by the rubber industry for their vulcanization processes, processes used for crosslinking the 
rubber. As with nearly all fungicides produced up until this point, the dithiocarbamates elicited 
fungicidal behavior via multi-site inhibition. Setting them apart was the unique difference that 
they were not general biocides, for this meant they were more selective for fungi and less toxic to 
the plants they were intended to protect. In turn, they were also safer for the operators applying 
them. After their original patent date in 1934, the dithiocarbamate fungicides were slow to take 
off and the premier compound from this class, thiram, wouldn‘t hit commercialization until 
about seven years later, about the same time that the chloroquinones were beginning to take off. 
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Like chloranil, thiram performed poorly in foliage applications and so was best used as a 
seed treatment. Still agitated that conventional wisdom still felt Bordeaux mixture was best, and 
driven to prove that superior fungicides for potato crops could exist, Horsfall, in collaboration 
with Rohm and Haas Company, developed several dithiocarbamates from ethylenediamine, and 
in 1943 disodium ethylenebisdithiocarbamate (nabam) was introduced.
68
 Within the same year as 
the publication release of nabam, John Heuberger, then working with Horsfall, formulated 
nabam into a zinc version of Bordeaux mixture (lime + zinc sulfate), which was meant to serve a 
two-fold purpose: (1) to stabilize nabam from degradation and (2) to provide for a more adhesive 
foliar spray.
69
 Later learned from these experiments was that once exposed to air the combination 
of chemicals converted nabam into its zinc salt, zineb.
70
 As a result, the response was to directly 
apply the zinc salt of the ethylenebisdithiocarbamate. By using zineb, farmers could now avoid 
dwarfing crops like potatoes while getting exceptional pest protection on their fields. By the mid-
1940s, dithiocarbamates had effectively become the most important fungicides of the time and 
Bordeaux mixture was finally retired. This occurred not because the new fungicides controlled 
disease better, but because they harmed the crops less. Throughout the mid-20
th
 century, 
chemists continued to expand on the dithiocarbamates, experimenting often with other heavy 
metal combinations (Figure 14). Most were highly successful and many are still used today. 
 
 
Figure 14. Dithiocarbamates and related fungicides. 
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With the emergence of the organic fungicide era, many companies began to take serious 
interest in fungicide chemistry. A revolution of sorts was beginning to take shape. Prior to the 
mid-20
th
 century, there was virtually no chemical crop protection industry to speak of, but after 
the induction of the dithiocarbamates competition had grown common. Having never been an 
industry prior to this, most agrochemicals at this time were being developed by already 
established chemical or oil companies, e.g., Du Pont, U.S. Rubber, Standard Oil, Merck and Co., 
etc. More than ever before, scientific efforts world-wide were being put into understanding 
exactly how fungicides worked. Mechanistic studies were beginning to get underway and 
considerable amounts of man-hours were being spent gathering knowledge of both plant and 
fungal physiology. Insightful biological information was being amassed by both companies and 
academics alike. On the heels of success following the dithiocarbamates, the phthalimides 
equally impacted the market for the better. These classes of compounds, together, represented a 
drastic improvement over the previously used inorganics and organomercurials. Not only were 
these compounds popular and effective then, these classes have grown into some of the most 
important fungicides in today‘s world. 
Post-World War II conditions allowed for substantial growths to be made within the 
industry. Environmental concerns were still largely nonexistent and ‗acquired‘ fungicidal 
resistance was still unheard of, and so the repertoire of chemical fungicides grew unbounded 
from restrictions. Table 3 bares a relatively small amount of the chemical diversity introduced 
between 1940 and 1970.
54
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Prior to the 1960s, relatively little was known about fungicidal resistance. Penicillin 
resistance was known, as it had just begun to emerge ca. 1947, but similar problems had yet to 
occur in the fields of farmers. Most of the previous agricultural fungicides were multi-site 
inhibitors and, thus, resistance wasn‘t much of an issue. As plant and fungal physiology revealed 
more secrets, the fungicides used to protect the crops became much more focused in what they 
targeted. What followed was that fungi, being the exceptionally adaptable organisms that they 
are, could then make facile mutations and survive prolonged exposure to the fungicide. Because 
it was not well understood at the time, when resistance began to transpire in fungal pathogens the 
Table 3.
54
 Key classes of fungicides introduced 1940-1970 
Chemical Class Fungicide and Year of Introduction Mechanism of Action 
Dithiocarbamate thiram (1942), zineb (1943), nabam 
(1943), maneb (1955), mancozeb (1961), 
propineb (1963) 
multi-site contact 
activity 
Aromatic Hydrocarbon biphenyl (1944), dicloran (1960) lipid and membrane 
synthesis 
Phthalimide captan (1952), folpet (1952), captafol 
(1962) 
multi-site contact 
activity 
Antibiotic blasticidin S (1955), kasugamycin (1965), 
polyoxins (1965) 
protein synthesis; 
glucan synthesis 
Triazine anilazine (1955) multi-site contact 
activity 
Guanidine dodine (1957), guazatine (1968) unknown; multi-site 
contact activity 
Benzimidazole thiabendazole (1964), benomyl (1968) β-tubulin assembly 
Sulfamide dichlofluanid (1964), tolyfluanid (1967) multi-site contact 
activity 
Phthalonitrile chlorothalonil (1964) multi-site contact 
activity 
Organophosphorous pyrazophos (1965), ditalimfos (1965) phospholipid 
biosynthesis 
Morpholine dodemorph (1965), tridemorph (1969) sterol biosynthesis 
Carboxanilide carboxin (1966), oxycarboxin (1966) respiration 
2-Aminopyrimidine dimethirimol (1969), ethirimol (1969) nucleic acid synthesis 
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human response was usually to apply more fungicide or to make applications more frequently. 
This significantly perpetuated the problem. 
Natural fungicide resistance was fairly well documented so farmers knew that if a 
particular fungicide didn‘t work initially, they could always apply a different fungicide and all 
would be solved. This ‗pre-existing‘ resistance was, and continues to be, quite common 
(sometimes called ‗inherent resistance‘). Often though, the reason for this type of resistance is 
seldom investigated as the more trivial, cost-effective solution is simply to try something else 
that might work. When a fungicide is able to kill a specific strain of fungi, that particular 
organism is said to be ‗sensitive‘ to that fungicide. What was being witnessed in the 1950s and 
60s was that numerous fungal strains were slowly losing their sensitivity to tried and true 
fungicides. Sadly, the overuse and mismanagement of chemical applications often led to the 
complete failure of disease control. 
Also, new to the time period was the appearance of ‗cross-resistance‘. Once able to 
aimlessly substitute one fungicide for another, farmers were now seeing entire classes of 
fungicides lose their effectiveness. For example, if an individual accustomed to using imazalil 
(an imidazole fungicide) to protect orchard crops started observing diminished efficacy, that 
individual might‘ve changed to using prochloraz (also an imidazole fungicide) but to no avail 
because both fungicides are in the imidazole class and, thus, are effected by the same resistance 
mechanism. What‘s worse is that a farmer might‘ve tried changing from an imidazole fungicide 
to a fungicide in the pyrimidine class, but also to no avail because both imidazoles and 
pyrimidines are inhibitors of C14-demethylase in the sterol biosynthesis pathway. Cross-
resistance like this is generally found among any two or more compounds that elicit obvious 
chemical similarities or identical modes of action. Therefore, when a dimethylation inhibitor 
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(DMI) fungicide, like imazalil, surrendered to resistance from a fungal species, it was generally 
clever to concede that that organism was now resistant to all DMIs. The same situation was 
especially true for the benzimidazoles, dicarboximides, phenylamides, quinone outside inhibitors 
(QoIs), and carboxylic acid amides (CAA).
71
  
Acquired resistance was becoming a threatening matter by the close of the mid-20
th
 
century. Several scourges had already decimated various regions and now it seemed like all the 
progress made in recent decades was being erased by these epidemics.
3
 Successive generations 
of chemists and plant pathologists would soon find themselves fighting a new battlefront. 
2.3. THE CLOSE OF THE 20
TH
 CENTURY: 
PATHOGENS FIGHT BACK AND WAR IS DECLARED 
The 1970s opened with the southern corn leaf blight epidemic emerging in the southeast 
U.S. and quickly sweeping northward across the great American corn belt. Since the first half of 
the 20
th
 century, the field of genetics had been developing disruptive technologies that were fast 
becoming competitive with the chemical pesticides of the day. Selective breeding programs 
allowed seed companies to supply the world with ample access to a variety of hybrid seeds that 
were capable of producing plants with greater crop yields, insect resistance, herbicide resistance, 
etc. Unlike the Irish potato famine of the 1840s, the southern corn leaf blight epidemic was a 
direct result of humans manipulating plant genetics without full knowledge of the potential 
consequences. 
2.3.1. The Fungicide Industry Becomes Permanent 
In the late 19
th
 and early 20
th
 centuries, corn was being selectively bred by planting 
alternating rows of two different corn varieties then manually removing the pollen-producing 
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tassel of the female parent. This emasculation process (called detasseling) was done as a form of 
pollination control to insure that the female parent didn‘t self-pollinate, thus, only allowing the 
desired cross-breed to result. Expensive, manual detasseling was commonplace for seed 
producers until the 1950s, when it was learned that backcrossing techniques allowed for stable 
hybrids to be made which where inherently male-sterile. The cytoplasmic genetics that gave rise 
to these male-sterile plants fostered faster and more profitable production of hybrid seeds for the 
next 20 years, as manual labor and machines were no longer needed for detasseling. These 
varieties of corn that harbored the genetics for male-sterility were designated Texas cytoplasmic 
male sterility (T cytoplasm or cms-T) maize due to the discovery of the cytoplasmic genetics 
having been made in Texas. 
By 1970, it was estimated that 85% of all corn planted within the U.S. was of the cms-T 
varieties.
72
 Bearing a catastrophic disadvantage, the cms-T lines carried an inextricable 
susceptibility to Bipolaris maydis race T (formerly known as Helminthosporium maydis race 
T),
72, 73
 which caused massive devastation to the U.S. corn crop. Within only a 4 month period in 
1970, the pathogen had destroyed 15% of all U.S. corn, which amounted to 20 million metric 
tons worth approximately $US 1 billion.
3
 The U.S. farmers took the most direct loss but 
downstream from them were the investment bankers and businessmen who had loaned them the 
money necessary to plant their fields. While the investors were worrying about repayment, the 
U.S. government was agonizing about the loss of exportable grains. The southern corn leaf blight 
epidemic of 1970 had a huge impact that rippled throughout the economy. 
With the approach of the 1970 harvest, officials from the U.S. Department of Agriculture 
(USDA) were beginning to acknowledge that U.S. farmers weren‘t going to have enough 
disease-resistant seed to replant the following year. Seed companies were already hard at work 
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trying to generate new seed stocks in Latin American countries, but by the spring of 1971 only 
23% of corn seed going into the U.S. soil was blight-resistant.
74
 Fearing that southern corn leaf 
blight would ravage the landscape again, most of the remaining cms-T varieties were planted in 
the drier regions of the western corn belt so as to dampen the tenacity of the blight, while much 
of the blight-resistant corn was planted in the southern states so as to buffer the northward spread 
of a second epidemic. Several severe outbreaks of southern corn leaf blight were reported in 
1971, but the devastation did not approach that of the previous year. By 1972, the U.S. farmers 
had been supplied with enough blight-resistant seed that the crisis was finally considered to be 
over. 
Due to the difficulty of reacquiring blight-resistant varieties of corn, bushel prices 
doubled during the early 1970s.
74
 And had it not been for the previous years‘ grain surplus and 
having had the ability to substitute other grains into livestock feeds, then other commodities that 
depend heavily on the corn production, e.g. beef, poultry, etc., most certainly would have seen 
more drastic stock market changes. In the wake of the 1970 blight epidemic, optimists who once 
thought that genetic alterations would replace the use of agrofungicides were now quickly 
shedding their beliefs, for it was apparent to all that the need for chemical fungicides would 
never be quenched.  
2.3.2. The Industry Booms 
From the 1970s onward, agrochemical technology advanced into an exponential growth 
period as entirely new chemical classes were rapidly being introduced (Table 4).
54
 New 
companies were materializing all over the globe to address the expanding market. Larger, more 
established companies, like BASF and Bayer, were budding new divisions especially devoted to 
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plant protection. As well, mergers were becoming commonplace events used to offset the 
increased costs of business while allowing effective competition.
75, 76
 
Because of the high cost of doing research, many companies strategized to focus 
extensively on analog chemistry, the so-called ‗me-too‘ strategy. Once a new class of compound 
was introduced, competitors would make facile adjustments to the preeminent compounds and 
quickly gain new high ground by patenting their new chemical entities without the extensive 
research costs. Table 4 exemplifies this me-too strategy with the MBCs, triazole DMIs, 
phenylamides, and quinone outside inhibitors (QoIs). While at the same time new classes were 
emerging, companies, academics, and governments were all investing extensive efforts to 
elucidate the underlying modes of action. Conceptually, understanding exactly how a class of 
compounds worked should‘ve provided a means to better understand fungal biology enough to 
allow for the design of subsequent fungicides with unsurpassed disease control. However, fungi 
once again proved far more unpredictable than anticipated. And though there was an obvious 
necessity to transition science from the empirical discovery approaches of yesteryear to a more 
intellectual knowledge-based approach, science, to this date, is still struggling to idealize this 
approach.
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Table 4. 
54
 Key fungicide classes introduced 1970-present. 
Chemical Class Fungicide and Year of Introduction Mechanism of Action 
Methylbenzimidazole 
carbamate (MBC) 
thiophanate (1970), thiophanate-methyl 
(1970), carbendazim (1976) 
β-tubulin assembly 
Phosphorothioate iprobenfos (1970) lipid and membrane 
synthesis 
Triazole DMI
a 
triadimefon (1973), bitertanol (1979), 
diclobutrazol (1979), fultriafol (1983), 
hexaconazole (1986), metconazole 
(1992), prothioconazole (2002) 
sterol biosynthesis in 
membranes 
Imidazole DMI
a
 imazalil (1973), prochloraz (1977), 
triflumizole (1982) 
sterol biosynthesis in 
membranes 
Pyrimidine DMI
a
 fenarimol (1975), nuarimol (1975) sterol biosynthesis in 
membranes 
Pyridine DMI
a
 buthiobate (1975), pyrifenox (1986) sterol biosynthesis in 
membranes 
Dicarboximide iprodione (1974), vinclozolin (1975), 
procymidone (1976) 
signal transduction 
Benzanilide benodanil (1973) respiration 
Cyanoacetamide oxime cymoxanil (1976) unknown 
Phenylamide metalaxyl (1977), furalaxyl (1977), 
benalaxyl (1981), oxadixyl (1983), 
mefenoxam (1996) 
nucleic acids 
synthesis 
Morpholine SBI
b 
fenpropimorph (1979), fenpropidin (1986) sterol biosynthesis in 
membranes 
Cinnamic acid dimethomorph (1988) lipid and membrane 
synthesis 
Phenylpyrrole fenpiclonil (1990), fludioxonil (1990) signal transduction 
Dinitroaniline fluazinam (1992) respiration 
Quinone Outside 
Inhibitor 
azoxystrobin (1992), metaminostrobin 
(1993), fenamidone (1998), 
trifloxystrobin (1998), picoxystrobin 
(2000), pyraclostrobin (2000) 
respiration 
Phenoxyquinoline quinoxyfen (1997) signal transduction 
Hydroxyanilide fenhexamid (1998) sterol biosynthesis in 
membranes 
a
demethylation inhibitor; 
b
sterol biosynthesis inhibitor 
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As the market broadened and chemists continued striving to reach the apogee of potency 
and efficiency, farmers slowly abandoned the older fungicides to concentrate on the higher return 
on investment offered by the newer fungicides. Figure 15 very much epitomizes just how 
efficient fungicides have become over the years, illustrating that usage needs in the U.S. have 
gone from 300 million pounds per year in the 1940s to only 108 million pounds per year in 
recent past, which amounts to only ~0.1 lb/acre versus 10-60 lb/acre.
77
 Unfortunately, what 
wasn‘t appreciated until the late 1970s was the fact that most of the newer fungicides were 
mono-site inhibitors and hence, were at higher risk to resistant populations. Though resistance 
was seen in the 1960s, e.g. mercury seed treatments,
78
 it was perceived as a minor annoyance. 
For the duration of the 1970s, farmers witnessed far more severe cases of resistance in which 
major classes of fungicides were failing due to their overuse and mono-site inhibitory activity. 
To thwart the problem, companies would either formulate their product mixtures to include at 
least two different fungicides with separate modes of action or they would completely withdraw 
a fungicide from a particular market region until resistant populations were believed to have 
disappeared. This cunning strategy worked, but only to a relatively small degree because there 
 
 
Figure 15.
77
 U.S. Crop Production Fungicide Use. 
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was no crosstalk between other companies within the industry. In order to make a profound 
difference, the industry had to work as a whole. Thus, in 1981 the Fungicide Resistance Action 
Committee (FRAC) was formed to collate information on international fungicide resistance and 
distribute that information to researchers, manufactures, farmers, and regulators. As well, FRAC 
provided a multitude of guidelines and advice as to how resistance should be managed. 
Throughout the past few decades, new fungicides have continued to enter the market. 
Perhaps most successful of the new and expanding classes were the triazoles and strobilurins, 
several of which are illustrated in Figure 16. Resistance problems have inevitably occurred 
within both classes,
79-81
 but owing in large part to the FRAC guidelines these classes continue to 
 
 
Figure 16. Examples from the triazole and strobilurin fungicides along with respective release dates. 
 32 
be quite useful today. In addition, pathogens and fungicides—or particular combinations of the 
two—each possess an inherent amount of risk to resistance (Figure 17).82 For example, it‘s well 
known that benzimidazoles carry a high risk of susceptibility to resistance, regardless to which 
crop disease they are being applied. And in perfect likeness, Botrytis is a pathogen at notoriously 
high risk to resistance regardless of which fungicide is used to control it. As one should expect 
from looking at Figure 17, using a benzimidazole fungicide to control Botrytis would be an utter 
disaster. Most governments and regulation agencies appreciate these innate risks and now require 
strict regulations and product labeling to insure that fungicides and pathogens are well paired to 
minimize resistance risk. While the established countermeasures aren‘t perfect, a wide variety of 
fungicides continue to be effective in many situations, seemingly protected from bereavement.  
 
 
 
Figure 17.
.82
 Combined resistance risk diagram based on inherent fungicide risk and inherent pathogen 
risk. Red shading indicates higher risk. 
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2.4. PRESENT AND FUTURE NEEDS 
Throughout the past 200 years, each successive fungicide has offered some 
unquestionable degree of variable advantage over precursory chemistries, whether it is potency, 
mobility, spectrum, safety, etc. But to all appearances, the globally invoked resistance 
management strategies, along with advances in formulations and delivery systems, are allowing 
many of 20
th
 century fungicides to remain highly effective. As most of the early fungicides are 
now coming off patent, the crop protection industry is now confronted with a market inundated 
with highly affordable fungicides that are still commercially attractive, e.g. mancozeb and many 
of the early triazoles. But does this mean that the future of fungicide discovery and development 
is fated? Perhaps not. 
Though it does seem that fungicide discovery has slowed in recent years, it is paramount 
to acknowledge that the world population is projected to grow from 6.1 billion in 2000 to 8.9 
billion by 2050, increasing therefore by about 60 million per year.
83
 At this rate, the annual 
demand for grain is expected to increase by about 26 million tons.
75
 Moreover, as standards of 
living improve in developing nations and people become more opulent, it is expected that grain 
demands will increase even more so because of the desire of many people to eat more meat and 
animal products—since about 7 pounds of grain is required for each pound of beef produced.75 
With the aggravated population strain and food demand, there is little doubt that future 
farmers may be forced to over-rely on the use of fertilizers and hybrid cultivars to maximize 
yields, which in turn could predispose crops to fungal attack, much in the same way that cms-T 
genetics predisposed maize to the 1970 southern corn leaf blight.
84
 In addition, chemical 
fungicides have recently begun to attract a heightened amount of economic and public concern as 
global trends move towards providing a more ‗green‘ society—that is, a society which relies on 
goods and services that inflict no harm to the environment. This unfortunately alludes to the 
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possibilty that more stringent regulatory processes could someday end the use of such fungicides 
as the multi-site inhibitors, given that such compounds are often considered general 
toxophores.
54
 Thus, many of the older compounds heavily relied upon for effective resistance 
management strategies, e.g. dithiocarbamates and phthalimides, could potentially be lost to 
future regulatory battles. It is crucial then, that regulators carefully weigh the risks and benefits, 
for cancelling the use of older fungicides will almost certainly result in more serious resistance 
problems for other fungicides. 
As resistance continues to erode the value of new fungicides and hybrid cultivars, the 
crop protection industry will inevitably have to rely on more integrated strategies to support 
future needs. Biotechnologies and genetics will undeniably be of great importance, but equally 
important to sustainable disease control are chemical fungicides. Indeed, fungicides will continue 
to be a critically important part of disease control as will be their continued discovery and 
development. 
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III. SYNTHETIC APPROACHES 
TOWARDS 6-OH-BDE-47 BIOISOSTERES 
For nearly 200 years people have been researching and utilizing chemical fungicides, yet 
no one has explicitly recognized in the literature that indoles, similar to those generated from this 
particular research, may possess antifungal properties. The initial idea for this research spurred 
from the mental conception that when compared structurally, certain indolic compounds can 
greatly approximate the skeletal framework of 6-OH-BDE-47. Figure 18 provides an excellent 
visual comparison of this concept. And, of course, it was already known that 6-OH-BDE-47, and 
other closely related OH-PBDEs, elicited potent 
antifungal behavior against a number of pathogenic 
fungi, especially those relating to agricultural 
significance, e.g. Botrytis cinerea. Consequently, it 
was hypothesized that if OH-PBDEs are antifungal 
then structurally similar phenylindoles should also 
be antifungal. 
From the inception of this project, it was found that the scientific literature had never 
made reference to polybrominated 3-phenylindoles, nor similar polyhalogenated phenylindoles. 
This seemed bizarre at first that such a simple looking molecule had not been reported, but upon 
further inspection of the synthesis one quickly realizes that getting the halogen-substitution 
pattern exactly right is deceptively difficult. Thus, in order to test the hypothesis of antifungal 
phenylindoles, a formidable synthesis might have to be applied to access these novel compounds. 
And so, the retrosynthetic analysis of the polyhalogenated indoles began. 
 
Figure 18. 3-Dimentional overlay of 6-OH-
BDE-47 (magenta) and proposed bioisostere 4 
(green). 
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Basing the retrosynthetic analysis on known, reliable reactions, the most obvious 
disconnection that stood out was the C—C bond linking the indole ring system to the phenyl 
group (Figure 19). Though a Suzuki coupling was the first reaction that came into mind, other 
such C—C bond forming reactions, e.g. Negishi, Stille, Kumada, etc., were also considered for 
this coupling step. After surveying the wide 
commercial availability of aryl boronic 
acids it quickly seemed that the Suzuki 
coupling would provide the fastest route to 
derivatizing similar compounds—that is, if 
the 3-iodoindole could indeed be made. 
As of the writing of this dissertation, 3-iodo-4,6-dibromoindole had never been reported 
in the literature. However, decades of compiled knowledge surrounding indole chemistry 
strongly advised that the C-3 position of indoles was the second most nucleophilic site on the 
ring system, just after the N-1 position (recall indole numbering on p. 12). Hence, if both the C-2 
and C-3 positions of indoles are unoccupied, in addition to any unoccupied positions on the fused 
benzene ring, then electrophilic aromatic substitution occurs preferentially at the C-3 position. 
Further inspection of the retrosynthetic analysis (Figure 20) implied that a synthetic route 
towards 4,6-dibromoindole must now be achieved. Fortunately, 4,6-dibromindole is a known 
compound,
85, 86
 just not as readily available as one would 
desire. As a result, semi-novel methods had to be 
developed to arrive at such a molecule in good, 
affordable yields. 
 
Figure 19. First retrosynthetic disconnection of the 
ideal target molecule 4. 
 
 
Figure 20. Second retrosynthetic 
disconnection of target molecule 4. 
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3.1. SYNTHESIS OF THE 
POLYHALOGENATED INDOLE SCAFFOLD 
In 1985, Higa et al. first isolated 4,6-dibromoindole from the marine acorn worm 
Glossobalanus sp.
87
 The very closely related natural product 3,4,6-tribromoindole was also 
isolated by the same group in 1980 from Balanoglossus carnosus,
88
 yet another species of acorn 
worm. Because of the unusual halogen-substitution pattern of 
both molecules, and their antibacterial properties,
87
 chemists in 
the late 1980s became interested in synthesizing these bizarre 
molecules so that people could better study their properties. 
By 1987, Pierre Martin, then working at Ciba-Geigy in Basel, Switzerland, became the 
first chemist to report on the total synthesis of both 4,6-dibromoindole and 3,4,6-
tribromoindole.
85, 86
 Traditional synthetic avenues employed to access 2- and 3-unsubstituted 
indoles, e.g. the Reissert,
89
 Fischer,
90
 and Rees-Moody
91
 routes, frequently prove problematic 
due to the subsequent need to remove the ensuing 2-carboxyl function (Scheme 1).
92
 Often, 
extremely harsh and prolonged thermolysis conditions are unavoidable to remove this function 
and often these conditions will decompose the product of interest. Alternatively, it has become 
conventional to instead use decarbonylative procedures to remove the 2-carboxyl function, but of 
course, this inconveniences the reaction scheme with additional steps. Martin was able to avoid 
both of these problems in his synthesis by exercising a previous method developed by his group 
in 1984.
93
 This, then novel, method of indole synthesis employees as its quintessential step a 
hetero-Cope-rearrangement of various intermediate N-phenyl-O-vinylhydroxylamine derivatives. 
Martin‘s novel synthesis of 4,6-dibromoindole and 3,4,6-dibromoindole is outlined in Scheme 2. 
 
 
 
Figure 21. 
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In addition to the synthesis offered by Pierre Martin, other indole syntheses were also 
considered herein for the occasion that some of the desired compounds couldn‘t be effectively 
accessed through Martin‘s synthesis. Figure 22 offers a cognizant overview of other various 
routes that have been employed to construct the indole ring system, however, this depiction is 
not all-inclusive and additional approaches abound in the literature. As will be discussed later, 
other routes were in deed utilized later in this research project. 
Scheme 2
a
 
 
a
 Reaction conditions: (a) H2, Pt/C, THF, DMSO, NH3, H2O, 20 °C; (b) AcCl, Na2CO3, H2O, 
Et2O, 0 °C, 76% (two steps); (c) vinylacetate, 2-mol% Li2PdCl4, 55 °C, 55%; (d) NaOH, MeOH, 
room temp, 76%; (e) Br2, CH2Cl2, 0 °C, 95%. (f) NaOH, MeOH, room temp, 95%. 
Scheme 1
a 
 
a
 Typical Fischer Indole synthesis. Generally involves thermolysis or 
decarbonylative conditions to remove the 2-carboxyl function. 
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3.1.1. Cost Considerations 
To follow exactly Martin‘s procedure outlined in Scheme 2 meant using 
1,3-dibromo-5-nitrobenzene and immediately subjecting the material to platinum on carbon. In 
addition to the high cost of platinum, 1,3-dibromo-5-nitrobenzene is also highly valued, often 
retailed from U.S. chemical supply companies at greater than $60/g. In the interest of pursuing a 
more affordable route to the N-phenylhydroxylamine intermediates, it was decided that a more 
novel approach should be obeyed. In 2005, Ung et al. developed a highly effective method for 
the controlled reduction of nitro compounds using zinc metal and ammonium chloride under 
ultrasonic activation.
94
 By carefully governing the equivalents of zinc used in the reaction, 
various N-phenylhydroxylamines could be afforded in substantial yields within less than 
 
Figure 22. 
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10 minutes of reaction time. Best of all, this newer reduction method is extremely cost effective. 
Proceeding via single electron transfer, the mechanism proposed by Ung‘s group is outlined in 
Scheme 3. 
As for the expensive 1,3-dibromo-5-nitrobenzene, it was considered optimal to instead 
rehearse a series of ‗mock‘ reactions in which a cheaper substrate was carried through the 
reaction scheme. 1,3-dichloro-5-nitrobenzene proved ideal for this job since it was 
physiochemically similar to the desired substrate, yet, the cost of the material was only $2/g. 
Scheme 3 
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Once it was felt that the techniques and methods of the synthesis were streamlined using the 
inexpensive materials, 1,3-dibromo-5-nitrobenzene would be subjected to the same conditions. 
3.1.2. Synthetic Pursuits of Halogenated 3-Phenylindoles 
Having purchased 1,3-dichloro-5-nitrobenzene 26, this inexpensive starting material was 
sonicated in the presence of zinc dust and ammonium chloride to afford hydroxylamine 27 in 
respectable yields (Scheme 4). The only other compound detected by TLC was the starting 
material 26, which could of course be re-isolated quickly on a silica flash column. Purification of 
27 was seldom done as the reaction often produced high enough purity product that it was 
frequently directly engaged in the next step of the synthesis without further purification. A very 
facile acetylation with acetyl chloride promptly gave way to N-phenylhydroxamic acid 28 in 
great yield. Next came the palladium catalyzed formation of N-phenyl-O-vinylhydroxylamine 
followed by the in situ hetero-Cope-rearrangement to provide N-acetylindole 29 in respectable 
yields, however, the reaction took a disheartening 72 h to complete. When the reaction was 
halted prior to this, the yield was significantly less, often giving only 15-20% of the desired 
product 29. As will be addressed later in this manuscript, this particular indole-forming step was 
later reevaluated and optimized to allow superior yields within a fraction of the time. Regardless 
of the initial drawbacks, enough 29 was afforded at that point that subsequent chemistry could be 
easily investigated. 
Scheme 4
a
 
 
a
 Reagents and conditions: (a) zinc dust, sat. aq. NH4Cl, H2O, acetone, ))), room temp, 5 
min.; (b) NaHCO3, AcCl, Et2O, 0 °C, 1 h, 79% (two steps); (c) Li2PdCl4•xH2O, vinyl 
acetate, reflux, 72 h, 78%; (d) THF, NBS, -78 °C, 2 h, 56%. 
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In the interest of pursuing Suzuki style couplings, a ‗handle‘ was added to the C-3 
position in the form of a bromide substituent. Indole 30 was the resulting compound. Bromine 
was originally chosen as the halogen handle because the necessary bromination conditions were 
well described by Martin et al.
86
 Small gram quantities of indole 30 were prepared by the method 
in Scheme 4 and, thus, adequate material was available to explore optimal coupling conditions. 
X-Ray crystallography confirmed the absolute structure of 3-bromoindole 30. 
Unfortunately, the N-acetyl functionality in 30 prohibited successful Suzuki couplings of 
various phenylboronic acids (Scheme 5, Route A). If the desired 3-phenylindoles 31 and 32 
were, in fact, formed by Route A, they were not of significant yields to produce detectable 
amounts. A brief survey of the literature showed very few examples of N-acetylindoles involved 
in coupling reactions; indoles possessing tert-butyldimethylsilyl (TBS), N-methyl, and 
phenylsulfonyl protecting groups were far more common. Thinking that a different N-protecting 
group would favor better coupling conditions N-acetylindole 29 was efficiently deprotected and 
subsequently protected with TBS (Scheme 5, Route B). Though Route B was plagued by 
 
Figure 23. X-Ray crystal structure of 
N-acetyl-3-bromo-4,6-dichloro-1H-indole 30. Crystallized from hot 
EtOAc. 
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additional steps and a poor yielding coupling step (5% yield), 32 was successfully synthesized 
for the first time, unequivocally demonstrating that 32 was synthetically obtainable and stable. 
A devastating problem found within the Suzuki coupling of Route B was finding that 35 
not only yielded 36, but also debrominated early in the reaction progress to afford a nearly 
inseparable mixture of 34 and 36. Frustratingly, attempts to deprotect the N-1 position only 
afforded inseparable mixtures of 33 and 32. When trying to purify either mixture using normal 
phase silica columns the compounds repeatedly co-eluted. Crystallization was regrettably not an 
option at this juncture as the mixtures presented as oils. Mercifully, a significantly taller column 
separated only enough 33 and 32 to be well characterized by LR-MS and NMR, though the 
majority of 33 and 32 had again co-eluted. 
Endeavoring to divert the debromination problem, further experimentation revealed 
N-protecting groups were not strictly necessary for successful bromination and coupling 
Scheme 5
a 
 
a
 Reagents and conditions: (a) 4-chlorophenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 
°C, 8 h, 0 – 7%; (b) MeOH, NaOH, room temp, 1 h, quant.; (c) THF, -78 °C, n-BuLi, TBSCl, 2 h, 90%; (d) 
THF, -78 °C, NBS, 2 h, 75%; (e) THF, TBAF, room temp, 1 h, 90%. 
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(Scheme 5, Route C), nonetheless, Suzuki couplings of 3-bromo-4,6-dichloroindole 37 continued 
to result in entangled mixtures of 33 and 32. Opting to reverse the roles of the boronic acid and 
halogen similarly resulted in co-eluting mixtures of product and debrominated side-product, as 
illustrated by Scheme 6. 
Moreover, indole 35 was converted to the corresponding zinc chloride and Negishi 
conditions were applied. Again, a mixture of 34 and 36 resulted. An extensive review of the 
literature unearthed other chemists who articulated similar problems with Stille couplings,
95
 thus 
Stille conditions were disregarded.  
Perhaps the most influential decision addressing the co-elution problem was to simply 
subject the mixture to reverse-phase semi-preparative HPLC. Though the yields of these 
particular Suzuki conditions were poor, the appropriate HPLC methods allowed enough of the 
desired 3-phenylindole 32 to be collected for characterization and biological assay. With the help 
of HPLC, the synthetic routes described in Schemes 4 and 5 were now fruitful, though 
optimization was preferred to insure sufficient material could be prepared for the biological 
assay. 
Scheme 6
a 
 
a
 Reagents and conditions: (a) i. t-BuLi, THF, -78 °C, 
15 min.; ii. B(OMe)3, H2O, -78 °C, 1 h; (b) 
1-bromo-4-chlorobenzene, PhH, MeOH, sat. aq. Na2CO3, 
Pd(PPh3)4, 110 °C, 8 h, < 5%. 
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3.2. OPTIMIZING THE SYNTHETIC ROUTE 
TOWARDS HALOGENTATED 3-PHENYLINDOLES 
Miyaura and Suzuki provided an extensive review
96
 of their coupling reactions in which 
they addressed the reactivity of numerous organoborons, halogens, and pseudohalogens. It is 
clearly stated therein, ―The order of reactivity of halides and triflates for the cross-coupling 
reaction of boron reagents is I > Br > OTf >> Cl.‖96 Understanding this, logic seemed to suggest 
that an iodine handle would accelerate the cross-coupling reaction and provide less opportunity 
for dehalogenation to occur at the C-3 position. With some experimentation, this rationale 
proved accurate—the yields of the cross-coupling were increased from 5% to 10% in most cases. 
Though only a 5% increase, this improvement rendered significant benefit to the milligram 
reactions being performed. In contrast to the bromination, the iodination also generally occurred 
quantitatively, thus providing higher yields to the overall synthesis. 
Successful iodination of 4,6-dichloroindole 33 was achieved by following the 
undemanding procedures of Tanoue et al.
97
 Therein is described a method for regioselectively 
iodinating 1H-indoles at the C-3 position using sodium hydroxide, iodine, and aqueous 
potassium iodide. Recalling the previous step, deacetylation, also required sodium hydroxide, 
experiments were hastily conducted to telescope the reactions into a simple, one-pot reaction. 
Success was swiftly attained and Scheme 7 illustrates the improved route. Note: 3-iodoindoles 
are labile and must be immediately engaged in next step; decomposition was observed 
within 24 h at < 0 °C. Unfortunately, dehalogenation still occurred during the Suzuki coupling, 
though to a slightly lesser degree. 
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Going back one more step, to the hetero-Cope-rearrangement mentioned in Schemes 2 
and 4 (p. 38 and 41, respectively), optimization was desired at this juncture due to the long, 
sluggish reaction times required—often 72 h at reflux. Before the suggested mechanism for this 
reaction was excavated from the literature, in-house chromatographic efforts afforded a major 
side product which, when monitored by thin layer chromatography (TLC), slowly disappeared 
from the reaction as time progressed. Intriguingly, the amount of desired product was inversely 
proportional to the amount of side product witnessed on TLC. 
1
H- and 
13
C-NMR revealed the 
unknown compound to possess two saturated carbons, though X-ray crystallography was the key 
analytical technique that brought to light the absolute structure of the compound. While 
preparing another halogenated derivative of N-acetylindole 29, the corresponding side product 
beautifully crystalized from ethyl acetate. Figure 24 provides the crystal structure of the 
aggravating side product, which had been chromatographically purified from the crude reaction 
mixture. 
In his 1984 publication,
93
 Martin did not report the use of a protic acid and, likewise, he 
reported significant amounts of isolable indolines within his 1988 publication.
86
 With a new 
understanding of the reaction mechanism, it seemed a protic acid catalyst would speed the 
time-consuming dehydration step. In-house experiments promptly began to disclose which 
Scheme 7
a 
 
a
 Reagents and conditions: (a) i. EtOH, NaOH, room temp, 1 h; ii. KIaq, 
I2, room temp, 1 h, 95% (2 steps); (b) 4-chlorophenylboronic acid, PhH, 
MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 °C, 8 h, 0 – 7%. 
 47 
particular acid would be best suitable for this reaction. Of the four acids attempted (HCl, NH4Cl, 
pTSA, and formic acid), formic acid proved far superior, resulting in approximately 85% yields 
within only 2 h of reflux—a significant improvement over the lower yielding 72 h reaction. 
pTSA also catalyzed the dehydration, though the workup became painstakingly involved, 
resulting in lower yields with more time-consumption. NH4Cl and HCl were of negligible help, 
most likely due to their aqueous nature. AcOH was overlooked during these experiments, though 
it should be predicted to work equally as well as formic acid. 
To the best knowledge available, a precise mechanism for the palladium-mediated 
catalytic cycle has not been explicitly reported for these indole forming reactions reported by 
Pierre Martin. It would appear, and others agree, that palladium is used to coordinate the olefinic 
functionality of vinyl acetate, thus, making it appropriately electrophilic enough for nucleophilic 
attack to occur by hydroxamic acid. A consensus seems to exist that the vinylation of 
hydroxamic acid is palladium-mediated but chemists are unsure if the subsequent 
hetero-Cope-rearrangement is a purely spontaneous event or if palladium also mediates the 
 
Figure 24. X-Ray structure of 2-hydroxy- 4-bromo-N-acetylindolin. 
Ellipsoid diagram is no longer available due to loss of .cif file and raw 
acquisition data. Crystallized from EtOAc and hexanes. 
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rearrangement.
93, 98
 At least for the vinylation occurrence, Scheme 8 could represent a viable 
mechanism for the catalytic cycle. Unfortunately, no statement can be made as to whether the 
sigmatropic rearrangement is Pd-catalyzed or merely expires thermally. 
Turning attention back to the coupling step, the low yield was still problematic. 
Numerous solvents, boronic acids, boronic esters, bases, catalysts, and anhydrous conditions 
were explored but to no avail. Dehalogenation continued to occur. Astonishingly, few reports 
detail observations of dehalogenation products occurring in the Suzuki-coupling. Recently, 
however, there have been a few notable reports of this defiant problem resulting in 
dehalogenation as the major product.
95, 99-101
 Significant to this particular dissertation research, 
one such report specifically states therein: 
Interestingly, as we were pursuing these investigations, Dr. Cai of 
Hoffmann-La Roche informed us of a similar [dehalogentation] 
observation that they have made in the coupling of 3-bromoindoles 
in which protection of the indole nitrogen is required to avoid 
extensive dehalogenation.
95
 
To thwart the dehalogenation problem during the Suzuki coupling of 4-bromopyrroles, 
Handy et al.
95
 experimented with the influence of pyrrole protecting groups to control the degree 
of dehalogenation. Their results concluded that the BOC protecting group on the nitrogen 
prevented the dehalogenation and, thus, significantly improved yields. In addition, the BOC 
protecting group is thermally cleaved at the high temperatures normally required for the Suzuki 
coupling, therefore, there were no additional steps required to remove the BOC group. 
This discovery marked a profound landmark within this dissertation project. Immediately, 
a procedure
102
 was adapted to BOC protect the halogenated indoles at hand and methodology 
experiments were promptly applied. In agreement with Handy et al.,
95
 the N-BOC group 
provided higher yields of the polyhalogenated 3-phenylindoles. Though dehalogenation 
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persisted, reaction yields were now topping 25% desired product, more than double and triple the 
previous yields, depending on substrate. 
Silica TLC analysis was of significant value to monitoring the Suzuki coupling for the 
reason that 2,3-diunsubstituted indoles habitually stained red upon p-anisaldehyde staining, while 
3-phenylindoles consistently stained purple (Figure 25). To a short degree, TLC was used as a 
crude estimate of the product yield prior to workup: the more intense the red spot the more 
dehalogenated byproduct, while the more intense the purple spot the more 3-phenylindole 
(Figure 25, Lane 1). Ideally, one would like to see TLC profiles, in these cases, with ONLY a 
Scheme 8
a
 
 
 
 
a
 Proposed mechanism for the palladium-mediated vinylation of hydroxamic acids. Subsequent 
sigmatropic rearrangement and dehydration yields 2- and 3-unsubstituted indoles. 
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single purple spot—indicative of an effortlessly isolable product. Unfortunately, this was never 
the circumstance. 
Figure 25, Lane 1 represents a highly unique occurrence within this series of compounds, 
i.e. the Rf values were distinctive enough to allow for facile separation. Having dealt with 
numerous compounds within this series, the most pragmatic explanation for the separation 
observed in Figure 25 was owed to the H-bonding nature of fluorine. Abidingly, when no 
considerable H-bonding groups existed to differentiate the product, the two Rf values were 
consistently inextricable on silica gel, irrespective of solvent choice. 
 
 
Figure 25. TLC profile highlights the significance of the dehalogenation problem. 
Lane 1 - crude reaction mixture; Lane 2 – boronic acid derivative; Lane 3 – dehalogenated 
by-product; Lane 4 – desired product. The hydrogen-bonding nature of fluorine allowed for 
moderate separation to occur in this particular example; without fluorine these spots would 
share the same exact Rf value, thus overlapping. TLC was developed 1-dimentionally in 25% 
EtOAc/Hexanes on SiO2 and subsequently stained with p-anisaldehyde. Each compound was 
isolated and well identified with NMR spectroscopy and low resolution mass spectrometry. 
Compounds of the 3-phenylindole series habitually flush purple upon p-anisaldehyde 
staining while the less conjugated indoles often flush bright red. This is true of all 
polyhalogenated 2-unsubstituted indoles studied within this research. 
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Figure 26 remarkably illustrates an inseparable example of 
4,6-dichloro-3-(3-chlorophenyl)-1H-indole 55 and its dehalogenated counterpart, 
4,6-dichloro-1H-indole 33. Having a BOC-protected substrate allowed for significantly more 
product to be accessed via Suzuki coupling (Figure 26, Lane 2), yet 55 and 33 were still found 
overlapping in both Lanes 1 & 2 (observed color difference was owed to relative concentrations 
of 55 and 33). Preparative C18 reversed phase HPLC was unequivocally required the resolve 55 
and 33. With the help of BOC protection and HPLC, 15 - 30 mg of each desired polyhalogenated 
3-phenylindole could now be reasonably attained and subjected to various biological assays. 
 
Figure 26. TLC demonstrates the exceptional influence of the BOC 
protecting group during the Suzuki coupling. TLC also demonstrates the 
matching Rf values. Lane 1 – crude reaction mixture resulting from a 
non-protected substrate; Lane 2 – crude reaction mixture resulting from a 
BOC-protected substrate. Purple coloration is indicative of 3-phenylindoles, 
while red is the dehalogenated byproduct. TLC suggests the 
BOC-protecting group significantly suppressed dehalogenation. Recovery 
of purified products confirmed BOC‘s influence (yield of desired product 
was tripled). TLC was developed 1-dimentionally in 25% EtOAc/Hexanes 
on SiO2 and subsequently stained with p-anisaldehyde. Each compound was 
isolated and identified with NMR spectroscopy and low resolution mass 
spectrometry. 
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Scheme 9 provides the complete, optimized synthetic route used to obtain meaningful amounts 
of polyhalogenated 3-phenylindoles. 
With the synthesis outlined in Scheme 9, numerous compounds could be effortlessly 
derivatized from compounds 61, depending solely on the boronic acid introduced at that 
particular juncture. Indeed, many compounds were made this way. If repeating this synthetic 
route, recall 3-iodoindoles are unstable (p. 45) and CANNOT be stored! Consequently, 
indoles 59 are the most stable intermediates to stockpile prior to derivatization. To exemplify 
some of the diversity achieved by Scheme 9, Figure 27 illustrates some select compounds 
synthesized herein by this method. 
Scheme 9
a 
 
a
 Reagents and conditions: (a) zinc dust, sat. aq. NH4Cl, H2O, acetone, ))), room 
temp, 5 min.; (b) NaHCO3, AcCl, Et2O, 0 °C, 1 h, 79% (two steps); (c) 
Li2PdCl4•xH2O, vinyl acetate, HCO2H, reflux, 2 h, 85%; (d) i. EtOH, NaOH, room 
temp, 1 h; ii. KIaq, I2, room temp, 1 h, 95%; (e) CH2Cl2, Boc2O, Et3N, DMAP, room 
temp, 1 h, 95%; (f) phenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 
110 °C, 8 h; (g) C18 reversed phase HPLC, 65% ACN/H2O → 100% ACN, 10 - 35% 
(two steps). 
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3.2.1. Leimgruber-Batcho Indole Synthesis 
When affordable o-nitrotoluenes were readily available, the Leimgruber-Batcho indole 
synthesis was applied to the construction of 6-OH-BDE-47 mimics. The Leimgruber-Batcho 
synthesis is a brief series of reactions in which o-nitrotoluenes 75 are converted to enamines 76 
using N,N-dimethylformamide dimethyl acetal (DMF-DMA) and pyrrolidine, then reductively 
cyclized to afford 1H-indoles 62 (Scheme 10). This particular synthesis is highly efficient when 
the correct starting materials are available. Most appealing, this reaction affords 
2,3-diunsubstited indoles—a valuable feature to the project objectives. 
 
Figure 27. Examples of 6-OH-BDE-47 mimics synthesized by the methods outlined in Scheme 9. As 
will be discussed in the next chapter, all of these compounds successfully mimicked the biological 
activity for which they were designed. 
 54 
Pierre Martin‘s indole synthesis (p. 38) was capable of achieving the exact same 
substitution pattern on indoles 62 as the Leimgruber-Batcho synthesis, but Martin‘s synthesis 
afforded isomeric mixtures if the nitroarene starting materials 56 were not symmetrical. Using 
Martin‘s approach, unsymmetrical polyhalogenated indoles were, in fact, successfully 
synthesized herein (e.g. Figure 24 [p. 47] provides x-ray data of one such indoline intermediate 
isolated using Martin‘s approach). However, because of the short length and ease of synthesis, 
the Leimgruber-Batcho approach was used whenever possible. Generally though, halogenated 
o-nitrotoluenes are difficult to come by commercially (Figure 28). 
Scheme 10
a
 
 
 a
 Reagents and conditions: (a) DMF, DMF-DMA, 
pyrrolidine, 90 °C, 1.5 h; (b) NH4OAc, DMF, H2O, 
20% TiCl3 in 3% HCl, NaOH, 0 °C, 30 min., 90% (two 
steps). 
 
Figure 28. Commercially available halogenated o-nitrotoluenes. 
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Of course, if indoles 62 can be synthesized by the Leimgruber-Batcho method then a 
simple iodination of the C-3 position and subsequent BOC protection stages the derivatization 
junction for which the Suzuki coupling can then be applied. Figure 29 exemplifies a few of the 
indole scaffolds prepared by the Leimgruber-Batcho method during the course of this project. 
3.2.2. Synthesis of Polynitrated 3-Phenylindoles 
6-OH-BDE-47 mimics resulting from this research were continually being subjected to 
biological assays (discussed in next Chapter) and the activity results were periodically conveyed 
back to the synthesis investigators. Results from those assays, and anecdotal evidence from 
others, suggested that the pKa of the indole nitrogen might have influence over the observed 
biological activities, as mentioned earlier (p. 11). What transpired was a move to synthesize 
similar 3-phenylindoles with lowered pKas. In theory, it seemed that placing highly 
electron-withdrawing groups (EWGs) ortho and para to the N-1 position would best pull 
electron density away from the nitrogen, thus stabilizing the conjugate base of the mimics and 
lowering their pKas. One of strongest EWGs known is the NO2 group, and installing this group 
ortho and para to the indole nitrogen was not sincerely straightforward. 
If one wanted to attempt electrophilic aromatic nitration on a naked indole ring it would 
be earnestly impossible to accomplish nitration at the C-7 position (ortho position to the 
nitrogen; recall indole numbering on p. 12). Likewise, Pierre Martin‘s synthesis (p. 38) and the 
 
 
Figure 29. Examples of indole scaffolds synthesized 
herein by the Leimgruber-Batcho indole synthesis. 
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Leimgruber-Batcho indole synthesis (p. 53) were unlikely routes to realize the preferred 
5,7-dinitroindole scaffold. Traditional indole syntheses, e.g. the Fischer indole synthesis, were 
also not contemplated for this investigation because of their antecedent problems (p. 37). As an 
alternative, a new approach was developed herein for accessing the polynitrated 3-phenylindoles. 
Scheme 11 illustrates this notable synthesis. 
Helgen et al.
103
 recently published a straightforward synthetic route towards indoline 83. 
With facile access to 83, the next challenge became oxidizing the indoline to its respective indole 
84. Initially, MnO2 was employed for this experiment as many similar indolines have been 
oxidized in this way.
104-106
 The first oxidation attempt herein used MnO2 in CH2Cl2 at room 
temperature—the reaction failed. Heating the CH2Cl2/MnO2 mixture to reflux was also 
ineffective. Experimenting separately with refluxing benzene, toluene, and 1,4-dioxane 
additionally proved fruitless. Adding protic organic acids to the reaction changed nothing. 
Amusingly, the use of DDQ in refluxing 1,4-dioxane and formic acid promptly oxidized the 
indoline to indole 84 in near quantitative yield. The DDQ reaction was immediately repeated and 
Scheme 11
a 
 
 
a
 Reagents and conditions: (a) AcOH, AcCl, reflux, 5 h, quant.; (b) TFA, NaNO3, room temp, 21 h, 
58%; (c) MeOH, THF, sat. aq. K2CO3, room temp, 3 h, 95%; (d) 1,4-Dioxane, DDQ, HCO2H, reflux, 
13 h, 98%; (e) EtOH, NaOH, KIaq, I2, room temp, 1 h, 95%; (f) CH2Cl2, Boc2O, Et3N, DMAP, room 
temp, 1 h, 95%; (g) 3-nitrophenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 °C, 8 h; 
(h) C18 reversed phase HPLC, 65% ACN/H2O → 100% ACN, 20% (two steps). 
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the results unmistakably confirmed reproducibility. 5,7-dinitroindole 84 was now readily 
available for further chemistries. 
Similarly as established earlier (p. 52), 84 was successfully iodinated at the C-3 position 
and subsequently BOC protected (Scheme 11). Suzuki coupling and purification afforded the 
astonishing trinitrated 3-phenylindole 87, a seemingly stable compound. The pKa of 87 was 
estimated to be around pKa ~10. Though only weakly acidic, 87 was significantly more acidic 
than the corresponding trichloro derivative 55 (p. 53), which had a calculated pKa ~14. Upon 
triumphant synthesis, 87 was submitted to biological screening. Further derivatization of 
iodoindole 86 was postponed to await the assay results. 
3.3. EXPLORING ALTERNATIVE INDOLE-LIKE DERIVATIVES 
Another way in which to lower pKa is to place EWGs in the C-2 position of the indole 
scaffold. Adding additional heteroatoms to the ring, e.g. in the case of purines, also lowers pKa. 
Initially, this tactic was avoided because it was felt that (1) by encumbering the C-2 position with 
functionality the resulting indoles would not provide great overlay with PBDE1 (Figure 18, 
p. 35) and (2) additional heteroatoms were expected to overcomplicate the initial hypothesis. 
With biological proof in hand demonstrating the fungicidal activity of the 3-phenylindole 
series, efforts were next geared towards understanding the constraints of the C-2 position and the 
heteroatom allowances of the heterocyclic system. Figure 30 illustrates general structures of 
desired compounds chosen for this task. 
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Carboxylates 88 were most intriguing from a design perspective because they could be 
easily accessed using the Fischer indole synthesis. Additionally, the carboxylate functionality 
seemed an exquisite attachment point to explore solid-phase chemistries. The idea behind this 
spurred from the notion that the indole core could be bound to resins, Suzuki couplings could be 
accomplished, byproducts and reagents washed away, and the product cleanly cleaved from the 
resin to afford a pure product—no chromatography needed. Synthesis towards this goal began 
shortly before the discovery of the dehalogenation problem that occurred during the Suzuki 
coupling. Scheme 12 directs attention to this first synthetic approach towards carboxylates 88. 
 
 
Figure 30. General indole-like derivatives desired to explore the 
extended constraints of the C-2 position and heterocyclic ring. 
Scheme 12
a
 
 
 
a
 Reagents and conditions: (a) i. AcOH, conc. HCl, 0 °C; ii. NaNO2, H2O, 0 °C; iii. SnCl2, conc. 
HCl, 0 °C, 21 h, 90% (b) abs. EtOH, conc. H2SO4, ethyl pyruvate, reflux, 17 h, 90%; (c) PPA, 70 °C, 
20 min, 92%; (d) THF, LiOH, H2O, reflux, 4 h, 90%; (e) Cs2CO3, KI, Merrifield Resin, DMF, 90 °C; 
(f) iodination or bromination; (g) DME, Pd(PPh3)4, phenylboronic acid, sat. aq. Na2CO3, reflux; (h) 
THF, MeOH, NaOMe, reflux, 17 h. 
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Technically speaking, the solid-phase route of Scheme 12 afforded carboxylate 88, but 
regrettably this particular scheme was also plagued by the now notorious dehalogenation 
problem. That is, the carboxylic acid 95 could easily be linked to Merrifield Resin using the 
prescribed methods of Frenette et al.
107
 and subsequently halogenated with pyridinium 
tribromide
108
 or similar method, however the ensuing Suzuki coupling
108
 gave resin bound 
product 98 in addition to resin bound 99 (Scheme 13). Consequently, when cleaved from the 
resin the resultant product still required HPLC purification. In light of this flaw, the solid-phase 
approach was quickly abandoned for a more direct solution-phase approach. 
The solution-phase route in Scheme 14 allowed the first synthetic access to carboxylate 
88b in sufficient amounts to allow for biological testing. As before, BOC-protection also proved 
fruitful and could easily be protected and deprotected as described before (p. 52). Interestingly, 
compounds from this series elicited absolutely no fungicidal activity when assayed. 
Scheme 13
a
 
 
 
a
 Reagents and conditions: (a) DME, Pd(PPh3)4, phenylboronic acid, sat. aq. Na2CO3, reflux; (b) 
THF, MeOH, NaOMe, reflux, 17 h. 
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In addition to the carboxylates just described, a handful of halogenated indazoles were 
also synthesized and tested for fungicidal behavior. Bewilderingly, they too witnessed a 
significantly diminished activity compared to the 3-phenylindoles, though slightly more activity 
than the carboxylates. Figure 31 illustrates three particular indazoles screened in this study. All 
indazoles were synthesized as outlined in Scheme 15. 
Scheme 14
a
 
 
a
 Reagents and conditions: (a) i. AcOH, conc. HCl, 0 °C; ii. NaNO2, H2O, 0 °C; iii. SnCl2, conc. HCl, 
0 °C, 21 h, 90% (b) abs. EtOH, conc. H2SO4, ethyl pyruvate, reflux, 17 h, 90%; (c) PPA, 70 °C, 20 min, 
92%; (d) EtOH, NaOH, KIaq, I2, room temp, 1 h, 95%; (e) phenylboronic acid, PhH, MeOH, sat. aq. 
Na2CO3, Pd(PPh3)4, 110 °C, 8 h; (f) C18 reversed phase HPLC, 65% ACN/H2O → 100% ACN, 10 - 35% 
(two steps). 
 
Figure 31. Select indazoles synthesized and screened for 
fungicide activity. 
Scheme 15
a
 
 
a
 Reagents and conditions: (a) MeOH, Py, H2NOH•HCl, reflux, 16 h, 89%; (b) CH2Cl2, Et3N, MsCl, 
room temp, 16 h, 19%. 
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The indazoles illustrated in Figure 31 were used to gather preliminary biological data 
before attempting to synthesize the more involved polyhalogenated derivatives. Unfortunately, 
oximes 106 were difficult to acquire in which halogen groups were present on either ring. Few 
benzophenones 105 were commercially available, as only a select few could be synthesized by 
the Friedel–Crafts acylation.109 In attempting to synthesize benzophenones yielding 
polyhalogenated derivatives, difficulties persisted in the Friedel-Crafts acylation. Most likely, 
this could be associated to the overt deactivating nature of the halogen groups. Alternatively, 
indazole 104 was subjected to bromination conditions using Br2 in AcOH.
110
 Di- and 
tri-brominated indazoles resulted though it never was ascertained which positions were 
brominated. Regardless, both partially characterized compounds were subjected to biological 
analysis and both possessed insignificant activities. Perhaps other synthetic routes could have 
been explored to access additional halogenated indazoles, but considering the loss of activity 
witnessed it seemed unwise to pursue indazoles. 
Owing to the considerable loss of fungicidal activity observed in the carboxylate and 
indazole series, further efforts to alter the C-2 position were abandoned and attention was again 
turned to exploring more extensive derivatization of the 3-phenylindoles. Figure 32 demonstrates 
some of the carboxylates, indazoles, and intermediate compounds which possessed little or no 
activity in the fungicide screening. 
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With the successful synthetic routes developed herein, screening assays promptly 
commenced to test the biological activity of the various 6-OH-BDE-47 mimics. Chapter 4 offers 
to discuss the significance of the biological assays and the associate data and methods. 
 
 
Figure 32. Carboxylates, indazoles, and intermediates possessing little or no fungicidal activity. 
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IV. BIOLOGICAL SCREENING OF 
6-OH-BDE-47 AND ITS BIOISOSTERES 
The initial appreciation for 6-OH-BDE-47‘s fungicidal activity came about when extracts 
from the marine sponge Dysidea herbacea were first submitted to Mississippi‘s National Center 
for Natural Products Research wherein the extracts were screened against a number of 
microorganisms and relevant drug controls (Table 5). Once purified from the extracts, 6-OH-
BDE-47 exhibited inhibitory activities comparable to amphotericin B and ciprofloxacin. 
 
 
Table 5. Initial microorganism screen. 
Microorganism Drug Control IC50 (µg/ml)
a
 
MIC 
(µg/ml)
b
 
MFC/MBC 
(µg/ml)
c
 
Candida albicans Amphotericin B 0.18 0.63 0.63 
Candida glabrata Amphotericin B 0.23 1.25 1.25 
Candida krusei Amphotericin B 0.54 1.25 1.25 
Aspergillus fumigatus Amphotericin B 0.43 0.63 2.50 
Cryptococcus neoformans Amphotericin B 0.37 0.63 0.63 
Staphylococcus aureus Ciprofloxacin 0.10 0.25 0.50 
Methicillin-resistant S. 
aureus 
Ciprofloxacin 0.13 0.25 0.50 
Escherichia coli Ciprofloxacin 0.007 0.031 0.13 
Pseudomonas aeruginosa Ciprofloxacin 0.089 1.000 NT 
Mycobacterium 
intracellulare 
Ciprofloxacin 0.34 0.50 NT 
a
The concentration that affords 50% inhibition of growth; 
b
MIC (Minimum Inhibitory Concentration) is 
the lowest test concentration that allows no detectable growth; 
c
MFC/MBC (Minimum 
Fungicidal/Bactericidal Concentration) is the lowest test concentration that kills the organism; NT = not 
tested. Biological data reflects activity of the respective drug controls (not 6-OH-BDE-47). 
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Though 6-OH-BDE-47 elicited both fungicidal and bactericidal activity, its fungicidal 
activity was particularly interesting for the reason that triclosan (p. 8), with its astounding 
structural similarities, could not mimic the fungicidal potency of 6-OH-BDE-47 (hence, triclosan 
is only marketed as an antibacterial agent). With an activity profile established from the 
preliminary screenings, 6-OH-BDE-47 was subsequently slated to undergo SAR studies to 
elucidate the structural features that allowed for its fungicidal behavior. While contemplating the 
SAR study, strong considerations were given to possible industrial applications of 6-OH-BDE-
47, but with such an extremely lipophilic nature (CLog P = 6.7) 6-OH-BDE-47 would require an 
extensive overhaul to reach the bioavailability needs of the human drug market. In contrast to the 
needs of the drug market, a lipophilic character is highly suitable to the agrochemical sector. 
This is because lipophilic compounds can readily incorporate themselves into the waxy leaf 
coatings of many crops wherein they become less prone to removal from the leaf surface by 
rainfall. Following the decision to exploit the agrochemical benefits of 6-OH-BDE-47, it and its 
newly developed synthetic mimics discussed in Chapter 3 were reallocated to a set of assays 
which screened for fungicidal activity in a number of critical fungal phytopathogens, e.g.: 
Botrytic cinerea 
Colletotrichum acutatum 
Collectotrichum fragariae 
Colletotrichum gloeosporoides 
Fusarium oxysporum 
Phomopsis viticola 
Phomopsis obscurans 
 65 
4.1. BIOAUTOGRAPHIC TLC ASSAY 
Originally, the plant pathogen screening was prearranged to be carried out in the plant 
pathology labs of the U.S. Department of Agriculture. There, as a prelude to the extensive 
quantitative reporting required for SAR studies, test compounds were first subjected to a 
qualitative bioautographic TLC assay wherein dissolved test compounds were spotted onto a 
chromatographic silica gel plate (20 X 20 cm).
111, 112
 Suspensions of fungal conidia in nutrient 
rich broths were liberally applied to the TLC plates. Incubation in a humid atmosphere with a 
12 h photoperiod permitted the growth of the fungi. Within 3-4 days, zones of inhibition could be 
observed. Thus, antifungal compounds appeared as clear spots against a colored background 
(Figure 33). 
 
Figure 33. Bioautographic TLC assay of select compounds. Photo 
demonstrates five antifungal compounds (Top Row) and duplicate runs 
(Bottom Row). Background color represents Colletotrichum fragariae spores 
which have freshly germinated hyphae. White spots are indicative of zonal 
inhibition by the various test compounds. Left most TLC: 6-OH-BDE-47. 
 66 
If a compound proved inactive in the USDA‘s bioautography screen it most likely would 
not have moved forward to their more extensive bioassays, i.e. the mycelial growth test and 
detached leaf assay. Due to the high throughput appeal of the bioautography assay, dozens of 
compounds could be qualitatively anaylzed within 3–4 days. 
4.2. MYCELIAL GROWTH TEST 
Once a compound proved active in the USDA‘s bioautography assay, it then progressed 
to the mycelial growth test (also sometimes referred to as a microbroth assay). The mycelial 
growth test involved using 96-well microtiter plates to determine the sensitivity of several 
species of filamentous fungal plant pathogens to the various test compounds.
113
 As an example, 
each well received roughly 90 μL of buffered broth, 100 μL of conidia at ca. 1.0 X 104 colony 
forming units (CFU)/mL in buffered broth, and 10 μL of antifungal solution. In the current study, 
compounds were assayed at 0.3, 3.0, and 30 μM concentrations. Growth of the fungal isolates 
within each well were monitored using a microplate photometer set to record absorbance levels 
at 620 nm. Inoculum density, i.e. CFU per milliliter, was monitored at 48 and 72 hours. 
Graphical output data from the mycelial growth test can be viewed in APPENDIX A (p.166). 
In many cases, the fungal isolates demonstrated suggestively more sensitivity to 6-OH-
BDE-47 and it bioisosteres than the commercially used agrofungicide captan. Precise inhibition 
data cannot, unfortunately, be extrapolated from APPENDIX A because this particular batch of 
compounds was not sufficiently purified prior to the mycelial growth test. Strongly implied from 
the data was that the design concept of the project was heading in a highly positive direction, 
which in turn cultivated a keen yearning to devise an appropriate purification strategy. This 
moment marked the exact turning point in which preparative HPLC experiments were begun and 
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effectively applied towards separating the 3-phenylindoles from their dehalogenated 
counterparts. 
Within six months time, eleven more highly unique—and highly pure—bioisosteres were 
submitted to the USDA‘s mycelial growth test. Sadly, unanticipated health issues had begun 
effecting the collaboration and those eleven compounds were never screened nor were they 
returned. Anectodal observations appeared to suggest that the samples had, in fact, been 
tampered with and even had the samples been returned they would likely not have been reliable 
for resubmition to the biological screening. Because sample supplies were limited at the time, the 
only rational approach to accumulate ample replacements was to resynthesize all eleven 
compounds. 
Further screening with the mycelial growth test was never pursued as the collaborative 
commitments were deteriorating. Alternatives at this jucture were promptly prioritized and 
endeavored. 
4.3. DETACHED LEAF ASSAY 
Despite the failed mycelial growth test attempts, personnel exchanges between the 
University of Mississippi and the USDA made it possible to explore an advanced in vitro assay 
which utilized live plant tissues. In 2008, Wang et al. developed a miniaturized 24-well leaf disk 
bioassay in which 15 mm leaf disks were floated atop a nutrient rich media and inoculated with 
filamentous fungal plant pathogens.
114
 The assay was designed such that compounds could be 
applied directly to the leaf disk surface and evaluated in a dose-response fashion with regard to 
fungicidal activity and phytotoxicity. A Lemnatec Lemna HTS and SAW Scanalyzer (a digital 
imaging and analytical software technology; LemnaTec GmbH, Wuerselen, Germany) was used 
to quantitate dose-response data as required for the SAR study. 
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In the early development of the detached leaf assay, the investigators used 15 mm leaf 
disks harvested from strawberry seedlings. Two week old seedlings were preferred because the 
host defense systems were underdeveloped, thus allowing sufficient infection to take hold once 
inoculated. Strawberry leaves proved susceptible enough to the inoculum conditions such that a 
peer-reviewed publication was granted to the authors.
114
 However, one drawback to using 
strawberry plants was the extreme difficulty in growing them inside the University greenhouse. 
By the time 6-OH-BDE-47 and the synthetic bioisosteres were ready for the detached leaf 
assay, the USDA investigators chose to substitute the strawberry leaf disks with cucumber leaf 
disks. This modification to the assay was primarily done because of the ease at which cucumber 
plants could be grown in the greenhouse. Dauntingly though, this seemingly small adjustment 
required that every attribute of the assay be revalidated—from the nutrient media to the solvent 
systems in which the antifungal compounds were dissolved. 
4.3.1. Nutrient Media Validation 
The first order of business to validate the use of cucumber material in the detached leaf 
assay was to determine which media could best sustain the excised leaf disks. Upon the day of 
media validation, cucumber seedlings were brought from the University greenhouse to the 
USDA‘s plant pathology lab where the leaves were then disinfected and prepared as previously 
described.
114
 A 15-mm stainless steel cork borer was used to harvest the leaf disks. Three 
commerically available salt mixtures were evaluated: half-strength Hoagland‘s No. 2 
(Phytotechnology Laboratories, Shawnee Mission, KS), 2-N-morpholino ethanesulfonic acid 
(MES, Sigma M8250, Sigma-Aldrich, St. Louis, MO), and Murashige and Skoog basal salt 
mixture (M&S, Sigma M5524). The salt solutions were transferred to 24-well microplates (1.5 
mL each well) and the sterilized leaf disks were floated atop the media. Plates were maintained 
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at 25.0 ± 0.1 °C with a 12 h photoperiod for 7-10 days. Throughout the incubation period the 
plates were visually inspected for signs of tissue damage, i.e. leaf discoloration. Figure 34 
represents one such media validation experiment observed at ca. 4 days. 
At the end of the media validation experiments, the investigators chose Murashige and 
Skoog basal salt mixture (M&S) as the media that best sustained the cucumber leaf disks. This 
was different from the previously determined protocol as ½ strength Hoagland‘s No. 2 basal salt 
media was recommended for sustaining the strawberry tissues.
114
 Thus, it was decided that if the 
assay were to continue forward with cucumber leaves, M&S was the new best option for the 
nutrient media. 
 
 
Figure 34. Nutrient media validation. Each 15 mm cucumber leaf disk is floated atop 1.5 mL of 
media. Row A: half strength Hogland‘s No. 2; Row B: Murashige and Skoog basal salt mixture 
(M&S); Row C: 2-N-morpholino ethanesulfonic acid (MES); Row D: water (control). Medias were 
evaluated for their ability to sustain harvested leaf disks for 7-10 days under controlled temperature 
and 12 h photoperiod. Leaf color is indicative of chlorophyll content and, hence, tissue health (dark 
green = healthier tissue). 
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4.3.2. Solvent Validation 
The solvents in which the test compounds were to be dissolved and applied to the leaf 
surface had to meet several criteria to be validated for use in the detached leaf assay. First, the 
proposed solvent, or mixture of solvents, could not be so harsh that it dissolved away the waxy 
cuticle of the leaf. This would cause the leaves to be over susceptible to the onslaught of fungal 
attack and would in turn provide for questionable interpretations of the assay data. Secondly, the 
solvent could not be one which dissolved or etched the microplate. The microplates being used 
were chemically non-resistant to harsh organic solvents such as acetone, DMSO, and CH2Cl2. If 
etched, the microplate would certainly provide for inaccurate data. Thirdly, the solvent had to 
sufficiently dissolve or suspend the test compounds. And lastly, and perhaps most obvious, the 
solvent itself could not elicit toxicity to the leaf material. 
Immediately, the use of organic solvents like acetone, DMSO, and CH2Cl2 was ruled out 
due to their ability to ruin the microplate. Solvent systems exceeding ca. 30–40% EtOH or 
MeOH were barred because they devalued the integrity of the leaf cuticle. Surfactants, e.g. 
Tween® 20, Tween® 80, Cremophor®, etc., could fortunately be used to boost the solubility of 
lipophilic compounds in aqueous mixes, yet their usage was restricted to a maximum 
concentration of ca. 0.7% because they too could ruin the cuticle. Despairingly, 6-OH-BDE-47 
and all its bioisosteres were so extremely lipophilic that they were immensely insoluble in 
water— limiting the use of water. 
With extensive experimentation, 20% EtOH/H2O spiked with 0.5% Tween® 20 provided 
the best opportunity for introducing the compounds onto the leaf surface. Though still insoluble 
within the matrix of this solvent mixture, the mixture provided for a well dispersed suspension. 
The predominate drawback was that the mixture had to be vigorously shaken immediately before 
application onto the leaf surface to insure uniform doses could be administered to each well. 
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4.3.3. Application Considerations 
Application method was another variable which had to be addressed. If, for instance, 20 
μL of antifungal solution were pipetted onto the leaf disk, the compounds often did not disperse 
evenly over the leaf surface. Instead, the hydrophobic nature of the leaf surface often caused the 
tiny dose to bead atop the surface and roll off to one side of the leaf. On the other hand, the leaf 
disk could be dipped into the antifungal solution prior to being placed into the microplate well. 
This method also had flaws because the edges of the leaf disk, which had been freshly cut by the 
cork borer, acted as artificial wounds which allowed test compounds and solvent to unwelcomely 
enter the leaf. Such internalization negatively skewed the assessments of phytotoxicity. In the 
end, dipping was preferred because the inoculum could easily destroy a leaf disk that was not 
well coated with antifungal solution. 
4.3.4. Inoculum Validation 
Depending on the fungal species, isolates were grown on either ½ strength potato 
dextrose agar (PDA) or potato dextrose & oatmeal agar (PO) in 9-cm Petri dishes and incubated 
under fluorescent lighting (55 ± 5 µmols·m
-2
·sec
-1
) at 25 °C as previously described.
115
 Fungal 
conidia were harvested from 7–14 day old solid cultures and filtered through sterile MiraCloth 
(Calbiochem-Novabiochem Corp., La Jolla, CA) to remove hyphae. The aqueous conidial 
suspensions were then analyzed photometrically at 625 nm to determine the stock concentrations 
as described.
113, 114, 116
 Stock suspensions were then diluted to between 1.0 x 10
4–3.0 x 105 
CFU·mL
-1
 using Tween® 20/H2O to aid spore dispersion and infection rate. Of course, as part of 
the validation process, variable Tween® 20 concentrations (0.3, 0.5, & 0.7%) and conidial 
concentrations had to be investigated to determine which set of parameters provided the best 
infection rates. Figure 35 provides once such validation experiment with C. gloeosporioides. 
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C. gloeosporioides, C. fragariae, and B. cinerea all proved too virulent at 
3.0 x 10
5
 CFU·mL
-1
. Follow-up experiments investigating lower conidia concentrations began to 
suggest that cucumber leaf was too susceptible at all standard concentrations of inoculum. Even 
at 1.0 x 10
4
 CFU·mL
-1
 the leaf disks were severely assaulted by the pathogens, i.e. the leaf disks 
were destroyed within 3–4 days—not enough time to gauge the inhibitory effects of the 
antifungal compounds. An infection rate of 7–10 days was preferred. Figure 36 depicts this 
immense virulence C. gloeosporioides had on cucumber. C. fragariae and B. cinerea were 
equally malicious to the cucumber leaves.  
 
 
Figure 35. Validation experiment investigating Tween® 20 concentrations and conidial concentrations. Left 
plate: Infected leaf disks with each well inoculated with 20 μL of conidia at 3.0 x 105 CFU·mL-1. 
Tween® 20 concentrations were randomized. Right plate: Non-inoculated leaf disks. Again, Tween® 20 
concentrations were randomized. As observed in the blank control, Tween® 20 concentrations of 0–0.7% all 
allowed for good sustainability of the leaf tissue. This particular experiment inferred that cucumber leaf was 
extremely too susceptible to these inoculum parameters. Follow-up experiments were done with lower 
conidia concentrations. Photos taken 2–3 days post-inoculation. 
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4.3.5. Antifungal Concentrations 
When following the antifungal concentrations suggested by Wang et al.
114
 (antifungal 
solutions were reported therein as ppm concentrations), the unit conversion suggested 6-OH-
BDE-47 and the bioisosteres should be evaluated at 1.25, 2.5, and 5.0 mM concentrations—
seemingly massive evaluation doses considering the mycelial growth test (APPENDIX A) 
showed 6-OH-BDE-47 and the bioisostere to be active at submicromolar concentrations. In light 
of this, 6-OH-BDE-47 had to undergo validation experiments to determine the optimal dose 
ranges in the detached leaf assay. 6-OH-BDE-47 was tested at concentrations ranging from 
0.5 µM to 5.0 mM. Dosing concentrations above 1.0 mM required astringent solvent conditions 
to solubilize the compound. Phytotoxicity often resulted from these higher compound 
concentrations though it was never ascertained whether it was 6-OH-BDE-47 or the solvent was 
causing the observed phytotoxicity. Figure 37 exemplifies this observed toxicity within the 
assay. 
 
 
Figure 36. Infected leaf disks under evaluation to determine inoculum concentrations. Photos are 
of the same exact plate taken within 24 h. Note the explosion of fungal mycelium on Day 4. 
Experiment suggests cucumber is too susceptible to this pathogen. 
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4.3.6. Detached Leaf Assay Summary 
Attempts to bring together all aspects of the leaf assay—M&S basal salt mixtures, 
excised cucumber leaves, mild conidia concentrations (ca. 1.0 x 10
4
 CFU·mL
-1
), antifungal 
solutions (0.5–1000 µM), etc.—completely failed to provide interpretable data due to the high 
susceptibility of cucumber to the fungal isolates (Figure 37). USDA investigators were amidst 
discussions to start the validation experiments from the beginning in hopes of validating the use 
of yet another plant species, e.g. petunia or grape, but considering several months had already 
been wasted on disastrous attempts to validate cucumber, the project leaders decided to forgo the 
USDA and search for alternative collaborations. Thus, the detached leaf assays, mycelial growth 
tests, and bioautography assays were all abandoned. 
 
 
Figure 37. Phytotoxicity study of 6-OH-BDE-47. Row A: Azoxystrobin applied in 
various concentrations with 50% EtOH/H2O (positive control); Row B: 6-OH-BDE-
47 applied in various concentrations with 75% EtOH/H2O; Row C: 6-OH-BDE-47 
applied in various concentrations with 50% EtOH/H2O; Row D: Blank 50% 
EtOH/H2O (negative control). Bleaching is indicative of phytotoxicity. 
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4.4. HUMAN CELL ASSAY: A TEMPORARY FIX 
While searching for new collaborators who could provide consistently reliable plant 
assay data, the chemists synthesizing the 6-OH-BDE-47 bioisosteres were still in dire need of 
SAR feedback to point the chemistry in a progressive direction. Being that 6-OH-BDE-47‘s 
biological activity was first discovered in a human pathogen assay (p. 63), a snap decision was 
made to temporarily supply the novel synthetics back to this initial collaborator who could at 
least provide some form of meaningful biological activity during the interim. As before, 
compounds were screened against the human pathogens listed in Table 5 (p. 63). APPENDIX B 
provides the complete set of data gathered from the human pathogen assay (p. 175). 
Notable attention was garnered from the carboxylates as none of the compounds from 
this class showed biological activity. On the other hand, their indolic counterparts, which were 
 
 
Figure 38. Photo expresses the high susceptibility of the cucumber leaves. Top Row: 
Blank (control). All other leaf disks were devastated by the pathogen, including the 
positive controls which contained azoxystrobin. 
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unsubstituted in the C-2 position, elicited significant 
biological activity. Even the simplistic 
non-phenylindoles followed this same pattern 
(Figure 39). In fact, this trend was true in all cases 
within these series, regardless of the substituents 
around the fused benzene ring of the indole or the 
phenyl ring occupying the C-3 position. 
From APPENDIX B it is also easy to see 
that the indazoles possessed marginal biological 
activity, often showing activities between that of the 
indoles and carboxylates. In some isolated cases, e.g. 5-chloro-3-phenylindazole 103 and 
Aspergillus fumigatus, the indazoles elicited biological activities that were intriguing. 
Unfortunately, the indazoles failed to demonstrate the same broad spectrum antimicrobial 
activity as the indoles. Thus, the screeners deferred the indazoles from the tertiary screens as the 
3-phenylindoles were more appealing. 
What was certain from the human pathogen assay was that the 3-phenylindole series were 
fungicidal, and in most cases also bactericidal. Compounds such as 4,6-dichloroindoles 32 and 
54 conveyed biological activities exceptionally near that of 6-OH-BDE-47—exactly on course 
with what the project was meant to achieve. Of course, the data from this particular assay could 
only guide the project forward for so long, as questions still remained around the toxicity profiles 
and the utility of these compounds with regard to plant pathogens. Simply put, more biological 
data was demanded which this assay could not produce. The search for new collaborators 
continued. 
 
Figure 39. Examples of carboxylates with no 
biological activity, despite having significantly 
active counterparts. 
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4.5. A NEW COLLABORATION AND 
FUTURE PROMISE FOR 6-OH-BDE-47 BIOISOSTERES 
While at the same time the provisional human pathogen SAR data was being pursued at 
Mississippi‘s National Center for Natural Products Research, project leaders were actively 
seeking an independent lab that could screen 6-OH-BDE-47 and its bioisosteres for fungicidal 
activity in plant tissue assays. With much deliberation, exciting new research agreements were 
locked into place between The University of Mississippi, School of Pharmacy and Syngenta 
Crop Protection, Inc. As per the agreement, Mississippi was to supply Syngenta Crop Protection 
with 6-OH-BDE-47 and seventeen (17) synthetic analogues of the natural product. In return, 
Syngenta Crop Protection was to provide feedback to Mississippi regarding the compounds‘ 
performance within their biological assays, which screened for fungicide, herbicide, nematicide, 
and insecticide activity. 
Exciting to the new venture was the fact that Syngenta Crop Protection was a subsidiary 
of the global agricultural colossus, Syngenta AG (hereinafter ―Syngenta‖). Headquartered in 
Basel, Switzerland, Syngenta boasts a product portfolio that dominates more than 25% of the 
global fungicide market.
28, 117
 In 2008 alone, Syngenta revenued more than US$2.6 billion from 
its global fungicide sales.
117
 Table 8 (p. 79) illustrates several antifungal chemicals which 
Syngenta uses throughout their fungicide product line. Although Syngenta markets dozens of 
agrofungicidal mixtures worldwide, most all of them have unique formulations incorporating 
 
 
Figure 40. 4,6-Dichloroindoles with comparable biological activities to 
6-OH-BDE-47. 
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only those molecules mentioned in Table 8, e.g. azoxystrobin, chlorothalonil, difenoconazole, 
etc. Ironically, the fungicide used as a positive control within many of the USDA‘s bioassays 
mentioned in Section 4.3 (p. 67) was a Syngenta product, azoxystrobin. Further affirming the 
status of Syngenta was a seminal publication by Syngenta scientists Eric Clarke and John 
Delaney in which they put forth a set of ―Lipinski rules for agrochemicals‖.118 Their guidelines 
are referred to as the Clarke-Delaney Rules and are used by chemists to help them design 
compounds with optimal agrochemical properties. 
Upon disclosure of the compound structures to Syngenta, a team of Syngenta scientists 
handpicked 17 synthetic analogs to screen in their pesticide assays. Their preliminary screen for 
fungicidal activity was similar to the USDA‘s mycelial growth test (p. 66) and leaf-piece assay 
(p. 67), although Syngenta chose to screen against seven different fungal crop pathogens. 
Compounds were screened in 96-well plates at concentrations ranging from 2–200 ppm, 
depending on the pathogen of interest (Table 6 & 7). 
Table 6. Mycelial growth tests
a 
Test species Media Rate (ppm) 
Pythium dissimile Semi-solid 20 and 2 
Alternaria solani Semi-solid 20 and 2 
Botryotinia fuckeliana Semi-solid 20 and 2 
Gibberella zeae Semi-solid 20 and 2 
a
 Compounds were evaluated in mycelial growth tests in 
artificial media against Pythium dissimile, Alternaria solani, 
Botryotinia fuckeliana and Gibberella zeae, at rates of 
20ppm and 2ppm. 
 
 
Table 7. Leaf-piece assay
a
 
Test species Host Rate (ppm) 
Septoria tritici Wheat 100 
Phytophthora infestans Tomato 200 and 60 
Uromyces viciae-fabae Bean 100 
a
 The compounds were evaluated at 100ppm against Septoria 
tritici on wheat, and 200ppm and 60ppm for Phytophthora 
infestans on tomato and 100ppm for Uromyces viciae-fabae on 
bean.  Chemicals were applied prior to inoculation in the leaf-piece 
assays. 
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Herbicidal assays were carried out against Arabidopsis thaliana at 10 ppm and Pao 
annua at 32 ppm (Table 9). Compounds were further tested for insecticidal activity against aphid 
species in a leaf-disc assay at 1000 ppm and also evaluated on Plutella xylostella at 500 ppm in 
an artificial diet assay (Table 10). Activity against nematode species were evaluated using 
Caenorhabditis elegans in liquid cultures at 10 ppm (Table 10). 
 
Table 9. Herbicide assays
a 
Test species Treatment timing Rate (ppm) 
Arabidopsis thaliana Pre emergence 10 
Poa annua Pre emergence 32 
a Compounds were tested for herbicidal activity against Arabidopsis 
thaliana at 10ppm and Poa annua at 32ppm. Test plates were stored for 
seven days in a controlled environment cabinet. 
 
Table 10. Insecticide & nematicide assay
a 
Test species Treatment type Media Rate (ppm) 
Aphid species Feeding/contact leaf disc 1000 
Plutella xylostella Feeding/contact Artificial diet 500 
Caenorhabditis elegans Feeding/contact Liquid culture 10 
a
 The compounds were tested for activity against an aphid species in a leaf-disc assay 
at 1000ppm. The compounds were also evaluated at a rate of 500ppm on Plutella 
xylostella in an artificial diet assay and against the nematode species Caenorhabditis 
elegans in liquid culture at 10ppm. Chemicals were applied to feeding aphids, prior to 
infestation with P. xylostella larvae, or diluted into the C. elegans culture. 
 
Syngenta‘s preliminary pesticide assays were meant as a qualitative measure of 
biological activity and, thus, did not seek to explore inhibitory concentrations. Inhibitory 
concentrations would be evaluated during secondary-tier assays if compounds were to advance 
beyond preliminary biological screening. Syngenta‘s methods and results from preliminary 
screening are provided in APPENDIX D (p. 193).  
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4.6. RESULTS AND DISCUSSIONS 
As of the writing of this dissertation, the heterocyclic bioisosteres synthesized to date 
have been screened in the USDA‘s bioautography and mycelial growth tests, the National Center 
for Natural Products Research‘s human pathogen assay, and Syngenta‘s preliminary pesticide 
screens. Though meaningful data can be extracted from these assays, this task is made difficult 
due to less than ideal screening conditions and inconsistencies from assay to assay. Take for 
instance the fact that the USDA‘s bioautography assay was merely qualitative in its assessment 
of fungicidal activity and the mycelial growth test results were similarly qualitative in light of the 
circumstance that compounds were screened prior to appropriate HPLC purification methods 
being developed. The USDA‘s detached leaf assay failed validation studies and, moreover, was 
hampered by defective imaging instrumentation; the opportunity to submit test compounds to the 
detached leaf assay never presented itself. The human pathogen assay data, presented in 
APPENDIX B (p. 175), proved quite useful, but again strayed far from ideal due to the lack of 
agricultural relevance. And though the new collaboration with Syngenta promises the 
opportunity for numerical ranking of test compounds based on their respective inhibitory 
concentrations, the preliminary data provided to date is of qualitative character. 
4.6.1. Insight from the Human Pathogen Assay 
When considering only the human pathogen data, a number 
of conclusions can be drawn around the SAR of the synthetic 
analogues represented by Figure 41. In agreement with early 
studies of the natural PBDEs, blocking the acid/base properties of 
the N-1 position, using protecting groups, abolishes biological 
 
Figure 41. General 
structure of synthetic 
bioisosteres. 
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activity with regard to most pathogens. In the case of A. fumigatus and C. neoformans, some 
biological activity remains though attenuated (APPENDIX B). This data affirms that the N-1 
proton is important to biological activity. 
Derivatives possessing carboxylate functionalities at the C-2 position showed a 
widespread loss of activity across all pathogens studied in the human pathogen assay. Exampled 
carboxylates RAS-06-074, AF-07-005, AF-06-086, and AF-07-041A are all prime examples of 
this activity forfeiture, especially when compared head-to-head with their non-carboxylated 
derivatives, e.g. AF-07-041B, RAS-07-032, and AF-07-024 (APPENDIX B). Replacing the C-2 
carbon atom with a nitrogen atom, as in the case of indazoles RAS-04-080 and RAS-05-006, did 
not completely destroy all activity but the activity was severely diminished. Investigations into 
the carboxylate and indazole series strongly suggested that tampering with the C-2 position very 
negatively affected biological activity. 
In instances like AF-07-041B and AF-07-041C, where the C ring was omitted, activity 
was still maintained though lessened (APPENDIX B). While modes of action are not yet known 
for these compounds, it is reasonable to consider from this data that the C ring may have 
significance in occupying a deep cleft within the enzymatic binding pocket, or alternatively it 
may help with membrane permeation. Regardless of the logic, it seemed obvious that some form 
of C-3 substitution was necessary. 
pKa contributions to activity were interesting to note because pKa ranges of the synthetic 
analogs were calculated to be relatively close to pKa ≈ 14—values significantly higher than that 
of 6-OH-BDE-47 (ca. 6.8). The circumstance of having highly active compounds 10 million-fold 
less acidic than the natural product PBDEs begins to suggest that either the indolic compounds 
inhibit microbial growth via a different mode of action or the donatable N-1 proton is more 
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important for its hydrogen bonding capabilities rather than its acid/base properties. Nonetheless, 
it is thought-provoking that a pKa trend is still observable within the indolic compounds 
(APPENDIX B). Take for example indoles AF-07-018C, AF-07-024, and AF-07-032 which 
contain the halogens fluorine, chlorine, and bromine. Electron withdrawing functionalities 
located around the ring system increase N-1 acidity and it follows that the electron withdrawing 
ability of halogens follows as I < Br < Cl < F, where fluorine is the most electron withdrawing 
halogen and thus most acidifies the indolic proton. In accordance with the pKa hypothesis 
discussed in Chapter 1, AF-07-018C, AF-07-024, and AF-07-032 follow closely this trend of 
potency, i.e. the fluorinated indole (AF-07-018C) is most potent, the chlorinated indole 
(AF-07-024) less so, and the brominated indole (AF-07-032) least potent. 
Exploring the substitution patterns allowed on the C ring gave way to the idea that the 4‘ 
position might be the most influential position on the C ring. APPENDIX B offers examples of 
3-phenylindoles having ortho-, meta-, and para-chloro substitution on the C ring (Figure 41); as 
well, there is an example of a meta/para-dichloro derivative. Data suggests that monosubstitution 
is preferred on the C ring and of the monosubstituted derivatives, the para-substituted 
compounds possessed more potent inhibitory activity. The monosubstituted preference is 
illustrated yet again with RAS-03-016 (R2 = 2‘,4‘-difluoro) and AF-07-018C (R2 = 4‘-fluoro). 
The human pathogen assay revealed relatively little insight as to the allowances around 
the A ring because the 4,6-dichloro- and 4,6-dibromoindoles were predominately the only set of 
compounds screened in this particular assay. What little differences do exist on the A ring again 
suggest that the electron withdrawing strength of the chlorine atoms is preferred to bromine. This 
once more advocates that the more acidic the N-1 proton, the better the biological potency.  
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While a plethora of compounds have since been synthesized with a wide variety of 
substituents occupying different positions around the A and C rings, many of these compounds 
have yet to be screened in biological assays, even at the time of writing this manuscript. Many of 
the more exotically adorned indoles were withheld from the human pathogen assay due their 
limited availability and because there was a much greater demand to submit these compounds to 
a more agriculturally relevant assay. Unfortunately, the USDA‘s detached leaf  assay never 
witnessed the introduction of the bioisosteric compounds and as per the Syngenta agreements, 
Syngenta hand-selected only the compounds in which they were interested. So again, many of 
the compounds synthesized for the purpose of this project have yet to be screened for biological 
activity. 
4.6.2. Insight from Syngenta’s Preliminary Assays 
Little can be said about the structure-activity relationships of the compounds screened in 
Syngenta‘s preliminary fungicide assays (APPENDIX C; p. 183). Few compounds showed 
activity in this assay making it difficult to interpret SAR information. Complicating matters, 
Syngenta screened against seven different fungal pathogens; pathogens that were different from 
all of the USDA‘s biological assays and, of course, different from the human pathogen assays. 
Fungicidal data pertaining to carboxylate RAS-06-074 and meta/para-dichloroindole 
RAS-03-066 (APPENDIX C) fully disagreed with the results discussed above in the human 
pathogen assay. While carboxylates proved inactive against all the human pathogens tested, the 
carboxylates were among very few compounds active against Septoria tritici, a wheat fungal 
pathogen. Additionally, the disubstitution on the C ring allowed for potentiated activity against 
Septoria tritici when compared to the monosubstituted C ring, e.g. RAS-03-010 vs. RAS-03-066 
(APPENDIX C). Intriguingly, even 6-OH-BDE-47 showed relatively little activity against 
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Syngenta‘s array of fungal pathogens. This lack of activity is likely due to selectivity and not 
inhibitor concentrations. Recall that the USDA‘s mycelial growth test showed 6-OH-BDE-47 
activities as low as 0.3 μM (APPENDIX A) while the human pathogen assays exposed activities 
in the range of 40 nM–40 μM, depending on the pathogen (APPENDIX B). Syngenta‘s fungicide 
assays screened 6-OH-BDE-47 and its synthetic bioisosteres at 4–400 μM, concentrations 
10-fold greater than required to elicit biological responses from previous assays. What can be 
deemed from this information is that 6-OH-BDE-47 and the indolic bioisosteres are selectively 
active against particular fungal species. 
Compounds showed no activity in the herbicidal assays (APPENDIX C) which came as a 
relief as it‘s not desirable to elicit toxicity towards the very host one is trying to protect. But with 
no apparent activity in the herbicide assay no conclusions can accurately be drawn about the 
SAR of the compounds. And so attention must be turned to the insecticide and nematicide 
assays. 
At rates of 20 μM–2 mM, Syngenta‘s insecticide assays screened against Caenorhabditis 
elegans, Plutella xylostella, and an aphid species (APPENDIX C). Compounds showed 
selectivity from compound to compound and also from species to species. As with the SAR 
information gathered from the human pathogen assays, the carboxylates presented no activity 
towards the insects while the indazoles appeared to have a diminished amount of activity. Again, 
these assays were qualitative and so direct comparisons are made difficult. In further agreement 
with previous data, the compounds having para-substitution on the C ring provoked more 
inhibitory responses in the insect assay. The more electron withdrawing adornments, and hence 
more acidic compounds, also showed more activities in the assay. 
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Contradictory to the pKa hypothesis was trinitro compound RAS-08-037 (APPENDIX C). 
With a pKa 1000-fold more acidic than the other indoles, RAS-08-037 was expected to have a far 
more improved potency than the other compounds. A passible cause for the deficient activity 
may be related to compound instability. The thought for concern arose when several grams of the 
intermediate 5,7-dinitroindole 84 (p. 120) was found to have decomposed while under an argon 
atmosphere in the freezer for several weeks. Though the stability of RAS-08-037 was not 
determined, it too had remained stored for several weeks before biological screening 
commenced. The stability issues surrounding intermediate compound 84 were not realized until 
weeks after all 3–5 mg of RAS-08-037 were submitted to assay; due to the limited availability of 
RAS-08-037, no compound remained archived for instability studies. Another thought for 
concern is that RAS-08-037 has a much higher polar surface area—about 15-fold greater than 
that of the halogenated indoles and natural products. For purposes of SAR study, it would be 
worthwhile to resubmit a freshly synthesized batch of RAS-08-037 to the biological assays while 
retaining some sample for stability studies. Unfortunately, as per the material transfer agreement 
it will likely be to Syngenta‘s discretion as to whether or not RAS-08-037 can be rescreened. 
Curiously, when no substituents appeared around the C ring as in the case of 
RAS-08-031, or when heteroatoms were incorporated into the C ring as in the case of 
RAS-08-032, all insecticidal activity was abolished (APPENDIX C). Without a wider array of 
compounds tested, it is difficult to discern the reason for the lost activity in these compounds. 
Explanations may include, but are certainly not limited to, changes in the acid/base properties, 
lipophilicity, polar surface area, etc. 
Upon completion of their preliminary biological screens, Syngenta requested permission 
to advance fourteen compounds to their secondary-tier assays which would elucidate inhibitory 
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concentrations and perhaps modes of action. At the time of this writing, the secondary-tier assays 
have not yet been completed. It is expected that further SAR conclusions will be passible once 
secondary-tier assays are complete. 
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V. CONCLUSIONS AND FUTURE DIRECTIONS 
5.1. RESULTS SUMMARY 
With regard to Syngenta‘s preliminary biological data (APPENDIX C), none of the 
compounds were active on either herbicide assay, 12 compounds showed activity on the 
insecticide screens against aphid species & Plutella xylostella, 12 compounds were active on the 
nematicide assay, and 4 compounds showed weak to moderate activity in the fungicide assays 
against Septoria tritici & Alternaria solani. Active compounds have garnered enough industrial 
interest at this point to have progressed into secondary-tier assays where technical attention 
continues. Many compounds synthesized during the course of this dissertation work have 
additionally boasted fungicidal and bactericidal activity in other assays, such as those performed 
by the USDA and National Center for Natural Products Research. 20 compounds elicited 
inhibitory activity against a variety of human pathogens, e.g., Candida albicans and methicillin-
resistant Staphylococcus aureus. 
Exampled IC50s of the synthetic analogs ranged 1–100 μM in the case of screens against 
methicillin-resistant S. aureus, 6–40 μM with regard to C. albicans, and as low as 300 nM 
according to the USDA‘s screens against Botrytis cinerea, Phomopsis obscurans, & Phomopsis 
viticola. Control of nematode populations was observed quite readily at inhibitory concentrations 
ranging 20–40 μM, while the preliminary insecticide assays explored inhibitory concentrations in 
the range of 1–4 mM. 
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While some of these inhibitory concentrations seem quite high compared to 
pharmaceutical uses in humans, it may be important to first consider a commercial example. 
Take for instance the commercial use of the insecticide thiamethoxam, a positive control used in 
Syngenta‘s biological screening (p. 191). Thiamethoxam is a neonicotinoid marketed by 
Syngenta under the brand name Actara
®
, a product which contains 25 wt. % thiamethoxam. To 
protect barley crops against aphids, Syngenta‘s label directs users to apply Actara® at a rate of 
4 oz. per acre (oz./A) in a solvated state consisting of a minimum water volume of 10 gallons per 
acre (GPA). Even at a more conventional 20 GPA volume the commercial application rate of 
thiamethoxam is ca. 1.3 mM, as demonstrated by Equation 1, 
 
 mM 1.3
mol
mmol 1000
g 292
mol
L 75.7
xam thiamethog 28.4
OH gal. 20in  Actara oz. 4 2  , (1) 
 
where 292 g•mol-1 is the molecular weight of thiamethoxam. 
While a number of compounds show acceptable inhibitory concentrations towards a 
variety of microorganisms, it is when all details are considered together that one comes closer to 
understanding the SAR of these compounds. Indolic compounds of this class possessing 
heteroatoms and/or substituents at the C-2 position generally have attenuated biological activity. 
The C ring at the C-3 position appears important for the more potent inhibitory activities and it 
appears that carbocycles are more conducive to biological response than heterocycles. Electron-
withdrawing groups that do not increase polar surface area seem to be preferred at most positions 
around the A and C ring, but they especially seem to be preferred at the 4‘-position of the C ring; 
this is a position having significant electronic influence over the N-1 acidity. Increasing the 
acidity of the indolic proton appears to be a promising strategy for designing compounds with 
 91 
superior potency as long as the polar surface area can remain at a minimum and the C-2 position 
is left untouched. 
Although the original hypothesis of this project endeavored to explore the design and 
synthesis of novel fungicides as they pertained to agrochemical use, the assays have provided an 
interesting twist to the project, evoking that the compounds may prove more valuable to crop 
protection by means of their insecticidal function. Like agrofungicides, the global market for 
insecticides hovers around US$10 billion per year and there exists a substantial interest for 
scientists to continue development of novel insecticides. Along this line of interest, compound 
classes designed and synthesized during the course of this dissertation remain under 
investigational studies with regard to their biological activity and have demonstrated quite 
valuable as investigational tools for use by the agrochemical industry. 
5.2. FUTURE DIRECTIONS 
5.2.1. Chemical Investigations 
5.2.1.1. Suggested Thoughts for Optimization of the Suzuki Cross-Coupling 
Recalling the problems associated with the Suzuki cross-coupling introduced on p. 43, 
there exist a number of possible synthetic approaches to thwart the dehalogenation hurdle and 
boost yields. The synthetic route towards 3-phenylindoles via the Pd-catalyzed hetero-Cope 
rearrangement provides exceptional yields throughout the linear approach but bottlenecks at the 
Suzuki coupling in which the C ring is introduced. As presented in Chapter III, the hetero-Cope 
approach requires 7 synthetic steps to progress substituted nitrobenzenes to final compounds and 
can be diligently completed during the course of an average work week. Overall yields 
associated with this approach linger around 4%, a frustrating disappointment aggravated only by 
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the lost yield of the Suzuki coupling—the last step of the synthesis. If it were possible to enhance 
the yield of the Suzuki coupling to only ca. 70%, the overall yields would witness an 11-fold 
increase, climbing from a modest 4% to a far more pleasing 43% overall yield. 
During the past year, Phil Baran et al. published a promising methodology paper
119
 on 
arylation reactions involving electron-deficient heterocycles with arylboronic acids. Therein they 
present the use of catalytic amounts of silver(I) nitrate (< $1.00 g
-1
) in the presence of a 
persulfate co-oxidant (ca. $0.01 g
-1
). Their reactions proceed under ambient conditions and 
witness yields ranging 30% to >90%. While it is recognized that their methods sought to exploit 
direct C-H arylations of heterocycles with arylboronic acids, it may prove beneficial to perform 
some methodology studies using their coupling conditions to cross-couple substituted 
3-iodoindoles with arylboronic acids. Alternatively, recall that that 3-iodoindoles can easily be 
converted into indoleboronic acids (see Scheme 6; p. 44) and then coupled to other aryl groups, 
perhaps using the silver(I) nitrate and persulfate conditions to promote C-H direct-couplings. 
Other groups have additionally mentioned similar protonolysis problems
120
 as discussed 
herein, but sometimes contribute the problem to coupling partners having significant steric 
hindrance around the coupling handles. Chaumeil et al.
120
 attempted to address this problem with 
anhydrous benzene refluxing in the presence of sodium phenoxide, Pd(PPh3)4, and silver(I) 
carbonate. Their efforts may be worth investigating further with regard to the Suzuki 
cross-couplings discussed herein. 
5.2.1.2. Probing the pKa Questions Surrounding 6-OH-BDE-47 
Pursuing compounds with lowered pKas is still of high interest to the exploring 
hypothesis of this project. While the pKa of 6-OH-BDE-47 is understood to be ca. 6.5, it would 
be interesting to investigate what happens to the biological activity should one be capable of 
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acidifying 6-OH-BDE-47 to a pKa ≈ 1. While transitioning between collaborators, steps were 
being taken to access sulfate esters of 6-OH-BDE-47, but the synthesis was never completed as 
Syngenta‘s team of scientists ultimately chose which compounds would undergo their 
preliminary screening—the sulfate esters were not selected for preliminary screens. Nonetheless, 
it is still desirable to access the sulfate esters of 6-OH-BDE-47 for future biological screening. 
Initial attempts to perform a direct sulfation on 6-OH-BDE-47 using reagents like 
chlorosulfuric acid failed to provide an isolable product because the resulting phenol sulfuric 
acid was NOT hydrolytically stable and, unless neutralized, decomposed to form sulfuric acid 
and the original phenol. An alternative approach that was being pursued is outlined in Scheme 
16, in which an aryl sulfate protecting group strategy
121
 was hoped to allow for isolation of the 
presumably stable sulfate 114. Compound 113 was successfully synthesized in respectable yields 
and well characterized by NMR, but removal of the 2,2,2-trichloroethyl (TCE) moiety via 
hydrogenolysis or Zn/NH4HCO2 was never endeavored as Syngenta‘s compound quota was 
already filled. But should the opportunity for further testing present, it would be worthwhile to 
complete the synthesis of sulfate ester 114 and its phosphate ester counterpart. The acidity of 
these compounds is expected to be pKa ≈ 1 while the PSA is ca. 70 Å
2
. It would be appealing to 
see how these groups effect biological activity. 
Scheme 16
a
 
 
 
a 
Reagents and conditions: (a) 2,2,2-trichloroethoxysulfuryl chloride, Et3N, DMAP, 
THF, room temp.; (b) 10% Pd/C, NH4HCO2, MeOH; or Zn poweder, NH4HCO2, MeOH. 
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5.2.1.3. Optimizing the Partial Reduction of Nitrobenzenes to Hydroxylamines 
The need for performing partial reductions on nitrobenzenes was introduced on p. 39 in 
order to access hydroxylamines which could then be acetylated and subsequently subjected to 
hetero-Cope conditions providing high yields of substituted N-acylindoles. Ung et al. had 
modified a conventional approach (Zn/NH4Cl) to the partial reduction of nitrobenzenes by the 
introduction of ultrasound,
94
 and it was this modified approach which was used throughout this 
project to access various N-aryl hydroxylamines. Though these reaction conditions proved 
exceptionally useful, they rarely went to completion without over reducing and quite often had to 
be stopped when only 60% complete. The other 40% of the crude reaction mixture was often 
recovered as unreacted starting material. 
A slightly more recent approach optimized the ultrasound conditions by instead using a 
convenient Zn/HCOONH4/CH3CN system.
122
 This procedure, reported by Shi and co-workers, 
allowed for repeated yields in excesses of 90%. In optimizing the syntheses described herein, it 
may be sensible to perform some methodology studies regarding the reduction procedures 
communicated by Ung et al.
94
 and Shi et al.
122
 
5.2.1.4. Improving the Protecting Group Strategy and Reflections on the Hetero-Cope 
Acetyl protected N-arylhydroxylamines were pursued as precursory intermediates for the 
hetero-Cope rearrangement due to literature precedence (introduced on p. 37).
86, 98
 Nitrogen 
protection is required for successful hetero-Cope rearrangements of these compounds, but it is 
uncertain as to the allowance of the protecting group functionality. Because late in the synthetic 
development of this project it was discovered that BOC protection of the indole nitrogen 
provided optimal yields during the cross-coupling reactions (p. 48), there was a loss of elegance 
in having to toggle between protecting groups to fit the needs of the cross-coupling step (Scheme 
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9; p. 52). It seems highly possible, though unexplored, that one could instead BOC protect the 
N-arylhydroxylamines and still accomplish the hetero-Cope rearrange to provide a direct route 
towards BOC protected indoles. Porzelle et al. have already reported on chemistries surrounding 
differentially protected N-arylhydroxylamines, including BOC protected analogs.
123
 It seems 
quite likely that using BOC protected intermediates exemplified by Scheme 17 would present a 
facile solution to the drawbacks of the current protection strategy and allow for a more 
streamlined synthesis. Additionally, the expensive Li2PdCl4 required in the hetero-Cope 
rearrangement can be generated in situ using LiCl and PdCl2; this may present a cheaper 
alternative for the hetero-Cope conditions and should be explored further. 
5.2.1.5. Prodrug Considerations 
A recent synthetic study employed a prodrug approach to increasing the antibacterial 
potency of triclosan and successfully illustrated a 4-fold increase in potency when tested against 
Escherichia coli and Plasmodium falciparum.
124
 Because of the structural similarities of triclosan 
and the natural OH-PBDEs (Figure 6; p. 8), it seems appropriate that introducing a prodrug 
Scheme 17
a
 
 
 
a
 Reagents and conditions: (a) zinc dust, sat. aq. NH4Cl, H2O, acetone, ))), room temp, 
5 min.; (b) BOC2O, THF; (c) LiCl, PdCl2, vinyl acetate, HCO2H; (d) EtOH, H2O, KIaq, I2; 
(e) phenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 °C, 8 h; (f) C18 
reversed phase HPLC, 65% ACN/H2O → 100% ACN. 
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functionality mimicking that discussed by Surolia et al. could increase the potency of 6-OH-
BDE-47, and perhaps the synthetic analogs as well. Their approach used a pro-moiety containing 
an amine functionality to enhance hydrophilicity and cellular uptake, as the weakly basic nature 
facilitated accumulation inside the bacterial cells. Scheme 18 exemplifies one such pro-moiety 
used by Surolia et al. 
5.2.1.6. Advice for the Completion of Pipeline Intermediates 
Inopportune circumstances repeatedly halted the flow of synthetic progress throughout 
this project and as a result there exist a number of highly advanced intermediates which never 
secured advancement to final compounds. Several of these advanced intermediates are 
highlighted in Figure 42. Compounds S3 and S4 were the predominate series of compounds 
subjected to biological testing, but there exist more opportunities to exploit the iodine handle for 
derivatizations. Compound S10 was advanced to only one final compound (73; described on 
p. 147) but due to the low quantity that was yielded from that reaction compound 73 never 
visited the biological screenings. Compound 86 was also advanced to only one final compound. 
Scheme 18
a
 
 
 
a
 Reagents and conditions: (a) CH2Cl2, DIPEA; (b) i. CDI, DMF; ii. triclosan, CH2Cl2; 
(c) methyl iodide, THF; (d) Sephadex. 
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And many, but not all, of the compounds listed in Figure 42 have been inventoried in-house on 
multi-gram scales and await further synthetic development. 
 
In addition to the many advanced intermediates mentioned in Figure 42, numerous 
different boronic acids have been purchased and inventoried in-house with the anticipation of 
producing a plethora of final compounds for biological screening and SAR studies. Figure 43 
illustrates many of the boronic acids purchased for this derivatization purpose. Unfortunately due 
to the inconsistent nature of the collaborations discussed herein, less than 50% those boronic 
acids purchased in Figure 43 were actually utilized during the course of this project. By simply 
combining the under exploited indolic intermediates in Figure 42 with only the available boronic 
acids in  Figure 43, one could synthesize 384 possible final compounds for biological 
 
 
Figure 42. Advanced intermediates which were successfully synthesized and described herein, but 
never advanced to final compounds—with the exception of only a few, e.g., S3 and S4. 
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screening—a sum far exceeding the allowed number of compounds screened herein. If the 
diversity-oriented synthesis of these compound classes were to continue, it is advisable to start 
from the readily accessible building blocks outlined in Figure 42 & 43. 
5.2.2. Biological Investigations 
5.2.2.1. Potential for Anticancer Activity 
Recent publications like that of Chang et al. report that 6-OH-BDE-47 and similar 
OH-PBDEs illustrated in Figure 44 showed antiproliferative activities against the human breast 
adenocarcinoma cancer cell line MCF-7 at low micromolar concentrations.
8
 Interestingly, the 
authors progressed 6-OH-BDE-47 to a secondary-tier assay for evaluation in a cell cycle 
progression study. While the synthetic bioisosteres presented herein are expected to possess poor 
bioavailability profiles in mammals, it remains intriguing that, like the OH-PBDEs, they too may 
 
 
Figure 43. Boronic acids purchased and inventoried in-house. Less than 50% were utilized 
during the course of the project due to the inconsistent nature of the collaborations for 
biological screening. 
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possess anticancer activity in in vitro models. If the opportunity presents, the synthetic 
bioisosteres of this dissertation work should be screened in similar MCF-7 biological assays as 
discussed by Chang et al.
8
 
5.2.2.2. Antimalarial Potential 
Publications like that Surolia et al. have pointed out that triclosan elicits low micromolar 
IC50s against the malaria parasite Plasmodium falciparum,
124
 and others have also worked out the 
mechanism of P. falciparum inhibition by triclosan.
125-129
 With the apparent similarities of 
triclosan and compounds discussed herein, it is likely that the synthetic analogs of this 
dissertation work may possess antimalarial activity. If the opportunity presents, the synthetics 
bioisosteres of this dissertation should be screening in similar P. falciparum biological assays as 
discussed by Surolia et al.
124
 
5.2.3. Closing Thoughts 
While there are numerous pesticide options commercially available to farmers, no single 
product is a cure-all for the thousands of crop pests around the world. Over time, regulation 
agencies will undoubtedly ban many of the currently used pesticides as environmental awareness 
continues to grow, while other currently used compounds will assuredly someday loose 
 
 
Figure 44. Chemical structures of compounds isolated from the sponge Dysidea sp. which elicited 
antiproliferative activities against the cancer cell line MCF-7. 
 100 
importance due to the natural development of acquired resistance. And as the world population 
persists to enlarge and farmland remains limited the options for feeding a growing population are 
narrow: farm new land or get more production from existing farmland. Food production will 
have to increase 70% by the 2050
130
 and producing more from less will be essential to 
agriculturalists. The continued development of better ways to protect crops from insects, weeds, 
and disease will be forever important. 
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VI. EXPERIMENTAL 
General methods: 
Moisture- and oxygen sensitive reactions were carried out in flame dried glassware under an 
inert argon atmosphere. Dry tetrahydrofuran (THF), diethyl ether (Et2O), and 1,4-dioxane were 
distilled from sodium metal and benzophenone. Dry dichloromethane (CH2Cl2) was distilled 
from CaH2.  All commercially available starting materials and reagents were purchased at the 
highest commercial quality and used without further purification, unless otherwise stated. 
Reactions were monitored by thin-layer chromatography (TLC) carried out on 225 µm aluminum 
backed TLC sheets coated with silica gel 60 F254 (EMD Chemicals Inc. Gibbstown, NJ, USA). 
TLCs were visualized under UV (254 nm) and by staining with either ethanolic p-anisaldehyde 
stain or aqueous acidic iron(III) chloride solution. NMR spectra were recorded at room 
temperature on Bruker Avance DRX 400 (400 MHz) and DRX 500 (500 MHz) spectrometers. 
The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet. IR spectra were recorded on a Bruker Vector 33 FT-IR 
spectrometer. Electrospray ionization (ESI) mass spectrometry (MS) experiments were 
performed on a Waters ZQ single quadrupole mass spectrometer. High resolution mass spectra 
(HR-MS) were recorded using a Micromass Q-TOF micro instrument. HPLC analysis was 
conducted using a Waters Delta Prep 4000 System with a 7725I Rheodyne injector, a Waters 
2487 Dual Wavelength Absorbance Detector, and a XTerraTM MS C18 5 µm 4.6 x 100 mm 
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Column. Elemental Analysis was obtained using a PerkinElmer 2400 Series II CHNS/O 
Analyzer. 
 
Preparation of bromoindole (S3): 
 
 
Nitrobenzene (20): 
 
Using an adapted method of Chanteau et al.
131
 and Carlin et al.,
132
 NaNO2 (14.90 g, 215.9 mmol, 
3.2 eq) was slowly added to a refluxing solution of 2,6-dibromo-4-nitroaniline (19.80 g, 
66.9 mmol, 1 eq) and conc. H2SO4(aq) (25.0 mL) in EtOH (250 mL). Reaction stirred under air at 
reflux for 40 min before being cooled to RT and subsequently poured onto ice H2O (~400 mL). 
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The resulting crude orange precipitate of nitrobenzene 20 (17.04 g) was collected via vacuum 
filtration over sintered glass and further washed with ice-cold H2O, and later used directly in the 
next step. Rf = 0.23 (100% Hexanes); 
1
H NMR (400 MHz, CDCl3) δ 8.33 (d, J = 1.6 Hz, 2H), 
8.00 (d, J = 1.6 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 281 [M+2]
-
 (100), 279 [M]
-
 (51), 
283 [M+4]
-
 (50). Spectroscopic data provided on p. 194–195. 
 
Hydroxylamine (S1): 
 
Using an adapted method of Ung et al.,
94
 H2O (~67 mL) was added to a suspension of 20 
(17.02 g, 60.6 mmol, 1 eq; p. 102) in acetone (350 mL) and sat. aq. NH4Cl (25 mL) until the 
solution became clear. Zinc dust (8.24 g, 126.8 mmol, 2.1 eq) was added slowly by portions 
while sonicating the mixture at RT for 5-10 min. TLC monitoring (SiO2; 25% EtOAc/Hexanes) 
of the reaction was done until the starting material was no longer getting consumed. Resulting 
zinc salts were filtered off and the filtrate was concentrated in vacuo. Resulting residue was 
partitioned in H2O/EtOAc and extracted with EtOAc (3 x 150 mL). Organic extracts were 
combined and dried over Na2SO4, filtered and concentrated in vacuo to give a crude red oil of S1 
(18.63 g) which was then directly engaged in the following step. Rf = 0.00 (100% Hexanes); 
LRMS (ESI-) m/z: [ion] (rel. int. %) 264 [M-H]
-
 (49), 266 [M-H+2]
-
 (100), 268 [M-H+4]
-
 (51). 
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Hydroxamic acid (21): 
 
Using an adapted method of Lobo et al.,
133
 AcCl (6.19 g, 79.4 mmol, 1.14 eq) was added to a 
solution of S1 (18.63 g, 69.8 mmol, 1 eq; p. 103) and NaHCO3 (6.55 g, 78.0 mmol, 1.12 eq) in 
Et2O (360 mL) stirring under air at 0 °C. Reaction continued stirring for 1 h at 0 °C and was 
subsequently quenched with H2O. The organic layer was set aside and the aqueous layer 
extracted with Et2O (2 x 150 mL). Combined extracts were dried over Na2SO4, filtered and 
concentrated in vacuo, taking care not to allow the temperature to vary above 30–35 °C. Note: 
Product decomposes at temperatures > 35 °C! Purification of the crude residue by flash 
chromatography (35% EtOAc/Hexanes) gave 21 as an off-white solid (10.58 g, 51% over 3 
steps). Rf = 0.46 (50% EtOAc/Hexanes; stains red with FeCl3); LRMS (ESI-) m/z: [ion] (rel. int. 
%) 308 [M-H+2]
-
 (100), 306 [M-H]
-
 (51), 310 [M-H+4]
-
 (51). 
 
N-Acetylindole (24): 
 
Using an adapted method of Martin et al.,
86
 a solution of 21 (10.58 g, 34.2 mmol, 1 eq; p. 104) 
and Li2PdCl4•xH2O (467.0 mg, 1.8 mmol, 0.05 eq) in vinyl acetate (200 mL) was refluxed for 
2 h under argon, after which time 96% formic acid (15 mL, 375.7 mmol, 11.0 eq) was added and 
the reaction continued to stir at reflux for another 40 min. Solvent was removed in vacuo and the 
residue then dissolved in EtOAc (200 mL) and washed with H2O (3 x 50 mL). The organic layer 
was dried over MgSO4, filtered and concentrated in vacuo. Purification of the resulting crude red 
 105 
oil by flash chromatography (20% EtOAc/Hexanes) gave pure 24 as a white solid (7.0 g, 64%). 
Rf = 0.53 (35% EtOAc/Hexanes; stains red with p-anisaldehyde); 
1
H NMR (500 MHz, CDCl3) δ 
8.52 (s, 1H), 7.53 (s, 1H), 7.38 (s, 1H), 6.59 (s, 1H), 2.62 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 
168.56, 135.80, 129.96, 129.10, 126.12, 118.65, 118.53, 114.79, 108.59, 23.89; DEPT-135 (126 
MHz, CDCl3) δ 129.10, 126.13, 118.65, 108.59, 23.89. Elemental Analysis Calcd for 
C10H7Br2NO: C, 37.89; H, 2.23; N, 4.42. Found: C, 37.71; H, 1.96; N, 4.37. Spectroscopic data 
provided on p. 196–198. 
 
Iodoindole (S2): 
 
Using an adapted method of Tanoue et al.,
134
 a solution of 24 (436.2 mg, 1.4 mmol, 1 eq; p. 104) 
and NaOH (126.2 mg, 3.2 mmol, 2.3 eq) in absolute EtOH (25 mL) was stirred under air at RT 
for 1.5 h. KI (226.8 mg, 1.4 mmol, 1 eq) in H2O (2 mL) was added, quickly followed by I2 
(368.3 mg, 1.5 mmol, 1.1 eq). After 1 h at RT, the reaction was quenched with 5% aq. sodium 
metabisulfite and concentrated in vacuo. Upon concentrating, S2 crashed out of solution as an 
off-white solid and was collected by vacuum filtration over sintered glass then washed with H2O 
(533.1 mg, 95%). Product had to be used immediately in subsequent step or else decomposition 
occurred. Rf = 0.31 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) δ 11.97 (s, 1H), 7.68 
(s, 2H), 7.37 (d, J = 1.4 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 400 [M-H+2]
-
 (100), 398 
[M-H]
-
 (51), 402 [M-H+4]
-
 (51). Elemental Analysis Calcd for C8H4Br2IN: C, 23.97; H, 1.01; N, 
3.49. Found: C, 24.21; H, 0.82; N, 3.46. Spectroscopic data provided on p. 199–200. 
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N-Boc-Indole (S3): 
 
Using an adapted method of Mothes et al.,
135
 a solution of iodoindole S2 (1.28 g, 3.18 mmol, 1 
eq; p. 105), Boc2O (1.07 g, 4.90 mmol, 1.6 eq), Et3N (1.50 mL, 10.8 mmol, 3.4 eq), and DMAP 
(276.6 mg, 2.26 mmol, 0.7 eq) in CH2Cl2 (60 mL) was stirred under air at RT for 3 h. Solution 
was washed with 5% aq. sodium metabisulfite (3 x 50 mL) and the organic layer concentrated in 
vacuo to afford crude N-Boc-indole S3 as a yellow solid (1.51 g, 95%). Product was directly 
engaged in next reaction without further purification. Rf = 0.57 (20% EtOAc/Hexanes);
 1
H NMR 
(400 MHz, DMSO) δ 8.31 (s, 1H), 7.91 (d, J = 1.2 Hz, 1H), 7.62 (d, J = 1.6 Hz, 1H), 1.59 (s, 
9H). Elemental Analysis Calcd for C13H12Br2INO2: C, 31.17; H, 2.41; N, 2.80. Found: C, 31.52; 
H, 2.20; N, 2.79. Spectroscopic data provided on p. 201. 
 
Preparation of Chloroindole (S4): 
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3,5-Dichlorophenylhydroxylamine (27): 
 
The same procedure employed in the synthesis of hydroxylamine S1 (p. 103) was followed using 
3,5-dichloronitrobenzene (5.04 g, 26.3 mmol, 1 eq), Zn dust (3.85 g, 59.2 mmol, 2.3 eq), sat. aq. 
NH4Cl (17 mL), H2O (50 mL), with acetone (260 mL) as solvent undergoing sonication for 5-10 
min. at RT. The resulting crude solid (3.78 g) was directly engaged in the next step without 
further purification. Rf = 0.38 (5% EtOAc/Hexanes); LRMS (ESI-) m/z: [ion] (rel. int. %) 176 
[M-H]
-
 (100), 178 [M-H+2]
-
 (66). 
 
N-Phenyl-3,5-dichloroacetylhydroxamic acid (28): 
 
The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed 
using 27 (2.90 g, 16.3 mmol, 1 eq; p. 107), NaHCO3 (1.52 g, 18.1 mmol, 1.1 eq), and AcCl (1.40 
mL, 19.6 mmol, 1.2 eq) with Et2O (85 mL) as solvent for 1 h at 0 °C. Isolation and 
chromatographic purification (10% EtOAc/Hexanes → 20% EtOAc/Hexanes) afforded the title 
compound as an off-white solid (2.63 g, 79% over 2 steps). Rf = 0.21 (10% EtOAc/Hexanes; 
stains red with FeCl3); 
1
H NMR (400 MHz, CDCl3) δ 7.46 (s, 2H), 7.23 (s, 1H), 2.24 (s, 3H); 
LRMS (ESI-) m/z: [ion] (rel. int. %) 218 [M-H]
-
 (100), 220 [M-H+2]
-
 (65), 176 [M-COCH3]
-
 
(40), 178 [M-COCH3+2]
-
 (25). Spectroscopic data provided on p. 202–203. 
 
  
 108 
N-Acetyl-4,6-dichloroindole (29): 
 
The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using 
28 (2.65 g, 11.6 mmol, 1 eq; p. 107) and Li2PdCl4•xH2O (218 mg, 0.83 mmol, 0.07 eq) in vinyl 
acetate (40 mL) for 4 h at reflux, later adding 96% formic acid (5 mL, 125.2 mmol, 10.4 eq) and 
continuing the reflux for another 1 h. Isolation and chromatographic purification (20% 
EtOAc/Hexanes) afforded pure 29 as a yellow solid (2.15 g, 78%). Rf = 0.49 (25% 
EtOAc/Hexanes; stains red with p-anisaldehyde); 
1
H NMR (400 MHz, CDCl3) δ 8.27 (d, J = 0.9 
Hz, 1H), 7.34 (d, J = 3.8 Hz, 1H), 7.19 (d, J = 1.7 Hz, 1H), 6.61 (dd, J = 3.8, 0.6 Hz, 1H), 2.59 
(s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 168.47, 135.75, 130.93, 127.65, 126.16, 126.12, 123.65, 
115.32, 106.76, 23.74; DEPT-135 (101 MHz, CDCl3) δ 126.12, 123.65, 115.32, 106.76, 23.74. 
Elemental Analysis Calcd for C10H7Cl2NO: C, 52.66; H, 3.09; N, 6.14. Found: C, 52.54; H, 2.94; 
N, 6.05. Spectroscopic data provided on p. 204–206. 
 
3-Iodo-4,6-dichloroindole (39): 
 
The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using N-
acetyl-4,6-dichloroindole 29 (498.7 mg, 2.2 mmol, 1.0 eq; p. 108), NaOH (196.6 mg, 4.9 mmol, 
2.2 eq), abs. EtOH (40 mL), I2 (577.2 mg, 2.3 mmol, 1.0 eq), and KI (381.7 mg, 2.3 mmol, 
1.0 eq). Product was collected over a sintered glass filter (579.3 mg, 85%). Rf = 0.49 (25% 
EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) δ 11.94 (s, 1H), 7.64 (s, 1H), 7.49 (s, 1H), 7.07 
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(s, 1H); 
13
C NMR (101 MHz, DMSO) δ 137.63, 134.12, 126.61, 126.04, 122.48, 120.98, 111.67, 
51.78; DEPT-135 (101 MHz, DMSO) δ 134.12, 120.98, 111.67; LRMS (ESI-) m/z: [ion] (rel. int. 
%) 309.7 [M-H]
-
 (100), 311.7 [M-H+2]
-
 (77). Spectroscopic data provided on p. 207–210. 
 
N-Boc-Indole (S4): 
 
The same procedure employed in the synthesis of compound S3 (p. 106) was followed using 39 
(373.6 mg, 1.20 mmol, 1 eq; p. 108), Boc2O (425.0 mg, 1.95 mmol, 1.6 eq), Et3N (0.6 mL, 
4.32 mmol, 3.6 eq), DMAP (82.4 mg, 0.67 mmol, 0.6 eq), and CH2Cl2 (10 mL). Crude product 
presented as a brownish solid which was immediately engaged in the next reaction. 
1
H NMR 
(400 MHz, CDCl3) δ 8.25 (s, 1H), 7.74 (s, 1H), 7.25 (d, J = 1.7 Hz, 1H), 1.66 (s, 9H); LRMS 
(ESI-) m/z: [ion] (rel. int. %) 309.7 [M-C5H9O2]
-
 (100), 311.7 [M-C5H9O2+2]
-
 (66.2). 
Spectroscopic data provided on p. 211–212. 
 
Preparation of Bis(trifluoromethyl)indole (S10): 
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Hydroxylamine (S6): 
 
The same procedure employed in the synthesis of S1 (p. 103) was followed using 3,5-
bis(trifluoromethyl)nitrobenzene (26.6 g, 102.5 mmol, 1 eq), Zn dust (14.1 g, 215.5 mmol, 2.1 
eq), sat. aq. NH4Cl (44 mL), H2O (100 mL), with acetone (500 mL) as solvent undergoing 
sonication for 5-10 min. at RT. The resulting crude solid (33.2 g) was directly engaged in the 
next step without further purification. Rf = 0.63 (50% EtOAc/Hexanes). 
 
Hydroxamic acid (S7): 
 
The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed 
using S6 (33.2 g, 102 mmol, 1 eq; p. 110), NaHCO3 (9.72 g, 115 mmol, 1.1 eq), and AcCl (8.0 
mL, 112 mmol, 1.1 eq) with Et2O (500 mL) as solvent for 14 h. Reaction warmed from 0 °C to 
RT overnight. Crude product was subjected to next reaction conditions without further 
purification. Rf = 0.33 (35% EtOAc/Hexanes; stains red with FeCl3). 
 
N-Acetylindole (S8): 
 
The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using 
27 (30.1 g, 90.0 mmol, 1 eq; p. 110) and Li2PdCl4•xH2O (421.1 mg, 1.61 mmol, 0.02 eq) in vinyl 
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acetate (400 mL) for 3 h at reflux, later adding 96% formic acid (35 mL, 0.84 mol, 9.3 eq) and 
continuing the reflux for another 3.5 h. Isolation and chromatographic purification (25% 
EtOAc/Hexanes) afforded pure N-acetylindole S8 as a white crystalline solid (17.9 g, 59% over 3 
steps). Rf = 0.3 (25% EtOAc/Hexanes; stains red with p-anisaldehyde); 
1
H NMR (500 MHz, 
CDCl3) δ 8.98 (s, 1H), 7.81 (s, 1H), 7.69 (d, J = 3.7 Hz, 1H), 6.88 (s, 1H), 2.71 (s, 3H); 13C 
NMR (126 MHz, CDCl3) δ 168.55, 135.40, 129.39, 129.30, 127.05, 126.79, 125.06, 124.75, 
122.89, 122.87, 122.60, 117.74, 117.70, 117.46, 117.43, 106.87, 23.64; DEPT-135 (126 MHz, 
CDCl3) δ 129.30, 117.74, 117.71, 117.67, 117.46, 117.43, 106.87. Elemental Analysis Calcd for 
C12H7F6NO: C, 48.83; H, 2.39; N, 4.75. Found: C, 48.63; H, 2.12; N, 4.69. Spectroscopic data 
provided on p. 213–216. 
 
Iodoindole (S9): 
 
The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using S8 
(656.1 mg, 2.2 mmol, 1.0 eq; p. 110), NaOH (354.7 mg, 8.9 mmol, 4.0 eq), abs. EtOH (30 mL), 
I2 (645.5 mg, 2.5 mmol, 1.1 eq), and KI (470.0 mg, 2.8 mmol, 1.3 eq). Product collected via 
vacuum filtration over a cellulose filter (849.0 mg, quant.). Rf = 0.3 (25% EtOAc/Hexanes); 
1
H 
NMR (500 MHz, DMSO) δ 9.41 (s, 1H), 8.12 (s, 1H), 8.05 (s, 1H), 7.64 (s, 1H); 13C NMR (126 
MHz, DMSO) δ 140.17, 138.13, 126.48, 125.98, 123.82, 114.80, 114.23, 51.48; DEPT135 (126 
MHz, DMSO) δ 140.17, 114.83, 114.22; LRMS (ESI+) m/z: [ion] (rel. int. %) 380.1 [M+1]+ 
(100). Spectroscopic data provided on p. 217–220. 
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Bis(trifluoromethyl)indole (S10): 
 
The same procedure employed in the synthesis of compound S3 (p. 106) was followed using S9 
(419.7 mg, 1.1 mmol, 1.0 eq; p. 111), Boc2O (339.7 mg, 1.6 mmol, 1.4 eq), Et3N (0.5 mL, 
3.6 mmol, 3.3 eq), DMAP (69.5 mg, 0.6 mmol, 0.5 eq), and CH2Cl2 (7 mL). Crude product 
presented as a brownish solid (445.9 mg, 85%) which was immediately engaged in the next 
reaction. 
1
H NMR (400 MHz, DMSO) δ 8.77 (s, 1H), 8.30 (s, 1H), 7.92 (s, 1H), 1.65 (s, 9H). 
Spectroscopic data provided on p. 221. 
 
Preparation of N-Acetyl-5-chloroindole (S14): 
 
 
N-(4-Chlorophenyl)hydroxylamine (S12): 
 
The same procedure employed in the synthesis of hydroxylamine S1 (p. 103) was followed using 
4-chloronitrobenzene (24.75 g, 157.1 mmol, 1.0 eq), Zn dust (21.2 g, 324.3 mmol, 2.1 eq), sat. 
aq. NH4Cl (65 mL), H2O (175 mL), with acetone (500 mL) as solvent undergoing sonication for 
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5-10 min. at RT. Crude product presented as a yellow solid. The resulting crude product 
(19.23 g) was directly engaged in the next step without further purification. 
 
N-(4-Chlorophenyl)-N-hydroxamic acid (S13): 
 
The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed 
using S12 (19.23 g, 133.5 mmol, 1.0 eq; p. 112), NaHCO3 (12.37 g, 147.3 mmol, 1.1 eq), and 
AcCl (10.5 mL, 147.1 mmol, 1.1 eq) with Et2O (600 mL) as solvent for 19 h. Reaction warmed 
from 0 °C to RT overnight. Isolation and chromatographic purification (60% EtOAc/Hexanes) 
provided 10.48 g of pure product as a yellow solid (36% over two steps). Rf = 0.12 (35% 
EtOAc/Hexanes; stains red with FeCl3). 
 
N-Acetyl-5-chloroindole (S14): 
 
The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using 
S13 (10.48 g, 56.3 mmol, 1.0 eq; p. 113) and Li2PdCl4•xH2O (579.9 mg, 2.2 mmol, 0.04 eq) in 
vinyl acetate (250 mL) for 2 h at reflux, later adding 96% formic acid (24 mL, 601.0 mmol, 
10.7 eq) and continuing the reflux for another 11.5 h. Isolation and chromatographic purification 
(35% EtOAc/Hexanes) afforded pure S14 as a white crystalline solid (6.90 g, 63%). Rf = 0.45 
(35% EtOAc/Hexanes; stains red with p-anisaldehyde); 
1
H NMR (500 MHz, CDCl3) δ 8.32 (d, J 
= 8.7 Hz, 1H), 7.46 (d, J = 1.9 Hz, 1H), 7.35 (d, J = 3.6 Hz, 1H), 7.25 (dd, J = 8.8, 2.0 Hz, 1H), 
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6.50 (d, J = 3.7 Hz, 1H), 2.57 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 168.46, 133.82, 131.61, 
129.07, 126.52, 125.07, 120.35, 117.50, 108.26, 23.68; DEPT-135 (126 MHz, CDCl3) δ 126.52, 
125.07, 120.35, 117.50, 108.27, 23.69. Elemental Analysis Calcd for C10H8ClNO: C, 62.03; H, 
4.16; N, 7.23. Found: C, 61.82; H, 4.03; N, 7.01. Spectroscopic data provided on p. 222–225. 
 
Preparation of N-Acetyl-5-bromoindole (S18): 
 
 
N-(4-Bromophenyl)hydroxylamine (S16): 
 
The same procedure employed in the synthesis of hydroxylamine S1 (p. 103) was followed using 
4-bromonitrobenzene (26.00 g, 128.7 mmol, 1.0 eq), Zn dust (17.3 g, 264.6 mmol, 2.1 eq), sat. 
aq. NH4Cl (53 mL), H2O (150 mL), with acetone (600 mL) as solvent undergoing sonication for 
5-10 min. at RT. Crude product presented as a yellow solid. The resulting crude product (19.35 
g) was directly engaged in the next step without further purification. Rf = 0.33 (35% 
EtOAc/Hexanes). 
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N-(4-Bromophenyl)-N-hydroxamic acid (S17): 
 
The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed 
using S16 (19.35 g, 102.9 mmol, 1.0 eq; p. 114), NaHCO3 (9.65 g, 114.9 mmol, 1.1 eq), and 
AcCl (8.0 mL, 112.1 mmol, 1.1 eq) with Et2O (500 mL) as solvent for 14 h. Reaction warmed 
from 0 °C to RT overnight. Isolation and chromatographic purification (60% EtOAc/Hexanes) 
provided pure product as a solid. Rf = 0.32 (60% EtOAc/Hexanes; stains red with FeCl3). 
 
N-Acetyl-5-bromoindole (S18): 
 
The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using 
S17 (14.67 g, 63.8 mmol, 1.0 eq; p. 115) and Li2PdCl4•xH2O (795.0 mg, 3.0 mmol, 0.05 eq) in 
vinyl acetate (370 mL) for 2 h at reflux, later adding 96% formic acid (28 mL, 0.70 mol, 11.0 eq) 
and continuing the reflux for another 15 h. Isolation and chromatographic purification (35% 
EtOAc/Hexanes) afforded pure S18 as an off-white solid (10.21 g, 33% over 3 steps). Rf = 0.43 
(35% EtOAc/Hexanes; stains red with p-anisaldehyde); 
1H NMR (500 MHz, CDCl3) δ 8.22 (d, J 
= 8.6 Hz, 1H), 7.58 (d, J = 1.6 Hz, 1H), 7.47 – 7.20 (m, 2H), 6.44 (d, J = 3.7 Hz, 1H), 2.52 (s, 
3H); 
13C NMR (126 MHz, CDCl3) δ 168.47, 134.09, 132.09, 127.69, 126.41, 123.38, 117.85, 
116.80, 108.10, 23.73; DEPT-135 (126 MHz, CDCl3) δ 127.69, 126.41, 123.38, 117.85, 108.10, 
23.74. Elemental Analysis Calcd for C10H8BrNO: C, 50.45; H, 3.39; N, 5.88. Found: C, 50.31; 
H, 3.29; N, 5.64. Spectroscopic data provided on p. 226–229. 
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Preparation of Indoles via Leimgruber-Batcho Synthesis: 
 
 
6-Chloroindole (79): 
 
Using an adapted method of Prieto et al.,
136
 a 1000 mL flask was charged with 
4-chloro-2-nitrotoluene (6.92 g, 40.3 mmol, 1.0 eq), DMF-DMA (6.2 mL, 46.3 mmol, 1.2 eq), 
pyrrolidine (3.9 mL, 47.2 mmol, 1.2 eq), DMF (86 mL) and purged with argon. Reaction was 
refluxed for 1.5 h, after which it was cooled to 0 °C. To the flask was added DMF (350 mL), 4 M 
NH4OAc(aq) (175 mL), and 20% TiCl3 in 3% HCl (125 mL, 197.5 mmol, 4.9 eq). Mixture stirred 
under air at 0 °C for 15 min, then 4 M NaOH(aq) was added until pH > 9. Reaction was extracted 
with Et2O (4 x 100 mL) to give light brown solid as crude product. Chromatographic purification 
on silica gel (35% EtOAc/Hexanes) afforded pure product as a yellowish solid (4.30 g, 70%). 
Rf = 0.50 (35% EtOAc/Hexanes; stains red with p-anisaldehyde); 
1H NMR (500 MHz, DMSO) δ 
11.24 (s, 1H), 7.56 (d, J = 8.4 Hz, 1H), 7.48 (s, 1H), 7.44 – 7.37 (m, 1H), 7.02 (dd, J = 8.4, 1.8 
Hz, 1H), 6.47 (s, 1H); 
13C NMR (126 MHz, DMSO) δ 136.78, 126.92, 126.87, 126.13, 121.78, 
119.60, 111.50, 101.75; DEPT-135 (126 MHz, DMSO) δ 126.86, 121.76, 119.59, 111.49, 
101.74. Spectroscopic data provided on p. 230–233. 
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4-Chloroindole (78): 
 
The same procedure employed in the synthesis of 6-chloroindole 79 (p. 116) was followed using 
6-chloro-2-nitrotoluene (6.98 g, 40.7 mmol, 1.0 eq), DMF-DMA (6.2 mL, 44.7 mmol, 1.1 eq), 
pyrrolidine (3.9 mL, 47.2 mmol, 1.2 eq), and DMF (85 mL). Reaction was refluxed 1.5 h, then 
cooled to 0 °C. To the flask was added DMF (350 mL), 4 M NH4OAc(aq) (175 mL), and 20% 
TiCl3 in 3% HCl (100 mL, 158.0 mmol, 3.9 eq). Mixture stirred under air at 0 °C for 15 min, 
then 4 M NaOH(aq) was added until pH > 9. Isolation and chromatographic purification (20% 
EtOAc/Hexanes) afford desired product (3.26 g, 53%) as a red oil. Rf = 0.44 (35% 
EtOAc/Hexanes; stains red with p-anisaldehyde); 
1H NMR (500 MHz, CDCl3) δ 8.16 (s, 1H), 
7.40 (dd, J = 6.6, 1.4 Hz, 1H), 7.31 (d, J = 6.8 Hz, 2H), 7.23 – 7.16 (m, 1H), 6.90 (d, J = 1.9 Hz, 
1H); 
13
C NMR (126 MHz, CDCl3) δ 136.73, 126.92, 126.06, 125.41, 122.84, 119.79, 110.28, 
101.16; DEPT-135 (126 MHz, CDCl3) δ 125.41, 122.84, 119.79, 110.28, 101.16. Elemental 
Analysis Calcd for C8H6ClN: C, 63.38; H, 3.99; N, 9.24. Found: C, 61.90; H, 3.93; N, 9.14. 
Spectroscopic data provided on p. 234–237. 
 
6-Bromoindole (77): 
 
The same procedure employed in the synthesis of 6-chloroindole 79 (p. 116) was followed using 
4-bromo-2-nitrotoluene (4.93 g, 22.8 mmol, 1.0 eq), DMF-DMA (4.6 mL, 34.3 mmol, 1.5 eq), 
pyrrolidine (2.5 mL, 30.2 mmol, 1.3 eq), and DMF (50 mL). Reaction was refluxed 1.5 h, then 
cooled to 0 °C. To the flask was added DMF (200 mL), 4 M NH4OAc(aq) (100 mL), and 20% 
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TiCl3 in 3% HCl (60 mL, 94.8 mmol, 4.2 eq). Mixture stirred under air at 0 °C for 15 min, then 
4 M NaOH(aq) was added until pH > 9. Isolation and chromatographic purification (20% 
EtOAc/Hexanes) afford desired product (2.10 g, 47%) as a light yellowish solid. Rf = 0.47 (35% 
EtOAc/Hexanes; stains red with p-anisaldehyde); 
1
H NMR (500 MHz, DMSO) δ 11.27 (s, 1H), 
7.67 (s, 1H), 7.52 (d, J = 8.4 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.16 (dd, J = 8.3, 1.3 Hz, 1H), 
6.49 (s, 1H); 
13
C NMR (126 MHz, DMSO) δ 137.33, 127.19, 126.78, 122.22, 122.19, 114.51, 
114.20, 101.84; DEPT-135 (126 MHz, DMSO) δ 126.78, 122.22, 122.19, 114.51, 101.84. 
Spectroscopic data provided on p. 238–241. 
 
Preparation N-Boc-indole (86): 
 
 
N-Acetylindoline (81): 
 
Using an adapted method of Helgen et al.,
137
 a 200 mL flask was charged with indoline 80 
(5.29 g, 44.4 mmol, 1.0 eq), AcOH (60 mL), and AcCl (16 mL, 224.2 mmol, 5.0 eq). Solution 
was refluxed under air for 5 h then subsequently concentrated in vacuo to afford product as a 
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light brown solid (7.21 g, quant). Product was subjected to next reaction conditions with no 
further purification. Rf = 0.31 (80% EtOAc/Hexanes); 
1H NMR (400 MHz, CDCl3) δ 8.18 (d, J 
= 8.0 Hz, 1H), 7.14 (dd, J = 14.3, 7.2 Hz, 2H), 6.96 (t, J = 7.4 Hz, 1H), 3.93 (t, J = 8.5 Hz, 2H), 
3.10 (t, J = 8.5 Hz, 2H), 2.14 (s, 3H); 
13
C NMR (101 MHz, CDCl3) δ 168.67, 142.88, 131.18, 
127.38, 124.52, 123.48, 116.79, 48.68, 27.89, 24.16; DEPT-135 (101 MHz, CDCl3) δ 127.38, 
124.52, 123.48, 116.79, 48.67, 27.89, 24.16; LRMS (ESI+) m/z: [ion] (rel. int. %) 161.9 [M+1]
+
 
(100). Spectroscopic data provided on p. 242–245. 
 
N-Acetyl-5,7-dinitroindoline (82): 
 
Using an adapted method of Helgen et al.,
137
 NaNO3
 
(12.40 g, 145.9 mmol, 2.9 eq), TFA 
(75 mL), and indoline 81 (8.10 g, 50.2 mmol, 1.0 eq; p. 118) were stirred under air at RT for 
20.5 h then poured over ice cold H2O. Precipitate was collected via vacuum filtration over 
cellulose. Precipitate was recrystallized from hot toluene/EtOH (1:1) to afford pure product as 
yellow crystals (10.56 g, 84%). NOTE: Rubber septa should NOT be used because the 
corrosive conditions will dissolve the septa. Rf = 0.18 (80% EtOAc/Hexanes; stains yellow 
with p-anisaldehyde); 
1H NMR (400 MHz, DMSO) δ 8.40 (d, J = 5.0 Hz, 2H), 4.35 (t, J = 8.3 
Hz, 2H), 3.32 (t, J = 8.2 Hz, 2H), 2.25 (s, 3H); 
13C NMR (101 MHz, DMSO) δ 169.76, 143.05, 
140.34, 139.61, 138.67, 124.02, 119.56, 51.00, 28.48, 23.71; DEPT-135 (101 MHz, DMSO) δ 
124.02, 119.56, 51.00, 28.48; LRMS (ESI-) m/z: [ion] (rel. int. %) 250.7 [M]
-
 (100). 
Spectroscopic data provided on p. 246–249.  
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5,7-Dinitroindoline (83): 
 
Using an adapted method of Helgen et al.,
137
 N-acetylindoline 82 (10.56 g, 42.0 mmol, 1.0 eq; 
p. 119), MeOH (200 mL), THF (100 mL), and NaOH (10.12 g, 253.0 mmol, 6.0 eq) were stirred 
under air at RT for 3 h and thereafter concentrated in vacuo. H2O was added to the residue and 
the product was collected via vacuum filtration over sintered glass. Additional material was 
obtained by extracting the filtrate with EtOAc. Product presented as a light brown solid (6.07 g, 
69%). Rf = 0.52 (100% EtOAc; stains yellow with p-anisaldehyde); 
1
H NMR (400 MHz, DMSO) 
δ 9.01 (s, 1H), 8.51 (d, J = 2.1 Hz, 1H), 7.94 (s, 1H), 3.88 (t, J = 8.4 Hz, 2H), 3.16 (t, J = 8.2 Hz, 
2H); 
13C NMR (101 MHz, DMSO) δ 152.08, 137.87, 136.06, 125.71, 122.98, 121.51, 48.20, 
27.02. Spectroscopic data provided on p. 250–251. 
 
5,7-Dinitroindole (84): 
 
A 500 mL flame dried flask was charged with 5,7-dinitroindoline 83 (6.16 g, 29.5 mmol, 1.0 eq; 
p. 120), DDQ (12.04 g, 53.0 mmol, 1.8 eq), and anhydrous 1,4-dioxane (350 mL). Reaction was 
refluxed under argon for 15 min, at which time 96% formic acid (5.0 mL, 130.4 mmol, 4.4 eq) 
was added. Reflux was continued for 18 h and subsequently the reaction was concentrated in 
vacuo. The resulting residue was dissolved in EtOAc and then washed with sat. aq. K2CO3 
(6 x 200 mL) until the aqueous layers were colorless. The organic layer was dried (Na2SO4), 
filtered, and concentrated in vacuo to afford the desired product as a yellow solid (5.65 g, 93%) 
which could be recrystallized from hot EtOAc. 
1H NMR (400 MHz, DMSO) δ 12.43 (s, 1H), 
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8.83 (d, J = 2.0 Hz, 1H), 8.61 (d, J = 2.1 Hz, 1H), 7.74 – 7.59 (m, 1H), 6.91 (d, J = 2.3 Hz, 1H); 
13
C NMR (101 MHz, DMSO) δ 139.58, 132.47, 132.17, 131.82, 130.59, 123.71, 113.67, 106.27; 
DEPT-135 (101 MHz, DMSO) δ 132.47, 123.71, 113.67, 106.27; LRMS (ESI-) m/z: [ion] (rel. 
int. %) 205.7 [M-H]
-
 (100). Spectroscopic data provided on p. 252–255. 
 
3-Iodo-5,7-dinitroindole (85): 
 
The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using 84 
(105.4 mg, 0.51 mmol, 1.0 eq; p. 120), NaOH (53.7 mg, 1.34 mmol, 2.6 eq), and abs. EtOH 
(8 mL). Reaction was stirred under air at RT for 15 min and thereafter I2 (155.1 mg, 0.61 mmol, 
1.2 eq) and KI (98.9 mg, 0.60 mmol, 1.2 eq; dissolved in 1 mL of H2O) were added. Reaction 
continued to stir under air at RT for 2 h. Product collected via vacuum filtration over a cellulose 
filter (160.0 mg, 94%). 
1
H NMR (400 MHz, DMSO) δ 12.85 (s, 1H), 8.79 (d, J = 2.0 Hz, 1H), 
8.45 (d, J = 2.0 Hz, 1H), 7.93 (s, 1H). Spectroscopic data provided on p. 256. 
 
N-Boc-indole (86): 
 
The same procedure employed in the synthesis of compound S3 (p. 106) was followed using 85 
(109.3 mg, 0.33 mmol, 1.0 eq; p. 121), Boc2O (104.8 mg, 0.48 mmol, 1.5 eq), Et3N (150 µL, 
1.1 mmol, 3.3 eq), DMAP (18.2 mg, 0.15 mmol, 0.5 eq), and CH2Cl2 (2 mL). Crude product 
presented as a brownish solid (140.0 mg, 98%) which was immediately engaged in the next 
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reaction. 
1
H NMR (400 MHz, DMSO) δ 8.77 (s, 1H), 8.30 (s, 1H), 7.92 (s, 1H), 1.65 (s, 9H). 1H 
NMR (400 MHz, DMSO) δ 8.64 (d, J = 2.0 Hz, 1H), 8.36 (d, J = 2.0 Hz, 1H), 8.26 (s, 1H), 1.56 
(s, 9H); 
13C NMR (101 MHz, DMSO) δ 147.02, 143.08, 137.55, 137.21, 135.95, 127.43, 121.89, 
116.67, 87.88, 67.44, 27.67; DEPT-135 (101 MHz, DMSO) δ 137.21, 121.89, 116.67, 27.67. 
Spectroscopic data provided on p. 257–259. 
 
Preparation of Ethyl Carboxylate (S23): 
 
 
3,5-Dibromoaniline (S19): 
 
Using an adapted method of Chanteau et al.,
131
 SnCl2·2H2O (19.65 g, 87.1 mmol, 4.9 eq) was 
added to a room temperature solution of 3,5-dibromonitrobenzene 20 (5.02 g, 17.8 mmol, 1.0 eq) 
in abs. EtOH (40 mL) and THF (40 mL). Solution was stirred under air at RT for 15 h, after 
which the solvent was removed in vacuo and 4 M NaOH(aq) was added. Solution was stirred 
under air at RT for 6 h and the slurry was subsequently extracted with Et2O. The combined 
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organic layers were dried (MgSO4), filtered, and concentrated in vacuo to provide pure product 
as a yellowish-brown solid (3.73 g, 83%). Rf = 0.45 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, 
CDCl3) δ 7.02 (s, 1H), 6.75 (d, J = 1.5 Hz, 2H), 3.78 (s, 2H); LRMS (ESI-) m/z: [ion] (rel. int. 
%) 247.7 [M-H]
-
 (47), 249.7 [M-H+2]
-
 (100), 251.8 [M-H+4]
-
 (51). Spectroscopic data provided 
on p. 260–261. 
 
3,5-Dibromophenylhydrazine hydrochloride (S20): 
 
Using an adapted method of Jansen et al.
138
 and Chattaway et al.,
139
 conc. HCl was added to a 
solution of aniline S19 (9.34 g, 37.2 mmol, 1.0 eq; p. 123), in AcOH (150 mL) until a thin paste 
was achieved. The suspension was cooled to -4 °C and subsequently a -4 °C solution of NaNO2 
(2.81 g, 40.7 mmol, 1.1 eq) in H2O (20 mL) was slowly added, insuring that the internal 
temperature of the reaction remained below 0 °C. Manual stirring was necessary as the 
suspension was too thick for magnetic stirring. Stirring continued under air at -4 °C for 15 min. 
Next was slowly added a -4 °C solution of SnCl2·2H2O (17.0 g, 75. 4 mmol, 2.0 eq) in a minimal 
amount of conc. HCl, again making certain not to allow the reaction to warm above 0 °C. 
Reaction continued to stir under air at -4 °C for 1 h. Precipitate was collected via vacuum 
filtration over sintered glass and washed with ice cold 1 M HCl(aq) then dissolved in a minimal 
amount of boiling 1 M HCl(aq). Product recrystallized upon slow cooling towards room 
temperature (7.42 g, 66%). 
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Hydrazone (S21): 
 
Using an adapted method of Cugola et al.,
140
 a solution of hydrazine S20 (7.42 g, 24.5 mmol, 
1.1 eq; p. 123), abs. EtOH (50 mL), 9 M H2SO4(aq) (2 mL), and ethyl pyruvate (2.6 mL, 
23.4 mmol, 1.0 eq) was stirred under argon at reflux for 5.5 h. Reaction was poured into ice cold 
H2O and extracted with Et2O (3 x 150 mL). Organic layers were combined, dried (Na2SO4), 
filtered, and concentrated in vacuo to afford crude product as a yellow solid (9.2 g, quant.). 
Product was directly engaged in next reaction without further purification. E/Z isomers Rf = 0.39 
& 0.67 (20% EtOAc/Hexanes). 
 
Ethyl 4,6-dibromoindole-2-carboxylate (S22): 
 
Using an adapted method of Cugola et al.,
140
 a mixture of hydrazone S21 (9.2 g, 24.5 mmol, 
1.0 eq; p. 124) in PPA (32.5 g) was heated under air at 90 °C for 20 min until the mixture 
thinned and became paste-like. To this paste was added 400 mL H2O and then extracted with 
Et2O (3 x 150 mL). Organic layers were combined, dried (Na2SO4), filtered, and concentrated in 
vacuo to afford pure product as a light brown solid (7.0 g, 82%). Rf = 0.43 (20% 
EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) δ 12.41 (s, 1H), 7.61 (s, 1H), 7.45 (s, 1H), 6.98 
(s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 1.33 (t, J = 7.1 Hz, 3H); 
13
C NMR (101 MHz, DMSO) δ 
161.02, 138.09, 129.41, 126.92, 125.62, 117.41, 116.26, 115.18, 107.37, 61.41, 14.63; 
DEPT-135 (101 MHz, DMSO) δ 125.63, 115.19, 107.37, 61.41, 14.63; LRMS (ESI-) m/z: [ion] 
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(rel. int. %) 343.7 [M-H]
-
 (50), 345.7 [M-H+2]
-
 (100), 347.7 [M-H+4]
-
 (54). Elemental Analysis 
Calcd for C11H9Br2NO2: C, 38.07; H, 2.61; N, 4.04. Found: C, 38.35; H, 2.51; N, 3.96. 
Spectroscopic data provided on p. 262–265. 
 
Ethyl carboxylate (S23): 
 
The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using S22 
(426.8 mg, 1.23 mmol, 1.0 eq; p. 124), NaOH (55.1 mg, 1.38 mmol, 1.1 eq), and abs. EtOH 
(26 mL). Reaction was stirred under air at RT for 15 min and thereafter I2 (333.1 mg, 1.31 mmol, 
1.1 eq) and KI (212.0 mg, 1.28 mmol, 1.0 eq; dissolved in 2.5 mL of H2O) were added. Reaction 
continued to stir under air at RT for 1 h. Product collected via vacuum filtration over a cellulose 
filter and washed with H2O (552.5 mg, 95%). Rf = 0.43 (25% EtOAc/Hexanes); 
1
H NMR (400 
MHz, DMSO) δ 12.68 (s, 1H), 7.71 (d, J = 1.3 Hz, 1H), 7.46 (d, J = 1.3 Hz, 1H), 4.36 (q, J = 7.1 
Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H); 
13
C NMR (101 MHz, DMSO) δ 160.36, 138.57, 129.80, 
128.35, 124.32, 117.71, 117.19, 115.99, 63.01, 61.67, 14.62; DEPT-135 (101 MHz, DMSO) δ 
128.34, 115.99, 61.67, 14.62; LRMS (ESI-) m/z: [ion] (rel. int. %) 469.7 [M-H]
-
 (50), 471.8 [M-
H+2]
-
 (100), 473.7 [M-H+4]
-
 (50). Spectroscopic data provided on p. 266–269. 
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Preparation of Ethyl Carboxylate (S28): 
 
3,5-Chlorophenylhydrazine hydrochloride (S25): 
 
The same procedure employed in the synthesis of compound S20 (p. 123) was followed using 
3,5-dichloroaniline (5.10 g, 31.48 mmol, 1 eq) in AcOH (20 mL) adding conc. HCl until a thin 
paste was achieved. Subsequently was added NaNO2 (2.40 g, 34.78 mmol, 1.1 eq) in H2O 
(15 mL) and then SnCl2·2H2O (21.61 g, 95.78 mmol, 3.0 eq) in conc. HCl (40 mL). Precipitate 
was collected after 17.5 h at -4 °C to afford hydrazine S25 (3.29 g, 49%) as a white solid. LRMS 
(ESI+) m/z: [ion] (rel. int. %) 176.9 [M-Cl]
+
 (100), 178.9 [M-Cl+2]
+
 (92); m.p. = 219 °C. 
Spectroscopic data provided on p. 270. 
 
Hydrazone (S26): 
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The same procedure employed in the synthesis of compound S21 (p. 124) was followed using 
hydrazine S25 (2.0 g, 9.37 mmol, 1.1 eq; p. 126), abs. EtOH (20 mL), 1.5 M H2SO4(aq) (2.0 mL), 
and ethyl pyruvate (1.0 mL, 9.01 mmol, 1.0 eq) stirred under argon at reflux for 5 h. A cold 
H2O/Et2O workup afforded the desired crude product from the organic extracts as a yellow solid 
(2.21 g, 86%). No further purification was required for next step. E/Z isomers Rf = 0.34 & 0.60 
(20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.79 (s, 1H), 7.10 (s, 2H), 6.92 (s, 1H), 
4.33 (q, J = 7.1 Hz, 2H), 2.10 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H); LRMS (ESI-) m/z: [ion] (rel. int. 
%) 272.9 [M-H]
-
 (100), 274.9 [M-H+2]
-
 (63). Spectroscopic data provided on p. 271–272. 
 
Ethyl 4,6-dichloroindole-2-carboxylate (S27): 
 
The same procedure employed in the synthesis of compound S22 (p. 124) was followed using 
S26 (1.31 g, 4.76 mmol, 1.0 eq; p. 126) in PPA (6.61 g) heated to 105 °C for 30 min. An 
EtOAc/H2O workup afforded S27 as a yellow solid (1.14 g, 93%). Rf = 0.58 (20% 
EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3) δ 9.24 (s, 1H), 7.35 (d, J = 1.2 Hz, 1H), 7.31 – 
7.28 (m, 1H), 7.18 (d, J = 1.6 Hz, 1H), 4.45 (q, J = 7.1 Hz, 2H), 1.44 (t, J = 7.1 Hz, 3H); 
13
C 
NMR (101 MHz, CDCl3) δ 161.66, 137.08, 131.04, 128.50, 128.40, 125.34, 121.29, 110.54, 
107.11, 61.56, 14.32; IR (film) νmax 3317, 1699 cm
-1
; LRMS (ESI-) m/z: [ion] (rel. int. %) 227.8 
[M-CH2CH3]
-
 (84), 229.8 [M-CH2CH3+2]
-
 (57), 255.8 [M-H]
-
 (100); 257.8 [M-H+2]
- 
(65). 
Spectroscopic data provided on p. 273–276. 
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Ethyl Carboxylate (S28): 
 
The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using S27 
(500.5 mg, 1.94 mmol, 1.0 eq; p. 127), NaOH (85.3 mg, 2.13 mmol, 1.1 eq), and abs. EtOH 
(20 mL). Reaction was stirred under air at RT for 15 min and thereafter I2 (543.6 mg, 2.14 mmol, 
1.1 eq) and KI (321.9 mg, 1.94 mmol, 1.0 eq; dissolved in 2 mL of H2O) were added. Reaction 
continued to stir under air at RT for 1 h. Product collected via vacuum filtration over a cellulose 
filter and washed with H2O (600.1 mg, 81%). Rf = 0.35 (20% EtOAc/Hexanes); 
1
H NMR (500 
MHz, DMSO) δ 7.52 (s, 1H), 7.20 (s, 1H), 4.39 (s, 2H), 1.39 (s, 3H); 13C NMR (126 MHz, 
DMSO) δ 160.36, 138.45, 129.81, 129.58, 128.50, 123.41, 122.55, 112.48, 61.63, 61.15, 14.65; 
DEPT-135 (126 MHz, DMSO) δ 122.54, 112.47, 61.62, 14.65. Elemental Analysis Calcd for 
C11H8Cl2INO2: C, 34.41; H, 2.10; N, 3.65. Found: C, 32.10; H, 2.08; N, 3.42. Spectroscopic data 
provided on p. 277–280. 
 
4,6-Dichloroindole-2-carboxylic acid (S29): 
 
Using an adapted method of Salituro et al.
141
 and Jansen et al.,
138
 a solution of carboxylate S27 
(1.14 g, 4.96 mmol, 1.0 eq; 127), THF (20 mL), H2O (4 mL), LiOH·H2O (285.0 mg, 6.79 mmol, 
1.4 eq) was stirred under air at reflux for 1 h. The solution was then cooled to RT and 
concentrated in vacuo. H2O (150 mL) was added and then acidified with 6 M HCl(aq) and 
extracted with EtOAc (3 x 50 mL). Organic extracts were combined, dried (Na2SO4), filtered, 
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and concentrated in vacuo to afford crude product (0.92 g, ca. 90%). Rf = 0.00 (20% 
EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) δ 13.34 (s, 1H), 12.28 (s, 1H), 8.26 – 6.25 (m, 
3H); LRMS (ESI-) m/z: [ion] (rel. int. %) 227.8 [M-H]
-
 (100), 229.8 [M-H+2]
-
 (97). 
Spectroscopic data provided on p. 281. 
 
Preparation of 5,7-Dibromoindole-2-carboxylic acid (S33): 
 
 
2,5-Dibromopheneyl hydrazine (S31): 
 
The same procedure employed in the synthesis of compound S20 (p. 123) was followed using 
2,5-dichloroaniline (2.02 g, 6.68 mmol, 1.0 eq) in AcOH (16 mL) adding conc. HCl until a thin 
paste was achieved. Subsequently was added NaNO2 (621.0 mg, 9.00 mmol, 1.3 eq) in H2O 
(10 mL) and then SnCl2·2H2O (5.52 g, 24.47 mmol, 3.7 eq) in conc. HCl (16 mL). Precipitate 
was collected after 26 h at -4 °C to afford hydrazine S31 (1.07 g, 44%) as a white solid which 
was subjected to the next reaction without further purification. 
 130 
 
Hydrazone (S32): 
 
The same procedure employed in the synthesis of compound S21 (p. 124) was followed using 
hydrazine S31 (1.06 g, 3.51 mmol, 1.0 eq; p. 129), abs. EtOH (7.0 mL), 2.4 M H2SO4(aq) 
(0.6 mL), and ethyl pyruvate (0.40 mL, 3.60 mmol, 1.0 eq) stirred under argon at reflux for 19 h. 
A cold H2O/Et2O workup afforded the desired crude product from the organic extracts as a 
yellow solid (1.01 g, 80%). No further purification was required for next step. Rf = 0.69 (20% 
EtOAc/Hexanes); LRMS (ESI-) m/z: [ion] (rel. int. %) 247.7 [M-C5H8NO2]
-
 (43), 249.7 [M-
C5H8NO2+2]
-
 (82), 251.7 [M-C5H8NO2+4]
-
 (45), 332.8 [M-C2H5]
-
 (53), 334.8 [M-C2H5+2]
-
 
(100), 336.8 [M-C2H5+4]
-
 (57). Spectroscopic data provided on p. 282. 
 
Ethyl 5,7-Dibromoindole-2-carboxylate (S33): 
 
The same procedure employed in the synthesis of compound S22 (p. 124) was followed using 
S32 (0.99 g, 2.72 mmol, 1.0 eq; p. 130) in PPA (4.16 g) heated to 105 °C for 30 min. An 
EtOAc/H2O workup afforded S33 as a yellow solid (0.85 g, 90%). Rf = 0.55 (20% 
EtOAc/Hexanes); 
1H NMR (400 MHz, CDCl3) δ 9.14 (s, 1H), 7.56 (dd, J = 19.2, 4.9 Hz, 1H), 
7.34 (dd, J = 10.0, 1.9 Hz, 1H), 7.27 (s, 1H), 4.47 (dd, J = 14.2, 7.1 Hz, 2H), 1.47 (t, J = 7.2 Hz, 
3H); LRMS (ESI-) m/z: [ion] (rel. int. %) 315.7 [M-CH2CH3]
-
 (51), 317.8 [M-CH2CH3+2]
-
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(100), 319.8 [M-CH2CH3+4]
-
 (51); 343.8 [M-H]
- 
(18), 345.8 [M-H+2]
- 
(36), 347.8 [M-H+4]
- 
(18). Spectroscopic data provided on p. 283–284. 
 
5,7-Dibromoindole-2-carboxylic acid (S34): 
 
The same procedure employed for the synthesis of S29 (p. 128) was followed using carboxylate 
S33 (0.76 g, 2.19 mmol, 1.0 eq; p. 130), THF (100 mL), H2O (11 mL), LiOH·H2O (285.0 mg, 
6.79 mmol, 3.1 eq) stirring under air at reflux for 17 h. The solution was then cooled to RT and 
concentrated in vacuo. H2O (150 mL) was added and then acidified with 6 M HCl(aq) and 
extracted with EtOAc (3 x 50 mL). Organic extracts were combined, dried (Na2SO4), filtered, 
and concentrated in vacuo to afford crude product (0.66 g, ca. 95%). Rf = 0.00 (20% 
EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) δ 12.25 (s, 1H), 7.65 – 7.06 (m, 3H); LRMS 
(ESI-) m/z: [ion] (rel. int. %) 315.8 [M-H]
-
 (59), 317.8 [M-H+2]
-
 (100), 319.8 [M-H+4]
-
 (48). 
Spectroscopic data provided on p. 285–286. 
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Preparation of 5-Bromoindole-2-carboxylic acid (S39): 
 
 
4-Bromophenylhydrazine (S36): 
 
The same procedure employed in the synthesis of compound S20 (p. 123) was followed using 
4-bromoaniline (5.25 g, 30.52 mmol, 1.0 eq) in AcOH (20 mL) adding conc. HCl until a thin 
paste was achieved. Subsequently was added NaNO2 (2.34 g, 33.91 mmol, 1.1 eq) in H2O 
(15 mL) and then SnCl2·2H2O (21.25 g, 94.19 mmol, 3.1 eq) in conc. HCl (40 mL). Precipitate 
was collected after 26 h at -4 °C to afford hydrazine S36 as a white solid which recrystallized 
from boiling 1 M HCl(aq) (4.49 g, 66%). LRMS (ESI+) m/z: [ion] (rel. int. %) 186.9 [M+H]
+
 (97), 
188.9 [M+H+2]
+
 (100). Spectroscopic data provided on p. 287. 
 
Hydrazone (S37): 
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The same procedure employed in the synthesis of compound S21 (p. 124) was followed using 
hydrazine S36 (4.47 g, 20.00 mmol, 1.0 eq; p. 132), abs. EtOH (40 mL), 2.4 M H2SO4(aq) 
(2.8 mL), and ethyl pyruvate (2.20 mL, 19.82 mmol, 1.0 eq) stirred under argon at reflux for 
19 h. A cold H2O/Et2O workup afforded the desired crude product from the organic extracts as a 
yellow solid (4.96 g, ca. 87%). No further purification was required for next step. E/Z isomers 
Rf = 0.44 & 0.75 (100% CH2Cl2); LRMS (ESI-) m/z: [ion] (rel. int. %) 282.9 [M-H]
-
 (97), 284.9 
[M-H+2]
-
 (99). Spectroscopic data provided on p. 288 
 
Ethyl 5-Bromoindole-2-carboxylate (S38): 
 
The same procedure employed in the synthesis of compound S22 (p. 124) was followed using 
S37 (4.92 g, 17.26 mmol, 1.0 eq; p. 132) in PPA (21.68 g) heated to 105 °C for 30 min. An 
EtOAc/H2O workup afforded S38 as a brown solid (4.86 g, quant). Rf = 0.60 (20% 
EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3) δ 9.36 (s, 1H), 7.83 (d, J = 1.7 Hz, 1H), 7.40 (dd, 
J = 8.8, 1.9 Hz, 1H), 7.32 (d, J = 8.8 Hz, 1H), 7.16 (d, J = 1.2 Hz, 1H), 4.44 (q, J = 7.1 Hz, 2H), 
1.43 (t, J = 7.1 Hz, 3H); LRMS (ESI+) m/z: [ion] (rel. int. %) 268.0 [M+H]
+
 (100), 270.0 
[M+H+2]
+
 (96). Spectroscopic data provided on p. 289–290. 
 
5-Bromoindole-2-carboxylic acid (S39): 
 
The same procedure employed for the synthesis of S29 (p. 128) was followed using carboxylate 
S38 (4.77 g, 17.79 mmol, 1.0 eq; p. 133), THF (200 mL), H2O (22 mL), LiOH·H2O (2.21 g, 
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52.62 mmol, 3.0 eq) stirring under air at reflux for 19 h. The solution was then cooled to RT and 
concentrated in vacuo. H2O (300 mL) was added and then acidified with 6 M HCl(aq) and 
extracted with EtOAc (3 x 75 mL). Organic extracts were combined, dried (Na2SO4), filtered, 
and concentrated in vacuo to afford crude product (3.37 g, ca. 79%). Rf = 0.00 (20% 
EtOAc/Hexanes); 
1H NMR (400 MHz, DMSO) δ 13.08 (s, 1H), 11.95 (s, 1H), 7.85 (d, J = 1.6 
Hz, 1H), 7.35 (dt, J = 8.8, 5.3 Hz, 2H), 7.05 (d, J = 2.0 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. 
%) 237.8 [M-H]
-
 (100), 239.8 [M-H+2]
-
 (99). Spectroscopic data provided on p. 291–292. 
 
Preparation of 5-Chloroindole-2-carboxylic acid (S44): 
 
 
4-Chlorophenylhydrazine (S41): 
 
The same procedure employed in the synthesis of compound S20 (p. 123) was followed using 
4-chloroaniline (4.01 g, 31.43 mmol, 1.0 eq) in AcOH (20 mL) adding conc. HCl until a thin 
paste was achieved. Subsequently was added NaNO2 (2.40, 34.78 mmol, 1.1 eq) in H2O (15 mL) 
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and then SnCl2·2H2O (21.54 g, 80.23 mmol, 2.6 eq) in conc. HCl (40 mL). Precipitate was 
collected after 20 h at -4 °C to afford hydrazine S41 as a white solid (4.10 g, 73%) which was 
directly engaged in the next reaction without further purification. NOTE: Hydrazine S41 
decomposes readily at RT in the presence of light! 
 
Hydrazone (S42): 
 
The same procedure employed in the synthesis of compound S21 (p. 124) was followed using 
hydrazine S41 (4.10 g, 22.91 mmol, 1.0 eq; p. 134), abs. EtOH (46 mL), 2.4 M H2SO4(aq) 
(3.0 mL), and ethyl pyruvate (2.50 mL, 22.53 mmol, 1.0 eq) stirred under argon at reflux for 
19 h. A cold H2O/Et2O workup afforded the desired crude product from the organic extracts as a 
yellow solid (4.26 g, 77%). No further purification was required for next step. E/Z isomers 
Rf = 0.44 & 0.77 (20% EtOAc/Hexanes); LRMS (ESI-) m/z: [ion] (rel. int. %) 210.8 [M-C2H5]
-
 
(99), 212.8 [M-C2H5+2]
-
 (34), 238.8 [M-H]
-
 (100), 240.8 [M-H+2]
-
 (33). Spectroscopic data 
provided on p. 293. 
 
Ethyl 5-Chloroindole-2-carboxylate (S43): 
 
The same procedure employed in the synthesis of compound S22 (p. 124) was followed using 
S42 (4.29 g, 19.18 mmol, 1.0 eq; p. 135) in PPA (24.50 g) heated to 105 °C for 30 min. An 
EtOAc/H2O workup afforded S43 as a brown solid (4.13 g, 96%). Rf = 0.55 (20% 
EtOAc/Hexanes); 
1H NMR (400 MHz, CDCl3) δ 9.30 (s, 1H), 7.66 (d, J = 1.9 Hz, 1H), 7.36 (d, 
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J = 8.8 Hz, 1H), 7.28 – 7.25 (m, 1H), 7.16 (dd, J = 2.0, 0.8 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H), 
1.43 (t, J = 7.1 Hz, 3H); LRMS (ESI+) m/z: [ion] (rel. int. %) 224.0 [M+H]
+
 (100), 226.0 
[M+H+2]
+
 (34). Spectroscopic data provided on p. 294–295. 
 
5-Chloroindole-2-carboxylic acid (S44): 
 
The same procedure employed for the synthesis of S29 (p. 128) was followed using carboxylate 
S43 (4.08 g, 18.24 mmol, 1.0 eq; p. 135), THF (300 mL), H2O (33 mL), LiOH·H2O (2.19 g, 
52.14 mmol, 2.9 eq) stirring under air at reflux for 17 h. The solution was then cooled to RT and 
concentrated in vacuo. H2O (300 mL) was added and then acidified with 6 M HCl(aq) and 
extracted with EtOAc (3 x 75 mL). Organic extracts were combined, dried (Na2SO4), filtered, 
and concentrated in vacuo to afford crude product (2.92 g, ca. 82%). Purification was achievable 
via isocratic flash column chromatography (40% EtOAc/Hexanes) and subsequent 
recrystallization from hot EtOAc. Rf = 0.00 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, 
DMSO) δ 13.12 (s, 1H), 11.94 (s, 1H), 7.70 (d, J = 1.7 Hz, 1H), 7.43 (d, J = 8.8 Hz, 1H), 7.23 
(dd, J = 8.8, 2.0 Hz, 1H), 7.05 (d, J = 1.3 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 193.9 
[M-H]
-
 (100), 195.9 [M-H+2]
-
 (37). Spectroscopic data provided on p. 296–297. 
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Preparation of 3-(4-Bromophenyl)indazole (104): 
 
 
Bromo oxime (S46): 
 
Using an adapted method of Counceller et al.
142
 and Leroux et al.,
143
 a solution of 2-amino-4'-
bromobenzophenone (634.0 mg, 2.30 mmol, 1.0 eq), NH2OH·HCl (1.59 g, 22.88 mmol, 
10.0 eq), MeOH (16 mL), and pyridine (16 mL) were stirred under argon are reflux for 24 h. 
Thereafter, the reaction was cooled to RT and concentrated in vacuo. To the residue was added 
EtOAc (150 mL) and washed with 1 M HCl(aq) (3 x 50 mL). The organic layer was subsequently 
dried (Na2SO4), filtered, and concentrated in vacuo to afford a crude mixture of E/Z product 
isomers (594.1 mg, ca. 89%). Crude isomers were directly engaged in next reaction without 
further purification. E/Z isomers Rf = 0.30 & 0.38 (15% acetone/CHCl3); LRMS (ESI-) m/z: 
[ion] (rel. int. %) 288.8 [M-H]
-
 (100), 290.8 [M-H+2]
-
 (99). Spectroscopic data provided on 
p. 298. 
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3-(4-Bromophenyl)indazole (104): 
 
Using an adapted method of Counceller et al.,
142
 Et3N (0.56 mL, 4.03 mmol, 2.0 eq) and MsCl 
(0.20 mL, 2.58 mmol, 1.3 eq) were added to a solution of anhydrous CH2Cl2 (30 mL) and oxime 
S46 (594.0 mg, 2.04 mmol, 1.0 eq; p. 137) under argon at 0 °C. The reaction was left in the 
cooling bath to warm gradually to RT overnight (16 h). The solvent was subsequently removed 
in vacuo and chromatographic purification (5% acetone/CHCl3) afforded the desired product 
(103.4 mg, 19%). Rf = 0.27 (5% acetone/CHCl3); 
1
H NMR (400 MHz, CDCl3) δ 12.30 (s, 1H), 
7.97 (d, J = 8.2 Hz, 1H), 7.90 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.42 – 7.33 (m, 1H), 
7.29 – 7.21 (m, 1H), 7.18 (d, J = 8.4 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 144.51, 141.73, 
132.47, 132.18, 129.23, 127.06, 122.37, 121.69, 120.78, 120.71, 110.45; DEPT-135 (101 MHz, 
CDCl3) δ 132.18, 129.23, 127.06, 121.69, 120.78, 110.45; ); LRMS (ESI-) m/z: [ion] (rel. int. %) 
270.8 [M-H]
-
 (99), 272.8 [M-H+2]
-
 (100). Elemental Analysis Calcd for C13H9BrN2: C, 57.17; 
H, 3.32; N, 10.26. Found: C, 56.96; H, 3.13; N, 10.20. Spectroscopic data provided on p. 299–
302. 
 
Preparation of 5-Chloro-3-phenylindazole (103): 
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Chloro oxime (S48): 
 
The same procedure employed for the synthesis of S46 (p. 137) was followed using 2-amino-5-
chlorobenzophenone (10.04 g, 43.33 mmol, 1.0 eq), NH2OH·HCl (12.50 g, 179.86 mmol, 
4.2 eq), MeOH (120 mL), and pyridine (54 mL). Isolation and chromatographic purification 
(15% acetone/CHCl3) afforded mixture of E/Z isomers (6.36 g, 59%) which were directly 
engaged in the next reaction without further purification. E/Z isomers Rf = 0.29 & 0.37 (15% 
acetone/CHCl3); LRMS (ESI-) m/z: [ion] (rel. int. %) 244.9 [M-H]
-
 (100), 246.8 [M-H+2]
-
 (28). 
Spectroscopic data provided on p. 303. 
 
5-Chloro-3-phenylindazole (103): 
 
The same procedure employed for the synthesis of indazole 104 (p. 138) was followed using 
oxime S48 (488.2 mg, 1.98 mmol, 1.0 eq), anhydrous CH2Cl2 (40 mL), Et3N (0.55 mL, 
3.96 mmol, 2.0 eq), and MsCl (0.18 mL, 2.33 mmol, 1.2 eq). Chromatographic purification (5% 
acetone/CHCl3) afforded pure indazole 103 (27.0 mg, 6.0%). Rf = 0.34 (15% acetone/CHCl3); 
1
H 
NMR (400 MHz, CDCl3) δ 12.59 (s, 1H), 7.98 (dd, J = 5.8, 1.5 Hz, 3H), 7.58 (dd, J = 11.4, 4.4 
Hz, 2H), 7.54 – 7.48 (m, 1H), 7.28 – 7.22 (m, 1H), 6.89 (d, J = 8.9 Hz, 1H); 13C NMR (101 
MHz, CDCl3) δ 145.39, 140.27, 133.01, 129.39, 128.78, 127.99, 127.78, 127.25, 121.89, 120.35, 
111.83; DEPT-135 (101 MHz, CDCl3) δ 129.23, 128.63, 127.82, 127.62, 120.19, 111.67; LRMS 
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(ESI+) m/z: [ion] (rel. int. %) 229.0 [M+H]
+
 (100), 231.0 [M+H+2]
+
 (34). Spectroscopic data 
provided on p. 304–307. 
 
Preparation of 3-Phenylindazole (102): 
 
 
Aminophenyl oxime (S50): 
 
The same procedure employed for the synthesis of S46 (p. 137) was followed using 2-amino-3-
phenylbenzophenone (5.00 g, 25.35 mmol, 1.0 eq), NH2OH·HCl (17.88 g, 257.27 mmol, 5.9 eq), 
MeOH (176 mL), and pyridine (176 mL). Isolation and chromatographic purification (15% 
acetone/CHCl3) afforded mixture of E/Z isomers (6.49 g, 71%) which were directly engaged in 
the next reaction without further purification. E/Z isomers Rf = 0.27 & 0.36 (15% 
acetone/CHCl3). 
 
3-Phenylindazole (102): 
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The same procedure employed for the synthesis of indazole 104 (p. 138) was followed using 
oxime S50 (6.10 g, 28.75 mmol, 1.0 eq; p. 140), anhydrous CH2Cl2 (200 mL), Et3N (8.0 mL, 
57.56 mmol, 2.0 eq), and MsCl (2.9 mL, 37.47 mmol, 1.3 eq). Chromatographic purification 
(40% EtOAc/Hexanes) afforded pure indazole 102 (400.1 mg, 7.1%). Rf = 0.41 (40% 
EtOAc/Hexanes); 
1H NMR (400 MHz, CDCl3) δ 11.63 (s, 1H), 8.05 (dd, J = 5.2, 3.2 Hz, 3H), 
7.57 (dd, J = 10.3, 4.7 Hz, 2H), 7.48 (ddd, J = 7.4, 3.9, 1.2 Hz, 1H), 7.41 – 7.34 (m, 1H), 7.31 – 
7.20 (m, 2H); 
13C NMR (101 MHz, CDCl3) δ 145.62, 141.78, 133.67, 129.11, 128.27, 127.96, 
126.78, 121.32, 121.01, 120.95, 110.58; DEPT-135 (101 MHz, CDCl3) δ 129.11, 128.28, 
127.96, 126.78, 121.32, 121.01, 110.59; LRMS (ESI-) m/z: [ion] (rel. int. %) 193.0 [M-H]
-
 (100). 
Elemental Analysis Calcd for C13H10N2: C, 80.39; H, 5.19; N, 14.42. Found: C, 79.14; H, 4.97; 
N, 14.18. Spectroscopic data provided on p. 308–311. 
 
General Procedure for Suzuki Cross-Coupling: 
 
 
Using an adapted method of Kawasaki et al.,
144
 a typical experimental procedure for the Suzuki 
cross-coupling was as follows: a mixture of 3-iodoindole (1.1 mmol, 1 eq), arylboronic acid (1.8 
mmol, 1.6 eq), MeOH (6 mL), benzene (6 mL), sat. aq. NaHCO3 (6 mL) and Pd(PPh3)4 (139.0 
mg, 0.12 mmol, 0.1 eq) was refluxed under argon for 14 h. After cooling to RT, the reaction was 
extracted with EtOAc (3 x 20 mL). The combined organic extracts were dried over Na2SO4, 
 142 
filtered, and concentrated in vacuo. Purification of the resulting crude residue by silica gel flash 
column chromatography (20% EtOAc/Hexanes) gave a mixture of 3-unsubstituted indole and the 
desired 3-arylindole. Further purification using semi-preparative C18 reversed phase HPLC 
(35% H2O/MeCN → 100% MeCN) gave pure 3-arylindole (5–25%), which was then ready for 
biological assay. 
 
4,6-Dichloro-3-(2,4-difluorophenyl)indole (70): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
2,4-difluorophenylboronic acid. Rf = 0.28 (25% EtOAc/Hexanes; stains violet with 
p-anisaldehyde); 
1H NMR (500 MHz, CDCl3) δ 8.31 (s, 1H), 7.38 (dt, J = 14.7, 7.5 Hz, 1H), 
7.28 (t, J = 4.3 Hz, 1H), 7.17 (dd, J = 3.6, 2.0 Hz, 2H), 7.05 – 6.86 (m, 2H); 13C NMR (126 
MHz, CDCl3) δ 163.65, 163.55, 162.08, 161.99, 161.67, 161.58, 160.11, 160.02, 137.07, 133.75, 
133.72, 133.68, 133.64, 128.17, 126.88, 125.51, 122.75, 121.72, 118.61, 118.58, 118.48, 118.45, 
110.78, 110.64, 110.61, 110.47, 110.44, 110.23, 103.79, 103.58, 103.38; DEPT-135 (126 MHz, 
CDCl3) δ 133.75, 133.72, 133.68, 133.64, 125.52, 121.72, 110.64, 110.61, 110.48, 110.45, 
110.23, 103.79, 103.58, 103.38; LRMS (ESI-) m/z: [ion] (rel. int. %) 295.9 [M-H]
-
 (100), 297.8 
[M-H+2]
-
 (78). Spectroscopic data provided on p. 312–315. 
 
  
 143 
4,6-Dichloro-3-(4-chlorophenyl)indole (32): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
4-chlorophenylboronic acid. Rf = 0.30 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.32 (s, 1H), 7.43 (d, J = 8.5 Hz, 2H), 7.38 (d, J = 8.5 Hz, 2H), 
7.30 (d, J = 1.5 Hz, 1H), 7.17 (d, J = 1.5 Hz, 1H), 7.14 (d, J = 2.4 Hz, 1H); 
13
C NMR (101 MHz, 
CDCl3) δ 137.36, 132.95, 132.79, 132.12, 128.07, 127.67, 126.84, 124.99, 121.92, 121.80, 
118.00, 110.21; DEPT-135 NMR (101 MHz, CDCl3) δ 132.12, 127.67, 124.99, 121.80, 110.21; 
LRMS (ESI-) m/z: [ion] (rel. int. %) 293.8 [M-H]
-
 (100), 295.9 [M-H+2]
-
 (100); HRMS 
(ESI-TOF); calcd for C14H7Cl3N
-
 [M-H
+
]: 293.9644, found 293.9628. Spectroscopic data 
provided on p. 316–319. 
 
4,6-Dichloro-3-(2-chlorophenyl)indole (74): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
2-chlorophenylboronic acid. Rf = 0.28 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 7.50 (dd, J = 7.7, 1.1 Hz, 1H), 7.42 (dd, J = 7.1, 1.9 
Hz, 1H), 7.39 – 7.25 (m, 3H), 7.16 (d, J = 2.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 136.83, 
135.82, 133.73, 133.12, 128.97, 128.86, 128.09, 127.07, 125.98, 124.99, 122.97, 121.53, 115.70, 
110.15; DEPT-135 NMR (101 MHz, CDCl3) δ 133.12, 128.97, 128.86, 125.98, 124.99, 121.53, 
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110.15; LRMS (ESI-) m/z: [ion] (rel. int. %) 293.9 [M-H]
-
 (100), 295.9 [M-H+2]
-
 (98). 
Elemental Analysis Calcd for C14H8Cl3N: C, 56.70; H, 2.72; N, 4.72. Found: C, 55.98; H, 2.48; 
N, 4.65. Spectroscopic data provided on p. 320–323. 
 
4,6-Dichloro-3-(4-(trifluoromethyl)phenyl)indole (69): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
2-chlorophenylboronic acid. Rf = 0.27 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (500 MHz, CDCl3) δ 8.38 (s, 1H), 7.68 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 8.1 Hz, 2H), 
7.36 (d, J = 1.4 Hz, 1H), 7.22 (dd, J = 10.5, 1.9 Hz, 2H); 
13C NMR (126 MHz, CDCl3) δ 138.25, 
138.24, 137.44, 130.99, 128.91, 128.65, 128.33, 126.84, 125.61, 125.25, 124.44, 124.41, 124.38, 
124.35, 123.45, 122.02, 121.81, 118.04, 110.24; DEPT-135 (126 MHz, CDCl3) δ 130.99, 
125.26, 124.44, 124.41, 124.38, 124.35, 122.02, 110.24; LRMS (ESI-) m/z: [ion] (rel. int. %) 
327.9 [M-H]
-
 (100), 329.9 [M-H+2]
-
 (59). Elemental Analysis Calcd for C15H8Cl2F3N: C, 54.57; 
H, 2.44; N, 4.24. Found: C, 54.37; H, 2.26; N, 4.19. Spectroscopic data provided on p. 324–327. 
 
3-(4-Bromophenyl)-4,6-dichloroindole (71): 
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Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
4-bromophenylboronic acid. Rf = 0.24 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (500 MHz, CDCl3) δ 8.32 (s, 1H), 7.54 (d, J = 7.9 Hz, 2H), 7.35 (dd, J = 32.8, 16.8 Hz, 
3H), 7.18 (s, 2H); 
13C NMR (126 MHz, CDCl3) δ 137.38, 133.41, 132.45, 130.62, 128.17, 
126.92, 124.84, 121.88, 121.00, 118.12, 110.17; DEPT-135 (126 MHz, CDCl3) δ 132.45, 
130.62, 124.85, 121.87, 110.17; LRMS (ESI-) m/z: [ion] (rel. int. %) 337.8 [M-H]
-
 (26), 339.8 
[M-H+2]
-
 (100). Spectroscopic data provided on p. 328–331. 
 
4,6-Dichloro-3-(4-fluorophenyl)indole (54): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
4-fluorophenylboronic acid. Rf = 0.22 (10% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.31 (s, 1H), 7.50 – 7.42 (m, 2H), 7.31 (d, J = 1.7 Hz, 1H), 7.17 
(d, J = 1.7 Hz, 1H), 7.14 (d, J = 2.5 Hz, 1H), 7.11 (ddd, J = 9.6, 5.9, 2.5 Hz, 2H); 
13
C NMR (126 
MHz, CDCl3) δ 163.15, 161.20, 137.31, 132.44, 132.38, 130.41, 130.39, 127.98, 126.88, 124.91, 
122.09, 121.71, 118.13, 114.49, 114.32, 110.20; DEPT-135 (126 MHz, CDCl3) δ 132.44, 
132.38, 124.92, 121.71, 114.49, 114.32, 110.20; LRMS (ESI-) m/z: [ion] (rel. int. %) 277.9 [M-
H]
-
 (100), 279.9 [M-H+2]
-
 (87). Spectroscopic data provided on p. 332–335. 
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4,6-Dichloro-3-(3-chlorophenyl)indole (55): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
3-chlorophenylboronic acid. Rf = 0.37 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.48 (s, 1H), 7.39 – 7.35 (m, 1H), 7.32 (dd, J = 6.3, 
1.8 Hz, 3H), 7.16 (dd, J = 6.1, 2.0 Hz, 2H); LRMS (ESI-) m/z: [ion] (rel. int. %) 293.8 [M-H]
-
 
(100), 295.8 [M-H+2]
-
 (99). Spectroscopic data provided on p. 336–337. 
 
4,6-Dichloro-3-(3,4-dichlorophenyl)indole (72): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and 
3,4-dichlorophenylboronic acid. Rf = 0.27 (25% EtOAc/Hexanes; stains violet with 
p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 7.57 (d, J = 2.0 Hz, 1H), 7.44 (d, J 
= 8.2 Hz, 1H), 7.31 (dd, J = 7.8, 1.8 Hz, 2H), 7.16 (dd, J = 5.4, 2.1 Hz, 2H); 
13
C NMR (101 
MHz, CDCl3) δ 137.33, 134.57, 132.35, 131.35, 130.80, 130.26, 129.35, 128.29, 126.68, 125.20, 
121.98, 121.68, 116.88, 110.29; DEPT-135 (101 MHz, CDCl3) δ 132.34, 130.25, 129.34, 
125.18, 121.97, 110.28; ); LRMS (ESI-) m/z: [ion] (rel. int. %) 327.9 [M-H]
-
 (62), 329.8 [M-
H+2]
-
 (100). Elemental Analysis Calcd for C14H7Cl4N: C, 50.80; H, 2.13; N, 4.23. Found: C, 
50.40; H, 1.94; N, 4.16. Spectroscopic data provided on p. 338–341. 
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3-(2,4-Bis(trifluoromethyl)phenyl)-4,6-bis(trifluoromethyl)indole (73): 
 
Prepared by the general procedure described on p. 141 using bis(trifluoromethyl)indole S10 
(p. 112) and 2,4-bis(trifluoromethyl)phenylboronic acid. Rf = 0.29 (25% EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) δ 12.49 (s, 1H), 8.17 (s, 1H), 8.11 (s, 1H), 8.08 (d, J = 8.2 Hz, 1H), 
7.88 (s, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.64 (s, 1H); DEPT-135 (101 MHz, DMSO) δ 136.40, 
132.32, 131.98, 129.26, 129.14, 128.50, 122.77, 114.58; LRMS (ESI-) m/z: [ion] (rel. int. %) 
463.9 [M-H]
-
 (100). Spectroscopic data provided on p. 342–344. 
 
4,6-Dibromo-3-(4-bromophenyl)indole (64): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and 
4-bromophenylboronic acid. Rf = 0.37 (20% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1
H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 7.57 – 7.43 (m, 4H), 7.33 (d, J = 8.3 Hz, 2H), 7.16 
(d, J = 2.4 Hz, 1H); 
13C NMR (101 MHz, CDCl3) δ 137.41, 133.15, 132.96, 130.46, 127.46, 
125.03, 123.72, 121.18, 118.78, 115.50, 114.84, 113.62; LRMS (ESI-) m/z: [ion] (rel. int. %) 
425.6 [M-H]
-
 (31), 427.6 [M-H+2]
-
 (98), 429.6 [M-H+4]
-
 (100), 431.5 [M-H+6]
-
 (33). Elemental 
Analysis Calcd for C14H8Br3N: C, 39.11; H, 1.88; N, 3.26. Found: C, 39.14; H, 1.63; N, 3.20. 
Spectroscopic data provided on p. 345–348. 
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4,6-Dibromo-3-(2-bromophenyl)indole (65): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and 
2-bromophenylboronic acid. Rf = 0.31 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.65 (d, J = 7.9 Hz, 1H), 7.53 (d, J = 1.3 Hz, 1H), 
7.45 (dd, J = 11.3, 1.3 Hz, 1H), 7.39 (dd, J = 7.5, 1.6 Hz, 1H), 7.33 (t, J = 7.4 Hz, 1H), 7.29 – 
7.21 (m, 1H), 7.16 (d, J = 2.4 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 425.6 [M-H]
-
 (33), 
427.7 [M-H+2]
-
 (100), 429.7 [M-H+4]
-
 (99), 431.5 [M-H+6]
-
 (30). Elemental Analysis Calcd for 
C14H8Br3N: C, 39.11; H, 1.88; N, 3.26. Found: C, 39.78; H, 1.81; N, 3.22. Spectroscopic data 
provided on p. 349–350. 
 
4,6-Dibromo-3-phenylindole (68): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and 
phenylboronic acid. Rf = 0.30 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1
H NMR (400 MHz, CDCl3) δ 8.32 (s, 1H), 7.73 – 7.64 (m, 1H), 7.54 (d, J = 1.5 Hz, 1H), 7.47 
(dd, J = 7.3, 1.7 Hz, 4H), 7.38 (dd, J = 4.6, 2.5 Hz, 2H), 7.17 (d, J = 2.5 Hz, 1H); LRMS (ESI-) 
m/z: [ion] (rel. int. %) 347.7 [M-H]
-
 (51), 349.8 [M-H+2]
-
 (100), 351.7 [M-H+4]
-
 (51). 
Spectroscopic data provided on p. 351–352.  
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4,6-Dibromo-3-(6-bromopyridin-3-yl)indole (67): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and 
2-bromopyridine-5-boronic acid. Rf = 0.14 (25% EtOAc/Hexanes); 
1
H NMR (400 MHz, DMSO) 
δ 11.96 (s, 1H), 8.42 (d, J = 2.5 Hz, 1H), 8.30 (s, 1H), 7.80 (dd, J = 8.1, 2.3 Hz, 1H), 7.70 (d, J = 
0.9 Hz, 1H), 7.68 – 7.61 (m, 2H), 7.42 (d, J = 1.0 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 
426.8 [M-H]
-
 (32), 428.7 [M-H+2]
-
 (98), 430.7 [M-H+4]
-
 (100); 432.7 [M-H+6]
-
 (35). Elemental 
Analysis Calcd for C13H7Br3N2: C, 36.23; H, 1.64; N, 6.50. Found: C, 36.53; H, 1.44; N, 6.35. 
Spectroscopic data provided on p. 353–354. 
 
4,6-Dinitro-3-(3-nitrophenyl)indole (87): 
 
Prepared by the general procedure described on p. 141 using N-Boc-indole 86 (p. 121) and 
3-nitrophenylboronic acid. 
1
H NMR (400 MHz, DMSO) δ 12.89 (s, 1H), 8.97 (d, J = 1.9 Hz, 
1H), 8.80 (d, J = 1.9 Hz, 1H), 8.44 (t, J = 1.8 Hz, 1H), 8.25 (s, 1H), 8.22 – 8.13 (m, 2H), 7.78 (t, 
J = 8.0 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 326.9 [M-H]
-
 (100). Spectroscopic data 
provided on p. 355–356. 
 
  
 150 
6-Chloro-3-(4-chlorophenyl)indole (S52): 
 
N-Boc-3-iodo-6-chloroindole S51 was first prepared from 6-chloroindole 79 (p. 116) using the 
previously described methods for iodination and Boc-protection (p. 105–106). 3-Phenylindole 
S52 was then prepared by the general procedure described on p. 141 using S51 and 
4-chlorophenylboronic acid. Rf = 0.32 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde); 
1H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.78 (d, J = 8.6 Hz, 1H), 7.56 (d, J = 8.5 Hz, 2H), 
7.43 (d, J = 8.1 Hz, 3H), 7.34 (d, J = 2.5 Hz, 1H), 7.18 (dd, J = 8.6, 1.7 Hz, 1H); 
13
C NMR (101 
MHz, CDCl3) δ 136.97, 133.41, 131.98, 128.98, 128.60, 128.53, 124.19, 122.34, 121.25, 120.48, 
117.45, 111.39; DEPT-135 (101 MHz, CDCl3) δ 128.98, 128.60, 122.34, 121.25, 120.48, 
111.39; LRMS (ESI-) m/z: [ion] (rel. int. %) 259.8 [M-H]
-
 (100), 261.8 [M-H+2]
-
 (68). 
Elemental Analysis Calcd for C14H9Cl2N: C, 64.15; H, 3.46; N, 5.34. Found: C, 63.56; H, 3.25; 
N, 5.24. Spectroscopic data provided on p. 357–360. 
 
Ethyl 4,6-dichloro-3-(4-bromophenyl)indole-2-carboxylate (109): 
 
Prepared by the general procedure described on p. 141 using carboxylate S28 (p. 128) and 
4-bromophenylboronic acid. Rf = 0.32 (25% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3) 
δ 9.13 (s, 1H), 7.53 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 1.5 Hz, 1H), 7.26 (d, J = 8.8 Hz, 3H), 7.13 
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(d, J = 1.5 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 1.13 (t, J = 7.1 Hz, 3H); DEPT-135 (400 MHz, 
CDCl3) δ 133.06, 130.53, 123.07, 110.78, 61.47, 13.92; ; LRMS (ESI-) m/z: [ion] (rel. int. %) 
409.7 [M-H]
-
 (29), 411.7 [M-H+2]
-
 (100) , 413.7 [M-H+4]
-
 (10). Elemental Analysis Calcd for 
C17H12BrCl2NO2: C, 49.43; H, 2.93; N, 3.39. Found: C, 49.19; H, 2.75; N, 3.32. Spectroscopic 
data provided on p. 361–363. 
 
Ethyl 4,6-dibromo-3-(4-bromophenyl)indole-2-carboxylate (112): 
 
Prepared by the general procedure described on p. 141 using carboxylate S23 (p. 125) and 
4-bromophenylboronic acid. Rf = 0.37 (25% EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 
12.44 (s, 1H), 7.69 (s, 1H), 7.54 (d, J = 8.2 Hz, 2H), 7.42 (s, 1H), 7.26 (d, J = 8.2 Hz, 2H), 4.11 
(q, J = 7.0 Hz, 2H), 1.02 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, DMSO) δ 160.92, 137.79, 
133.95, 133.33, 130.25, 127.29, 126.37, 123.99, 122.15, 121.16, 117.62, 116.09, 115.34, 61.03, 
14.11; LRMS (ESI-) m/z: [ion] (rel. int. %) 497.7 [M-H]
-
 (32), 499.7 [M-H+2]
-
 (98), 501.7 [M-
H+4]
-
 (100), 503.7 [M-H+6]
-
 (32); HRMS (ESI-TOF); calcd for C17H11Br3NO2
-
 [M-H
+
]: 
497.8340, found 497.8338. Elemental Analysis Calcd for C17H12Br3NO2: C, 40.67; H, 2.41; N, 
2.79. Found: C, 41.14; H, 2.42; N, 2.65. Spectroscopic data provided on p. 364–366. 
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 166 
APPENDIX A 
MYCELIAL GROWTH TEST RESULTS
 167 
For the purpose of data interpretation the following structures and code names are 
provided for Appendix A. 
These compounds were submitted to David Wedge at the USDA-ARS for analysis in his 
mycelial growth test (described on p. 66). All compounds were compared against known 
fungicides, 6-OH-BDE-47 and captan. Purity was questionable of all compounds except for 6-
OH-BDE-47 and captan; namely because this particular assay was (1) executed before full 
understanding of the dehalogenation problem was appreciated (p. 43) and (2) because these 
compounds were not HPLC purified. Based on TLC and NMR data, impurities could easily have 
accounted for as much as 50% of the sample weight in some cases. The graphical biological data 
is presented hereafter on the following page. Inhibition is the desirable characteristic to note in 
the following graphs. 
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HUMAN PATHOGEN ASSAY RESULTS
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APPENDIX C 
PLANT ASSAY DATA PROVIDED 
BY SYNGENTA CROP PROTECTION, INC.
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Materials & Methods 
Methodology All testing was carried out in 96-well plates. 
 
Herbicide assays: Compounds were tested for herbicidal activity against Arabidopsis thaliana at 
10ppm and Poa annua at 32ppm. Test plates were stored for seven days in a controlled environment 
cabinet. Scores were given as 0 or 99, where 99 is any herbicidal effect, and 0 is no effect.  
 
Test species Treatment timing Rate (ppm) 
Arabidopsis thaliana Pre emergence 10 
Poa annua Pre emergence 32 
 
Insecticide assays:  The compounds were tested for activity against an aphid species in a leaf-disc 
assay at 1000ppm. The compounds were also evaluated at a rate of 500ppm on Plutella xylostella in 
an artificial diet assay and against the nematode species Caenorhabditis elegans in liquid culture at 
10ppm. Chemicals were applied to feeding aphids, prior to infestation with P. xylostella larvae, or 
diluted into the C. elegans culture. 
 
Mortality was assessed relative to control wells using a 2 band system (0 or 99 where 99 is 
significant mortality, and 0 is no significant effect), 5-9d after the treatments depending on the assay. 
C. elegans were also assessed for symptomology. 
 
Test species Treatment type Media Rate (ppm) 
Aphid species Feeding/contact leaf disc 1000 
Plutella xylostella Feeding/contact Artificial diet 500 
Caenorhabditis elegans Feeding/contact Liquid culture 10 
Fungicide assays:   Compounds were evaluated in mycelial growth tests in artificial media against 
Pythium dissimile, Alternaria solani, Botryotinia fuckeliana and Gibberella zeae, at rates of 20ppm 
and 2ppm. 
Test species Media Rate (ppm) 
Pythium dissimile Semi-solid 20 and 2 
Alternaria solani Semi-solid 20 and 2 
Botryotinia fuckeliana Semi-solid 20 and 2 
Gibberella zeae Semi-solid 20 and 2 
 
Leaf-piece assays were also conducted. The compounds were evaluated at 100ppm against Septoria 
tritici on wheat, and 200ppm and 60ppm for Phytophthora infestans on tomato and 100ppm for 
Uromyces viciae-fabae on bean.  Chemicals were applied prior to inoculation in the leaf-piece 
assays.   
Test species Host Rate (ppm) 
Septoria tritici Wheat 100 
Phytophthora infestans Tomato 200 and 60 
Uromyces viciae-fabae Bean 100 
 
Mycelial growth or disease inhibition was assessed visually and scored using a 3 band system (0, 55 
and 99 where 99 is total inhibition of hyphal growth/disease development, 55 is partial inhibition, 
and 0 is no inhibition), 4-14d after inoculation depending on the assay. 
 
Positive controls: Positive control compounds were included in each test (Azoxystrobin and 
Prochloraz for fungicide assays, Thiamethoxam and Indoxacarb for insecticide assays and 
Norflurazon for herbicide assays, all applied at rates).  
In all cases, data were recorded and averaged across replicates. 
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Table C.1. Syngenta‘s preliminary data from fungicidal assays
 
Fu
n
gi
ci
d
e 
ac
ti
ve
Substance Mississipi ID Rate Rep 1 Rep 2 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg
2High 55 0 27 0 55 0 18 NCH NC 0 0 0 99 99 99 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 55 0 0 18 0 NC 0 0 0 0 0 99 49 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 99 55 0 51 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 55 55 99 69 0 NC 0 0 0 0 55 0 27 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 55 55 36 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 99 0 0 33 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 99 49 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CSAA403019
CSCD763198
CSCD763197
CSCD763196
CSCD763195
CSCD763194
CSCD763193
CSCD763192
CSCD763191
CSCD763190
CSAA577296
FUNGICIDE ASSAYS
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Scores are given for numbered replicates, and average scores 
for the replicates (avg); Scores are                                                                                                                               
99- any herbicide effect (Herbicide assays); >70% mortality 
(Insecticide assays); complete control of pathogen in that 
replicate (Fungicide assays)                                                                            
55- Partial control of pathogen (Fungicide assays only)                                                                 
0- no activity                                                                                                       
NC- data not captured for this replicate (test failure)                                                        
NCH- replicate not assessable because of herbicidal effect on 
leaf-piece                                                                                             
Disease control Disease control Disease control Disease controlDisease control Disease control Disease control
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a
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w
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N
N
N
N
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N
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Table C.1. (continued)
 
Fu
n
gi
ci
d
e 
ac
ti
ve
Substance Mississipi ID Rate Rep 1 Rep 2 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 55 27 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 55 18 0 NC 0 0 0 0 0 55 27 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 55 0 18 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 55 0 0 18 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 99 49 0 0 0 0 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 55 99 51 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2High 0 0 0 0 0 0 0 0 NC 0 0 0 0 0 0 0 0 0 0 0 0 0
1low 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CSCD773306
CSCD763204
CSCD763203
CSCD763202
CSCD763201
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FUNGICIDE ASSAYS
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Scores are given for numbered replicates, and average scores 
for the replicates (avg); Scores are                                                                                                                               
99- any herbicide effect (Herbicide assays); >70% mortality 
(Insecticide assays); complete control of pathogen in that 
replicate (Fungicide assays)                                                                            
55- Partial control of pathogen (Fungicide assays only)                                                                 
0- no activity                                                                                                       
NC- data not captured for this replicate (test failure)                                                        
NCH- replicate not assessable because of herbicidal effect on 
leaf-piece                                                                                             
Disease control Disease control Disease control Disease controlDisease control Disease control Disease control
Se
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Table C.2. Syngenta‘s preliminary data from herbicide, insecticide, & nematicide assays 
  
H
er
b
ic
id
e 
ac
ti
ve
In
sc
ec
ti
ci
d
e 
ac
ti
ve
Substance Mississipi ID Rate Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg
2High 0 0 0 0 0 0 0 99 99 66 0 0 0 0 0 0 0
1low
2High 0 0 0 0 0 0 0 0 0 0 99 99 0 66 99 99 99
1low
2High 0 0 0 0 0 0 99 99 0 66 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 99 99 66 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1low
2High 0 0 0 0 0 0 0 0 99 33 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 0 99 99 66 99 99 99
1low
CSAA403019
CSCD763196
CSCD763195
CSCD763194
CSCD763193
CSCD763192
CSCD763191
CSCD763190
CSAA577296
HERBICIDE ASSAYS
Scores are given for numbered replicates, and average scores 
for the replicates (avg); Scores are                                                                                                                               
99- any herbicide effect (Herbicide assays); >70% mortality 
(Insecticide assays); complete control of pathogen in that 
replicate (Fungicide assays)                                                                            
55- Partial control of pathogen (Fungicide assays only)                                                                 
0- no activity                                                                                                       
NC- data not captured for this replicate (test failure)                                                        
NCH- replicate not assessable because of herbicidal effect on 
leaf-piece                                                                                             
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Table C.2. (continued) 
H
er
b
ic
id
e 
ac
ti
ve
In
sc
ec
ti
ci
d
e 
ac
ti
ve
Substance Mississipi ID Rate Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg
2High 0 0 0 0 0 0 0 99 99 66 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1low
2High 0 0 0 0 0 0 0 0 0 0 99 0 99 66 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1low
2High 0 0 0 0 0 0 0 0 0 0 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1low
2High 99 0 49 0 0 0 0 0 0 0 0 0 0 0 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 99 99 99 99 99 99 99
1low
2High 0 0 0 0 0 0 0 0 0 0 0 99 0 33 0 0 0
1low
CSCD773306
CSCD763204
CSCD763203
CSCD763202
CSCD763201
CSCD763199
CSCD763198
CSCD763197
CSCD763200
Scores are given for numbered replicates, and average scores 
for the replicates (avg); Scores are                                                                                                                               
99- any herbicide effect (Herbicide assays); >70% mortality 
(Insecticide assays); complete control of pathogen in that 
replicate (Fungicide assays)                                                                            
55- Partial control of pathogen (Fungicide assays only)                                                                 
0- no activity                                                                                                       
NC- data not captured for this replicate (test failure)                                                        
NCH- replicate not assessable because of herbicidal effect on 
leaf-piece                                                                                             
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Table C.3. Syngenta‘s fungicide standards 
  
Azoxys trobin rate (ppm) 1 2 avg
Azoxys tro
bin
rate (ppm) 1 2 avg
9 99 99 99 0.09 55 99 77
3 99 99 99 0.03 55 55 55
1 0 0 0 0.01 0 0 0
0.3 0 0 0 0.003 0 0 0
0.1 0 0 0 0.001 0 0 0
0.04 0 0 0 0.0004 0 0 0
0.01 0 0 0 0.0001 0 0 0
0.004 0 0 0 0.00004 0 0 0
0.001 0 0 0 0.00001 0 0 0
Azoxys trobin rate (ppm) 1 2 avg
Azoxys tro
bin
rate (ppm) 1 2 avg
13.5 99 99 99 0.9 55 99 77
4.5 0 0 0 0.3 0 0 0
1.5 0 0 0 0.1 0 0 0
0.5 0 0 0 0.03 0 0 0
0.2 0 0 0 0.01 0 0 0
0.1 0 0 0 0.004 0 0 0
0.02 0 0 0 0.001 0 0 0
0.01 0 0 0 0.0004 0 0 0
0.002 0 0 0 0.0001 0 0 0
Azoxys trobin rate (ppm) 1 2 3 avg
Prochlora
z
rate (ppm) 1 2 avg
4.5 99 99 99 99 16.2 99 99 99
1.5 55 55 55 55 5.4 99 99 99
0.5 0 99 99 66 1.8 99 99 99
0.2 99 0 55 51 0.6 55 0 27
0.1 0 0 0 0 0.2 99 0 49
0.02 0 0 0 0 0.07 99 55 77
0.01 0 0 0 0 0.02 0 0 0
0.002 0 0 0 0
Prochlora
z
rate (ppm) 1 2 avg
0.001 0 0 0 0 1.62 99 99 99
Prochloraz rate (ppm) 1 2 3 avg 0.54 99 99 99
81 99 55 0 51 0.18 0 55 27
27 0 0 0 0 0.06 0 0 0
9 0 55 0 18 0.02 0 0 0
3 0 0 0 0 0.007 0 0 0
1 0 0 0 0 0.002 0 0 0
0.3 0 0 0 0
0.1 0 0 0 0
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Table C.3. (continued) 
  
Azoxys trobin rate (ppm) 1 2 avg Prochloraz rate (ppm) 1 2 avg
4.5 0 99 49 16.2 99 99 99
1.5 99 99 99 5.4 99 99 99
0.5 99 99 99 1.8 99 99 99
0.2 99 99 99 0.6 99 99 99
0.1 99 99 99 0.2 99 99 99
0.02 55 55 55 0.07 0 0 0
0.01 55 0 27 0.02 0 0 0
0.002 0 0 0 Prochloraz rate (ppm) 1 2 avg
0.001 0 0 0 1.62 99 99 99
Prochloraz rate (ppm) 1 2 avg 0.54 99 99 99
81 99 99 99 0.18 99 99 99
27 0 0 0 0.06 0 0 0
9 0 0 0 0.02 0 0 0
3 0 0 0 0.007 0 0 0
1 0 0 0 0.002 0 0 0
0.3 0 0 0 Prochloraz rate (ppm) 1 2 avg
0.1 0 0 0 16.2 99 99 99
Azoxys trobin rate (ppm) 1 2 avg 5.4 99 99 99
0.9 99 99 99 1.8 99 99 99
0.3 99 99 99 0.6 0 0 0
0.1 99 99 99 0.2 0 0 0
0.03 55 55 55 0.07 0 0 0
0.01 0 0 0 0.02 0 0 0
0.004 0 0 0 Prochloraz rate (ppm) 1 2 avg
0.001 0 0 0 1.62 99 99 99
0.0004 0 0 0 0.54 55 55 55
0.0001 0 0 0 0.18 0 0 0
0.06 0 0 0
0.02 0 0 0
0.007 0 0 0
0.002 0 0 0
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Table C.4. Syngenta‘s insecticide standards Table C.5. Syngenta‘s herbicide standards 
Thiamethoxam rate (ppm) 1 2 3 avg Nor flurazon rate (ppm) 1 2 avg
8 99 99 99 99 0.9 99 99 99
4 99 99 99 99 0.3 99 99 99
2 99 99 99 99 0.1 99 99 99
0.5 0 0 0 0 0.03 99 99 99
0.1 0 0 0 0 0.01 99 99 99
Indoxacarb rate (ppm) 1 2 3 avg 0.004 0 0 0
2.5 99 99 99 99 0.001 0 0 0
0.63 99 99 99 99 0.0004 0 0 0
0.16 99 0 0 33 Nor flurazon rate (ppm) 1 2 avg
0.04 0 0 0 0 2.9 99 99 99
0.01 0 0 0 0 1.0 99 99 99
Compound A rate (ppm) 1 2 avg 0.3 99 99 99
10.00 99 0 49 0.1 0 0 0
0.04 0 0 0
0.01 0 0 0
0.004 0 0 0
0.001 0 0 0C
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Results 
Herbicide: None of the compounds were active on either herbicide assay. (Table C.2) 
Insecticide: 12 compounds showed activity on the insecticide screens: CSAA403019 (PDBE1), CSCD763190 (RAS-03-016) and 
CSCD763191 (RAS-03-010)  against the aphid species, and CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016), 
CSCD763191 (RAS-03-010), CSCD763193 (RAS-03-018), CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086), 
CSCD763196 (RAS-08-030), CSCD763197 (RAS-07-018C), CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029) and 
CSCD763204 (RAS-03-066) against P. xylostella. (Table C.2) 
Nematicide: 12 compounds were active on the nematicide assay: CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016), 
CSCD763191 (RAS-03-010), CSCD763193 (RAS-03-018), CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086), 
CSCD763196 (RAS-08-030), CSCD763197 (RAS-07-018C), CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029), 
CSCD763204 (RAS-03-066) and CSCD763203 (RAS-05-006). (Table C.2) 
Fungicide: The following compounds showed weak/moderate activity against Septoria tritici: CSCD763192 (RAS-06-074), 
CSCD763193 (RAS-03-018) and CSCD763204 (RAS-03-066). CSAA403019 (PDBE1), has shown activity at 20ppm against 
Alternaria solani. (Table C.1) 
 
Positive control- The results for positive controls were variable but within acceptable limits. (Table C.3–C.5) 
 
Conclusion 
13 compounds showed activity on the nematicide and/or insecticide assays, and 4 had weak activity on fungicide assays. None 
were active on the herbicide assays.  
 
 
Syngenta’s Recommendations 
The compounds active on fungicide and insecticide assays should be progressed to the fungicide and insecticide second-tier 
assays respectively, and the results of these tests communicated once screening is complete. 
For the following compounds, further fungicide testing should be carried out using the sample remaining at Jealott‘s Hill.   
CSAA403019 (PDBE1), CSCD763192 (RAS-06-074), CSCD763193 (RAS-03-018), CSCD763204 (RAS-03-066). 
 
For the following compounds, further insecticide testing should be carried out using the sample remaining at Jealott‘s Hill.   
CSAA403019 (PDBE1), CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016), CSCD763191 (RAS-03-010), 
CSCD763193 (RAS-03-018), CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086), CSCD763196 (RAS-08-030), 
CSCD763197 (RAS-07-018C), CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029), CSCD763204 (RAS-03-066). 
 
In addition to these tests, further evaluation in mini pouch experiments to evaluate nematode control are recommended in the first 
instance.   
CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016), CSCD763191 (RAS-03-010), CSCD763193 (RAS-03-018), 
CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086), CSCD763196 (RAS-08-030), CSCD763197 (RAS-07-018C), 
CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029), CSCD763204 (RAS-03-066),  CSCD763203 (RAS-05-006),  
 
For the following compounds, additional sample is required to complete these assays (5mg minimum).  
CSCD763196 (RAS-08-030) and CSCD763201 (RAS-08-029)  
 
Depending on the outcome of these experiments, compounds may be recommended for further tested on cell and enzyme based 
assays to detect known modes of action, or in further nematode assays (e.g. soil based test systems).  This testing will be 
dependent on sufficient sample being available, and on approval from University of Mississippi. 
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APPENDIX D 
SPECTRAL DATA
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